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ABSTRACT 
  
Accumulating evidence suggests that quinolinic acid has a role to play in disorders 
involving impairment of learning and memory. In the present study, the effect of the 
guanosine analogue antiherpetic, acyclovir, on quinolinic acid-induced spatial memory 
deficits was investigated, as well as some of the mechanisms which underlie this effect. 
 
Behavioural studies using a Morris water maze show that post-treatment of rats with 
acyclovir significantly improves spatial memory deficits induced by intrahippocampal 
injections of quinolinic acid. Histological analysis of the hippocampi show that the effect 
of acyclovir is related to its ability to alleviate quinolinic acid-induced necrotic cell death, 
through interference with some of the mechanisms of neurodegeneration. However, 
acyclovir is unable to alter a quinolinic acid-induced increase in glutamate release in the 
rat hippocampus, even though it alleviates quinolinic acid induced oxidative stress by 
scavenging the superoxide anion in vitro and in vivo in whole rat brain and hippocampus 
respectively. Due to the inverse relationship which exists between superoxide anion and 
glutathione levels, acyclovir also curtails the quinolinic acid-induced decrease in 
hippocampal glutathione levels. 
 
Acyclovir suppresses quinolinic acid-induced lipid peroxidation in vitro and in vivo, in 
whole rat brain and hippocampus respectively, through its alleviation of oxidative stress 
and possibly through the binding of iron (II) and / or iron (III), preventing the 
participation and redox recycling of iron (II) in the Fenton reaction, which quinolinic acid 
is thought to enhance by weak binding of ferrous ions. This argument is further 
 iii 
strengthened by the ability of the drug to suppress iron (II)-induced lipid peroxidation in 
vitro directly. Inorganic studies including ultraviolet and visible spectroscopy, 
electrochemistry and the ferrozine assay show that acyclovir binds to iron (II) and iron 
(III) and that quinolinic acid forms an easily oxidisable association with iron (II).  
 
Acyclovir inhibits the endogenous biosynthesis of quinolinic acid by inhibiting the 
activity of liver tryptophan-2,3-dioxygenase, intestinal indoleamine-2,3-dioxygenase and 
rat liver 3-hydroxyanthranillic acid oxygenase in vitro and in vivo, possibly through 
competitive inhibition of haeme, scavenging of superoxide anion and binding of iron (II) 
respectively. An inverse relationship exists between tryptophan-2,3-dioxygenase activity 
and brain serotonin levels. Acyclovir administration in rats induces a rise in forebrain 
serotonin and 5-hydroxyindole acetic acid and reduces the turnover of forebrain serotonin 
to 5-hydroxyindole acetic acid. Furthermore, it shows that acyclovir does not alter 
forebrain norepinephrine levels. The results of the pineal indole metabolism study show 
that acyclovir increases 5-hydroxytryptophol, N-acetylserotonin and the neurohormone 
melatonin, but decreases 5-hydroxyindole acetic acid.  
 
The results of this study show that acyclovir has some neuroprotective properties which 
may make it useful in the alleviation of the anomalous neurobiology in neurodegenerative 
disorders.    
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CHAPTER ONE 
LITERATURE REVIEW 
 
1.1           LEARNING AND MEMORY 
1.1.1.       Introduction 
“Learning has always been a crucial activity in human culture. From a young age, as 
members of society we are expected to learn beliefs, norms of behaviour, skills and facts. 
We even have educational institutions devoted to learning!” (Anderson, 2000). Learning 
can be formally defined as the ability to acquire new knowledge or skills through 
instruction or experience. However, learning would be a pointless activity unless we have 
the ability to recapture or recall the information, thus memory is an important associated 
process, in which the knowledge or skill learnt is retained over time. Research on 
learning and memory has been part of psychology since it began as a science in the 
1800’s (Anderson, 2000). Later in that same century, scientists began the search for an 
explanation of learning and memory at the molecular level. Eventually, the neural basis 
of learning and memory emerged from the assumption that information is stored in the 
brain as changes in synaptic efficiency (Bliss and Collingridge, 1993). This was 
suggested in the 1890’s upon the discovery that networks of neurons are not in 
cytoplasmic continuity but communicate with each other at junctions called synapses 
(Bliss and Collingridge, 1993). The ability of the brain to re-organise neural pathways 
based on experience is termed, neuroplasticity. 
 
1.1.2.       The Hippocampus and Learning and Memory 
The hippocampal formation is a relatively small bilateral structure (Amaral and Witter, 
1989) in the brain surrounded by the temporal cortex (Anderson, 2000). It forms part of 
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the limbic system which has a general role to play in emotion, motivation and memory 
(Butler, 1993). 
 
Each hippocampus consists of two thin sheets of neurons which are shaped like two inter-
locking C’s folded onto each other; one sheet is the dentate gyrus (DG) and the other is 
the Ammon’s horn. The Ammon’s horn has four divisions, of which the most important 
are the CA1 and CA3 (figure 1.1.). CA stands for Cornu Ammonis and means Ammon’s 
Horn in Latin (Amaral, 1978; Amaral and Witter, 1989; Bear et al., 2001).  It is also 
known as the hippocampus proper. Figure 1.1. shows that the structures are curved and 
subfields or regions are defined along the curves (only CA3, CA1 and DG are labelled). 
The regions are also structured depthwise in clearly defined strata. The stratum 
pyramidale is the main cell layer of Ammon’s horn and contains the cell bodies of 
pyramidal cells, whilst the stratum granulosum is the main cell layer of the DG, 
consisting of the cell bodies of granule cells (Amaral, 1978; Amaral and Witter, 1989). 
 
 
 
   Figure 1.1. Photomicrograph of the major regions of the hippocampus. 
   (http://en.wikipedia.org/wiki/Hippocampal_subfields) 
 
Most neural input to the hippocampus occurs via the entorhinal cortex (EC), which is 
connected to the granule cells of the dentate gyrus through the perforant-path of axons. 
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The granule cells of the dentate gyrus then project their axons, called the mossy fibre 
system to the large pyramidal cells of CA3 region (Amaral, 1978). Finally, the CA3 
pyramidal cells synapse on pyramidal cells of the CA1 subfield, via their axons, known 
as the Schaffer collateral system (Amaral, 1978). 
 
The importance of the hippocampus in memory was brought to the attention of 
researchers by the patient, HM. HM suffered from a number of anterograde and 
temporally-graded retrograde memory impairments following the bilateral removal of 
various medial-temporal lobe structures (including bilateral ablation of his hippocampi) 
to relieve frequent epileptic seizures (Terry, 2005). In later years, it was discovered that a 
few seconds of high-frequency electrical stimulation of a glutamatergic fibre pathway in 
the hippocampus enhances synaptic neurotransmission between stimulated axons and 
post-synaptic cells and that this change persists for weeks (Bliss and Lomo, 1973). This 
effect, called long term potentiation (LTP) was proposed to be the neural process which 
underlies learning and memory. Thus, this further defined the role of the hippocampus in 
learning and memory. 
 
1.1.3.      Long Term Potentiation 
1.1.3.1.    Induction of Long Term Potentiation  
The best understood form of LTP is by activation of N-methyl-D-aspartate (NMDA) 
receptors, which allows for the transduction of electrical signals to chemical signals at the 
post-synaptic membrane, which, in turn, activates both pre- and post-synaptic 
mechanisms to generate a persistent increase in synaptic strength (Bliss and Collingridge, 
1993). 
 
In the hippocampus, LTP is initiated by stimulation of the presynaptic neuron (Danysz 
and Parsons, 2003). This results in the release of glutamate, which binds to ionotropic 
glutamatergic receptors on the postsynaptic neuron. The α-amino-5-hydroxy-3- methyl-4-
isoxazole propionic acid (AMPA) receptors contain ligand-gated channels only, thus the 
binding of glutamate immediately results in an influx of sodium ions into the 
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postsynaptic neuron. On the other hand, the ion channels of NMDA receptors are both 
ligand-gated and voltage-gated, because of the voltage-dependent block of these channels 
by a magnesium ion. Thus, on NMDA receptors, glutamate binding alone is insufficient 
to bring about ion channel opening. It is the influx of sodium ions (due to AMPA 
stimulation) across the postsynaptic membrane which causes the depolarisation required 
to remove the magnesium ion. Since glutamate is already bound, once the magnesium ion 
has dissociated from the receptor, the ion channel is open to allow the passage of sodium 
and calcium ions (Bliss and Collingridge, 1993; Lodish et al., 1995). The induction of 
LTP could be blocked by the intracellular injection of ethylene glycol bis(2-aminoethyl 
ether)-N,N,N'N'-tetraacetic acid (EGTA), a calcium ion chelator (Lynch et al., 1983). 
This has implicated the post-synaptic cell, and in particular calcium signalling, in the 
induction process.  
 
 
 
Figure 1.2. Diagram showing the involvement of AMPA and NMDA receptors in the 
induction of LTP (Danysz and Parsons, 2003). 
 
During the induction of LTP, the NMDA receptor functions as a co-incidence detector, 
integrating activity of the post-synaptic cell (depolarised membrane) with the release of 
glutamate from the pre-synaptic cell, generating a greater response by the postsynaptic 
neuron than that caused by the neurotransmitter release alone (Lodish et al., 1995) The 
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increase in calcium ions also causes activation of nitric oxide synthase (NOS) to form 
nitric oxide (NO), which diffuses out of the postsynaptic cell to the presynaptic cell 
where it activates guanylate cyclase to synthesise cyclic guanylate monophosphate 
(cGMP), which increases the amount of glutamate released at each subsequent action 
potential (Lodish et al., 1995). Thus, it can be argued that both sides of the synapse are 
strengthened during induction of LTP. 
 
1.1.3.2.    Expression of Long Term Potentiation 
Several different calcium-sensitive enzymes have been proposed to play a part in 
converting the induction signal into persistent modifications of synaptic strength. These 
include the protease calpain (Oliver et al., 1989), phosphatases such as calcineurin 
(Halpain and Greengard, 1990), phospholipases and protein kinases. In addition to post-
translational modification of existing proteins there is evidence that protein synthesis 
itself is also necessary for LTP (Bliss and Collingridge, 1993). Proteins synthesised from 
pre-existing messenger ribonucleic acid (mRNA) are required for the maintenance of 
LTP during the first few hours. This suggests that LTP does not depend on gene 
transcription during this time. It does not preclude, however, the possibility that genes are 
normally transcribed at or shortly after the time of induction but exert their effects at later 
times (Bliss and Collingridge, 1993). Thus, it appears that the increase in synaptic 
response generated at potentiated synapses could be due to:  
 
1. Presynaptic modifications which result in an increase in the amount of L-
glutamate released per impulse,  
2. Postsynaptic modifications, such as an increase in the number of receptors or a 
change in their functional characteristics,  
3. An extrasynaptic change, such as reduction in uptake of L-glutamate by glial cells 
leading to increased neurotransmitter availability at the receptors, or  
4. Morphological modifications. 
(Bliss and Collingridge, 1993). 
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1.1.4. Disorders Involving Impairment of Learning and Memory 
Irrespective of socio-economic class, most spheres of our lives depend on our ability to 
acquire and retain information. Conceivably then, impairment of learning and memory is 
likely to have devastating effects on the quality of life of such affected patients. It may 
even become psychologically debilitating for family and friends as they watch their loved 
one deteriorate in cognitive function.  Based on the important role the hippocampus plays 
in learning and memory, any disease which results in damage or death of hippocampal 
neurons is likely to cause impairment of these two cognitive processes. The 
neuropathology of these disorders is often related to one or more of the following: 
1. The presence of foreign bodies; 
2. An immune response to foreign bodies; 
3. An immune response to physical or psychological stress. 
 
1.1.4.1. The Immune Mechanism of the Central Nervous System  
Microglia are non-neuronal cells in the central nervous system (CNS) which serve as the 
first line of defense as antigen-presenting cells (Kreutzberg, 1996). During this process, 
these become activated and thereafter follow a stereotyped pattern of events irrespective 
of the antigen (Mori and Kimura, 2001). In the first stage of activation, if the injury to the 
neurons is sublethal, microglia become activated but do not become phagocytic. 
Microglia at this stage likely provide neurons with trophic support by releasing a battery 
of molecular factors such as neurotrophins, basic fibroblast growth factor, and annexin V 
(Mori and Kimura, 2001). If neuronal death is induced by the injury, activated microglia 
are further transformed into phagocytic, and thus cytotoxic cells, known as microglia-
derived brain macrophages (Mori and Kimura, 2001). These microglia kill injured cells 
by releasing neurotoxic molecules such as free oxygen intermediates, NO, proteases, 
arachidonic acid derivatives, excitatory amino acids and cytokines like tumor necrosis 
factor α (TNFα) (Kreutzberg, 1996). TNFα is one of the many pro-inflammatory 
cytokines, including some interleukins (IL) and interferon-γ (IFN-γ) which have the 
ability to stimulate the activity of indoleamine-2,3-dioxygenase (IDO), possibly resulting 
in an increased production of another neurotoxin, quinolinic acid (QA), via the 
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kynurenine pathway (KP) (figure 1.10.) Within the brain, IL-1 has been found in several 
brain regions including the hippocampus (Fagan and Gage, 1990). 
 
1.1.4.2.    Alzheimer’s Disease 
Alzheimer’s disease (AD) is a chronic, progressive neurodegenerative disorder which is 
characterised by a decline in cognitive abilities, including learning and memory. Two of 
the hallmark morphological features of AD are ß-amyloid plaques (AP) and 
neurofibrillary tangles (NFT) (Mirra et al., 1993; Gandy and Petanceska, 2000) present in 
specific subcortical and cortical areas (Mirra et al., 1993). These are formed by the 
extracellular deposition of ß-amyloid peptide and the intra-neuronal accumulation of 
abnormal tau protein respectively (Selkoe, 2004). These abnormal bodies directly 
compromise the function and viability of neurons (Trojanowski and Lee, 2005), possibly 
leading to neuronal and synaptic loss. The most vulnerable circuit appears to be the 
perforant path (Hyman et al., 1984; Hyman et al., 1986) which, as described in section 
1.1.2., originates in the EC and terminates in the DG of the hippocampal formation. This 
circuit is progressively affected by NFT formation prior to the appearance of substantial 
cognitive decline (Gomez-Isla et al., 1996). Several studies have shown that the CA1 
subfield of Ammon’s horn is also severely affected by NFT (Braak and Braak, 1985; 
Squire and Zola-Morgan, 1988). AP are associated with evidence of neuroinflammation, 
especially activated microglia. Guillemin et al., (2003) discovered that ß-amyloid 1-42, 
one of the ß-amyloid peptides found in AP, is able to induce the production of the potent 
neurotoxin, QA, in neurotoxic concentrations, by human macrophages and microglia. 
Brain regions involved in learning and memory demonstrate the greatest degree of 
microglia cell activation early in the disease, ultimately showing the highest rate of 
neurodegeneration (Cagnin et al., 2001). In AD, neurons within the EC are particularly 
vulnerable to the consequences of chronic neuroinflammation (Hauss-Wegrzyniak et al., 
1998; Hauss-Wegrzyniak et al., 2002). This includes the loss of NMDA receptors (Rosi 
et al., 2004), which have a pivotal role to play in LTP (section 1.1.3.1). 
 
 
Literature Review_________________________________________________________ 
 8 
1.1.4.3. Herpes Simplex Encephalitis  
Herpes viruses are ubiquitous and usually cause asymptomatic or mild infections (Cinque 
and Lazzarin, 2000). However, following primary infection, these remain latent in the 
body and may subsequently be reactivated under particular circumstances such as 
immunodeficiency. During primary infection or reactivation, the virus may enter the CNS 
by nerve pathways or by crossing the blood brain barrier (Cinque and Lazzarin, 2000). 
Neuronal destruction is initially sustained by the direct cytotoxic effect of the virus and 
thereafter continued by immune mechanisms (Esiri, 1982). The relative importance of 
either mechanism will most likely depend on the balance between viral replication and 
the host inflammatory response (Price et al., 1973). For example, direct virus cytotoxicity 
is likely to be the most relevant pathogenic mechanism in an immunocompromised 
patient, in whom there is a limited inflammatory response. Although herpes simplex virus 
type-1 (HSV-1) may induce diffuse infection of the neonatal brain, adult herpes simplex 
encephalitis (HSE) is pathologically characterised by necrotising lesions commonly 
found in the CNS structures implicated in learning and memory, including the amygdala, 
hippocampus, and EC (Gordon et al., 1990) Consequently, the most frequently observed 
clinical finding in survivors of HSE is a deficit in intellectual function, in particular, a 
profound inability to store and recall information.  
 
1.1.4.4.      Mental Depression 
The monoamine hypothesis of depression proposes that low levels of one or more of the 
brain monoamine neurotransmitters; serotonin (5-HT), norepinephrine (NE) and 
dopamine (DA) could produce depression (Hirschfeld, 2000). This hypothesis has been 
further refined, emphasising that mental depression may arise, specifically, from 
decreased brain 5-HT function (Coppen, 1967). During psychological stress, more 5-HT 
is needed to cope with demands and up-regulation of 5-HT2 receptors (Hrdina, 1996) is a 
compensatory response. Ultimately, however, 5-HT turnover dysfunction occurs and 
major depression will develop (Stokes, 1995).  
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It has been hypothesised that cytokine hypersecretion may also be involved in the 
pathophysiology of depressive disorders (Leonard, 2001). A cytokine-5-HT interaction, 
linking the above two hypotheses has been identified through the discovery that pro-
inflammatory cytokines have profound effects on the metabolism of brain 5-HT, NE and 
DA in mice and rats (Dunn et al., 1999). In clinical studies, significant decreases in 
serum tryptophan (TRP) concentrations have been noted in patients receiving IL-2 or 
IFN-γ (Brown et al., 1989; Brown et al., 1991). There are two major mechanisms 
involved in cytokine-induced TRP depletion. The first mechanism is that cytokines may 
induce TRP depletion directly by reducing food intake since TRP levels are strongly 
modulated by dietary intake (Plata-Salaman, 1998). The second mechanism is that 
cytokines induce TRP depletion by enhancing the activity of IDO. TRP is a precursor of 
5-HT, thus depletion of TRP means that there is less of this amino acid available for the 
production of the brain monoamine. Moreover, as described in section 1.1.4.1, enhanced 
activity of IDO increases the production of the neurotoxin QA. It is this action which has 
given rise to the neurodegenerative hypothesis of depression (figure 1.3.), proposed by 
Myint and Kim, (2003).  
 
This hypothesis proposes that psychological stress induces TRP depletion due to the 
increased demand for 5-HT and mood changes develop. This is balanced by modification 
of 5-HT synthesis and expression of different 5-HT receptors. However, when the 
psychological stress continues over a period of time, an increase in pro-inflammatory 
cytokines occurs. The adverse effects of pro-inflammatory cytokines may be balanced by 
an increased production of anti-inflammatory cytokines. The pro-inflammatory cytokines 
activate IDO further depleting TRP through the KP. As a result of this pathway, 
neurodegenerative QA and neuroprotective kynurenic acid are produced in the brain, 
creating a challenge between neurodegeneration and neuroprotection. If the balance 
between pro- and anti-inflammatory cytokines is disturbed or stress continues further, the 
TRP degradation through the KP becomes more pronounced and the neurodegeneration–
neuroprotection challenge becomes extensive. When this challenge shifts to the 
degenerative side, neurodegeneration of areas of brain involved in neuroendocrinology of 
stress and memory such as the hippocampus occurs. This neurodegeneration may further 
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perturb serotonergic function. This neurodegeneration hypothesis is supported by the 
findings of Bremner et al., (2000) and Sheline (1996; et al., 1999) who showed that 
atrophy of the hippocampus occurs in major depression and that this effect increases with 
longer duration of depression. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3. Schematic diagram outlining the neurodegenerative hypothesis of depression, 
modified from Myint and Kim (2003). 
 
1.2. NEURODEGENERATION 
1.2.1.       Neuronal Cell Death 
1.2.1.1      Introduction 
Neuronal death is normal during nervous system development but becomes potentially 
pathological (Farber, 1994) in brain and spinal cord disease and injury (Martin, 2001). 
There are two types of cell death, namely, necrosis and apoptosis. 
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1.2.1.2.     Necrosis  
Necrosis is a passive process (Ankarcrona et al., 1995), ultimately resulting in the lysis of 
cells. It is characterised by a catastrophic deregulation of cellular metabolism, primarily 
due to adenosine triphosphate (ATP) depletion and electrolyte homeostasis (Toescu, 
1998). This imbalance results in typical morphological changes which include organelle 
and cell swelling (Ankarcrona et al., 1995), followed by the loss of integrity 
(disintegration) of the cell membrane. The latter may result in the release of cytoplasmic 
content into the extracellular medium (Toescu, 1998). This triggers an important 
inflammatory response, which includes local cellular infiltration, vascular damage and 
oedema (Ankarcrona et al., 1995), which initiates injury to the surrounding tissue, and, 
eventually leads to fibrosis.  
 
1.2.1.3.     Apoptosis 
Apoptosis is a genetically controlled, energy-dependent process which removes unwanted 
cells from the body (Blankenberg et al., 2000). Thus, the nuclei and mitochondria of cells 
are likely to play an important role in the process; in this respect, it is a disturbance of the 
function of one or both of these organelles, which ultimately initiates apoptosis by the 
activation of a cascade of cysteine aspartate-specific proteases (caspases) (van Loo et al., 
2002).  Cytochrome C is a necessary component in caspase activation, suggesting that 
mitochondria participate in apoptosis by releasing cytochrome C into the cytosol (Liu et 
al., 1996; Li et al., 1997).  Furthermore, cytosolic deoxy-ATP (dATP), a product of 
mitochondrial activity is a required cofactor for cytochrome C-induced caspase 
activation. (Liu et al., 1996, Li et al., 1997). The mitochondria also release caspase 9, 
apoptosis inducing factor (AIF) and perhaps other mediators that cause apoptosis (Beal, 
2000). Cytochrome C and dATP are involved in the conversion of pro-caspase 9 to an 
active caspase, which initiates a caspase cascade that leads to apoptotic cell death (Beal, 
2000). 
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1.2.1.3.1  The Role of Caspases in Apoptosis 
Caspases are constitutively expressed proenzymes that undergo proteolytic cleavage and 
rearrangement of subunits to produce active enzymes (Schwartz and Milligan, 1996). The 
substrates of these enzymes are primarily nuclear proteins, including, polyADPribose 
polymerase (PARP), deoxyribonucleic acid-dependent protein kinases (DNA-PK), 
heteronuclear ribonucleoproteins (HNRNPs), lamins, and cytoskeletal proteins such as 
actin and fodrin (Schwartz and Milligan, 1996). It is also possible that these proteases 
could contribute to deoxyribonucleic acid (DNA) fragmentation by activation of 
endonucleases (Wright et al., 1994). 
 
1.2.1.3.1.1.  Cleavage of PARP 
Under normal circumstances, PARP is an important molecule, which has a role to play in 
DNA repair, in response to DNA damage. Its precise role in DNA repair or replication 
remains to be defined (Herceg and Wang, 2001). The cleavage of PARP inhibits most of 
its DNA repair activity (Kaufmann et al., 1993), and this may contribute to the apoptotic 
demise of the cell. 
 
PARP cleaves nicotinamide adenine dinucleotide (NAD) into nicotinamide and adenine 
dinucleotide-ribose and uses the latter to synthesise long branching polyADPribose 
polymers covalently attached to acceptor proteins including histones, DNA repair 
enzymes, transcription factors and PARP (Virág, 2005). Depletion of NAD pools reduces 
the cells' ability to generate ATP and maintain energy-dependent processes (Sims et al., 
1983). Therefore, it has been postulated that PARP cleavage also occurs in order to 
prevent depletion of energy pools, and in this way, steer the neuron towards apoptotic, 
rather than necrotic death, which would occur due to overactivation of PARP (Eliasson et 
al., 1997; Endres et al., 1997). 
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1.2.1.3.1.2.  Cleavage of DNA-PK 
DNA-PK is essential in the repair of DNA double-strand breaks (Hartley et al., 1995, 
Jackson and Jeggo, 1995). The DNA-PK catalytic site is the 470-kDa catalytic subunit of 
DNA-PK. DNAPK. Catalytic site activity is induced by binding to the 70- and 80-kDa 
Ku heterodimer (Lees-Miller et al., 1990; Anderson and Lees-Miller, 1992), which in 
turn, binds to DNA in double-strand break repair reactions and thereby recruits DNA-PK 
catalytic sites to sites of DNA damage (Lees-Miller et al., 1995). The available evidence 
indicates that the DNA-PK catalytic site is cleaved into 240-, 150-, and 120-kDa 
fragments and that cleavage is associated with loss of DNA-PK activity (Song et al., 
1996) and thus an impaired ability of the cell to repair DNA double strand breaks. 
 
1.2.1.3.1.3. Cleavage of HNRNPs 
The HNRPs belong to a class of proteins that bind heterogeneous nuclear ribonucleic 
acids (RNA) or pre-mRNA (Waterhouse et al., 1996). These are thought to play a role in 
processing (splicing) pre-mRNA; however, the full range of functions and mechanisms of 
action are not yet known. There is evidence of cleavage of the HNRNPs C1 and C2 in 
apoptotic cells (Waterhouse et al., 1996). This interferes with the synthesis of mRNA. 
Without mRNA, the genetic code cannot be translated for the production of proteins, 
which undoubtedly constitute an integral part of normal cell function. 
 
1.2.1.2.1.4. Cleavage of Actin and Fodrin 
The cytoskeleton has an important role to play in different types of cellular motility, such 
as, intracellular transport, locomotion, maintenance of cell shape and cell division 
(Jokusch et al., 1986). Thus, proteolytic cleavage of cytoskeletal actin (Kayalar et al., 
1996) and the actin-associated fodrin (Martin et al., 1995) is likely to cause disassembly 
of the cytoskeleton. This contributes to the morphological changes of the cell membrane 
observed in apoptosis. 
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1.2.1.3.1.5.  Cleavage of Lamins and Endonucleases 
Lamin B1 degradation during apoptosis could lead to collapse of the chromatin due to the 
loss of attachment points on the nuclear matrix (Neamati et al., 1995). The cleavage of 
endonuclease activates the enzyme, which fragments the chromatin into nucleosomal 
units, of about 180-base pair oligomers (Matassov et al., 2004). This is an important early 
feature of apoptosis. 
 
1.2.1.3.2.    Morphological Features of Apoptosis 
The early morphological changes in apoptosis include cell shrinkage, organelle 
relocalisation and compaction, and nuclear chromatin condensation (Kerr et al., 1972, 
Arends and Wyllie, 1991). The condensed chromatin network then moves towards the 
nuclear envelope (Wyllie, 1987). The plasma membrane starts to convolute, giving the 
cell a blebbed surface. The cytoplasmic blebs pinch off as apoptotic bodies, which are 
usually rapidly phagocytised by macrophages, (Toescu, 1998) preventing inflammation 
and damage to the surrounding tissue (Duvall et al., 1985; Savill et al., 1993). Preventing 
the release of intracellular molecules is particularly important in the nervous system, 
where liberation of excitotoxic mediators, such as glutamate from dying cells can cause 
severe injury to neighbouring neurons (Leist and Nicotera, 1998). However, if local 
phagocytic capacity is limited, the apoptotic bodies can undergo secondary necrosis, in 
which the membrane breaks and the contents are released into the extracellular space 
(Toescu, 1998). These morphological features of apoptosis are illustrated in figure 1.4., 
and compared to those of necrosis. 
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Figure 1.4. Illustration of the morphological features of necrosis and apoptosis. (Wyllie 
et al., 1998). 
 
1.2.2.            Mechanisms of Neurodegeneration 
1.2.2.1. Introduction 
Necrosis and apoptosis are initiated by three inter-related mechanisms, namely, oxidative 
stress, excitotoxicity and mitochondrial dysfunction (Greene and Greenamyre, 1996, 
Simonian and Coyle, 1996; Alexi et al., 1998; Cassarino and Bennett, 1999). This 
relationship is depicted in figure 1.5. 
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Figure 1.5. The inter-relationship between excitotoxicity, free radicals and oxidative 
stress, and mitochondrial dysfunction in causing necrosis and / or apoptosis. (a) depicts 
the effects of a severe excitotoxic insult which results in cell death by necrosis. (b) 
depicts the effects of a mild excitotoxic insult that results in apoptosis (Beal, 2000). 
1.2.2.2. Free Radicals and Oxidative Stress 
Free radicals are chemical species which are unstable because these possess an unpaired 
electron in their outer orbit. Free radicals are generally very reactive (Cheeseman and 
Slater, 1993) due to the attempt to achieve stability by gaining an electron from 
molecules in close proximity. Thus, in biological systems, free radicals may do so by 
oxidising biomolecules, including nucleic acids, amino acids, proteins and fatty acids and 
lipids, which lead to cell injury and possibly cell death (Fridovich, 1999; McCord, 2000). 
 
1.2.2.2.1.     Superoxide Anion 
The superoxide anion (O2·-) is most commonly formed when molecular oxygen (O2) 
accepts an electron from a reducing agent. This occurs via cellular electron transport 
chains located in mitochondria and the endoplasmic reticulum (Halliwell and Gutteridge, 
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1990) where some electrons passing through the chain “leak” directly from the 
intermediate electron carriers onto O2. There are a number of other biochemical 
reduction-oxidation (redox) reactions which generate O2·-. Examples of these include, the 
auto-oxidation of catecholamines and oxidation of xanthine by the enzyme xanthine 
oxidase (Colton and Gilbert, 1987). The calcium-dependent activation of phospholipase 
A2 (PLA2) also yields O2-· through the metabolism of arachidonic acid by the 
lipoxygenases and cyclooxygenases to form eiconasoids (Chan and Fishman, 1980). 
 
The direct toxicity of O2-· is two fold. It has the ability to inhibit certain enzymes, 
including calcineurin, thereby attenuating vital metabolic pathways and the expression of 
LTP (section 1.1.3.2), and it has been shown to have a role to play in DNA damage 
(Touati and Farr, 1990). 
 
1.2.2.2.2. Nitric Oxide 
NO is one of the most widespread signalling molecules and plays a vital role in the 
functioning of many different types of cells (Ignarro et al., 1999). Physiologic levels of 
NO produced by endothelial cells are essential for regulating the relaxation and 
proliferation of vascular smooth muscle cells, leukocyte adhesion, platelet aggregation, 
angiogenesis, thrombosis, vascular tone, and hemodynamics (Ignarro et al., 1999) In 
addition, NO produced by neurons serves as a neurotransmitter, and NO generated by 
activated macrophages is an important mediator of the immune response (Fridovich, 
1999). 
 
It is known that in the course of ischaemia, AD and other degenerative conditions, NO 
concentrations increase in the brain (Torreilles et al., 1999). This excess NO is able to 
promote apoptosis in primary neuronal cultures, due to the formation of a far more potent 
free radical, peroxynitrite (Tomaszewicz et al., 1997; Brorson et al., 1999; Kim et al., 
1999). 
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1.2.2.2.3  Peroxynitrite 
The short lived, potent oxidant peroxynitrite (ONOO-) is the biological reaction product 
of O2·- and NO (Radi et al., 1991). The broad spectrum of toxic effects produced by 
ONOO- in biological systems includes lipid peroxidation (LP), protein oxidation and 
nitration, DNA cleavage, a reduction in cellular antioxidant defenses and inhibition of 
mitochondrial respiration (Misko et al., 1998; Szabó, 2003; Virág et al., 2003). These 
events are known to trigger apoptotic cell death at low concentrations of ONOO-, and 
necrosis at higher concentrations (Virág et al., 2003). 
 
1.2.2.2.4.      Hydroperoxyl Radical  
Hydroperoxyl (HOO·) is produced in biological systems by the reaction of O2·- with any 
substrate that contains acidic protons (Collins et al., 2001). The pH at sites very close to a 
membrane surface is very acidic, so the formation of HOO· there is favoured (Halliwell 
and Gutteridge, 1989). This is particularly relevant because the intracellular generation of 
its precursor, O2·- is formed in membrane bound systems, such as the mitochondria. 
Furthermore, HOO·, being uncharged, crosses membranes readily and appears to be 
somewhat more reactive than O2·-. For example, it, unlike O2·-, has the ability to initiate 
LP (Halliwell and Gutteridge, 1989). 
 
1.2.2.2.5.     Hydroxyl Radical  
In many systems in which O2·--generation has been shown to do damage, there is 
protection by known scavengers of the hydroxyl radical (HO·), such as mannitol and 
thiourea (Halliwell and Gutteridge, 1989). It was thus suggested by Fridovich, (1983) that 
O2-· and hydrogen peroxide (H2O2) react in the Haber-Weiss reaction to form the highly 
reactive HO·. However, the second-order rate constant for the reaction was found to be 
virtually zero and therefore not likely to occur at the low steady state concentrations of 
O2·- and H2O2 that exist in vivo. It was later shown (Halliwell and Gutteridge, 1986) that 
the HO· formation can be accounted for if the Haber-Weiss (H-W) reaction is catalysed 
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by traces of transition metal ions, for example, Fe2+ and Fe3+ in the Fenton reaction 
(Halliwell and Gutteridge, 1986), as shown in equations 1.1, 1.2 and 1.3. 
 
Fe3+    +    O2·-                            Fe2+    +    O2………………equation 1.1  
Fe2+    +    H2O2                         HO·     +    -OH   +    Fe3+….equation 1.2 
O2·-      +    H2O2    metal catalyst         O2       +     HO·     +    -OH...equation 1.3    Net reaction:H-W 
 
The potency of HO· lies in its ability to react with almost all molecules in living cells 
(Fridovich, 1986). Furthermore, no HO·-detoxifying enzyme exists in biological systems 
(Bird and Iversen, 1974). 
 
During normal cell functioning, free radicals are produced primarily during 
mitochondrial respiration, where oxygen is the last acceptor of the electron transport 
chain. However, the levels of these radicals are controlled by the deactivation 
mechanisms of the antioxidant defense system (Alexi et al., 2000). Oxidative stress 
occurs when generation of free radicals exceeds the capacity of antioxidant defense 
mechanisms (Poston and Raijmakers, 2004). Thus, excess free radicals have the ability to 
oxidise important cell components, including membranes, proteins and DNA and can be 
detrimental to cells if they accumulate in high levels or the antioxidant defense system is 
defective or saturated (Alexi et al., 2000). Mitochondrial dysfunction and excitotoxicity, 
although mechanisms of neurodegeneration in their own right, may contribute to one or 
both of these criteria. For years now, oxidative stress has been associated with the 
pathology of AD (Martins et al., 1986; Franceschi et al., 1990; Butterfield et al., 1999a;, 
1999b; Ansari et al., 2006; Onyango and Khan, 2006), whilst in HSE (Valyi-Nagy and 
Dermody, 2005) and depression (Khanzode et al., 2003), the notion and evidence is very 
recent and not well known. 
 
1.2.2.3.  Mitochondrial Dysfunction 
Mitochondrial dysfunction may occur as a consequence of excitotoxicity (section 
1.2.2.4.) or due to the presence of respiratory poisons such as cyanide and 1-methyl-4-
Fenton 
Reaction 
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phenyl-1,2,3,6-tetrahydropyridine (MPTP) (Alexi et al., 2000). Dysfunctioning of the 
mitochondria results in depression of oxidative phosphorylation (Zhang et al., 1990), the 
consequences of which are leakage of excess electrons and possible ATP depletion 
through the reduced production of ATP (Alexi et al., 2000). The electrons combine with 
O2 to form O2·- leading to the production of other free radicals, and ultimately, oxidative 
stress (Beal, 2000). Oxidative stress also has the potential to cause permeability transition 
(PT) of mitochondria (Gunter and Pfeiffer, 1990; Beal, 2000). This is associated with the 
opening of a pore in the inner mitochondrial membrane, which makes it permeable to 
ions and small molecules (Gunter and Pfeiffer, 1990, Beal, 2000). PT may be a key 
switch responsible for the induction of apoptosis by release of the caspase activator 
cytochrome C through the pore (Hengartner, 1998). However, if PT causes a dramatic 
change in ion homeostasis to occur, a breakdown of mitochondrial membrane potential 
and swelling of the mitochondria results (Hengartner, 1998) potentially leading to 
necrotic cell death. Since neurons rely on ATP for all energy-dependent processes, ATP 
depletion results in ATP-independent necrotic cell death. More specifically, it causes 
failure of ATP-dependent ion pumps. This may cause uncontrolled ion influx and thus 
depolarisation of the membrane (Alexi et al., 2000). Together with another consequence 
of mitochondrial dysfunction, which is the loss of intracellular calcium buffering capacity 
(Alexi et al., 2000); this may lead to calcium-dependent toxic processes as described in 
section 1.2.2.4. Experimental evidence has shown that mitochondrial dysfunction is very 
likely involved in the pathology of AD (Hauptmann et al., 2006; Onyango et al., 2006) 
and depression (Modica-Napolitano and Renshaw, 2004). 
 
1.2.2.4. Excitotoxicity 
Excitotoxicity is a mechanism of neuronal cell death mediated by overstimulation of 
ionotropic glutamate receptor sub-types, such as NMDA and AMPA (Griffiths et al., 
2000). Thus, in addition to modulation of LTP (section 1.1.3.1) these receptors are 
potential agents of neurodegeneration. The resulting massive depolaristion of neuronal 
membranes opens the ion pores of the receptors, allowing an influx of large amounts of 
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sodium and calcium ions (Cotman et al., 1989; Farooqui and Horrocks, 1991). It is this 
disturbance in ion homeostasis that can ultimately result in necrosis and apoptosis.  
 
It has been suggested that two separate processes occur in the excitotoxic mechanism.  
The influx of sodium ions is accompanied by influx of chloride ions as well, creating an 
osmotic imbalance between the neuron and the extracellular environment (Rothman and 
Olney, 1987). Water flows into the cell, causing acute cell swelling, damage and possible 
lysis, that is, necrosis (Olney, 1969; Rothman, 1985; Choi, 1987; Tilson and Mundy, 
1995).  
 
The massive calcium ion influx triggers the activation of intracellular calcium-dependent 
enzymes (Meldrum and Garthwaite, 1990). This causes a delayed toxicity in cells that 
survive the osmotic crisis and accounts for most cell deaths due to glutamatergic 
hyperstimulation (Choi, 1992). 
 
High concentrations of calcium ions activate various hydrolytic enzymes including 
proteases, nucleases and lipases (Choi, 1992). The general homeostatic disturbance of the 
nucleus and / or mitochondria signals the mobilisation of caspases in their zymogen form 
for activation by calcium-dependent proteases, ultimately resulting in the initiation of the 
apoptotic cascade.  
 
Among lipases, the calcium-dependent PLA2 has been implicated in neurotoxicity. Its 
activation by calcium ions results in the release of arachidonic acid and related 
polyunsaturated fatty acids (PUFA) from lipid membranes, which are further metabolised 
by lipoxygenases or cyclooxygenases with concomitant generation of free radicals 
(Traystman et al., 1991). The cleavage of PUFA may cause disruption of the structure 
and integrity of lipid membranes and, as discussed in section 1.2.2.2., the free radicals 
contribute to oxidative stress, which causes cell damage and may facilitate cell death. 
Furthermore, free radicals promote elevations in calcium ion concentrations, (Mattson 
and Mark, 1996), precipitating a vicious cycle. The release of arachidonic acid following 
activation of PLA2, can also inhibit glutamate uptake into both neurons and glial cells and 
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may, therefore, prolong the excitotoxic action of this amino acid on its receptors 
(Volterra et al., 1992). 
 
There is also evidence which suggests that intracellular calcium overload could result in 
the activation of NOS, which catalyses the production of NO (Kiedrowski et al., 1992), 
the potential toxicity of which was discussed in section 1.2.2.2.2. Moreover, increases in 
intracellular calcium may cause mitochondrial dysfunction by depression of oxidative 
phosphorylation (Zhang et al., 1990) and PT, the consequences of which were mentioned 
in section 1.2.2.3. Metabolic and neurochemical perturbations, which give rise to 
excitotoxicity, are prevalent in AD (Olney et al., 1995; Hynd et al., 2004) and depression 
(Hayley et al., 2005; Yao and Reddy, 2005). 
 
1.2.3.           Oxidation of Macromolecules 
1.2.3.1.        Introduction 
The three mechanisms of neurodegeneration, whether causes or effects of 
neurodegeneration, ultimately result in oxidation of biomolecules and thus damage to 
cells. The role of oxidative damage in the pathogeneses of AD (Sultana et al., 2006), 
HSE (Valyi-Nagy and Dermody, 2005) and depression (Bilici et al., 2001) have all been 
explored. 
 
1.2.3.2. Oxidation of Nucleic Acids 
The presence of oxidised DNA bases is often used as a marker for free radical-mediated 
DNA damage (Helbock et al., 1999). The guanine base is particularly sensitive to 
oxidation making this a reasonable biomarker for oxidative injury. Oxidised DNA bases 
always exist at some basal level, although cells have numerous repair systems to remove 
such species (Lindahl and Wood, 1999). However, if these occur at critical sites, or are 
not quickly repaired, oxidised purines or pyrimidines can cause functional problems. As a 
result, oxidised DNA bases are considered an important event in chemical carcinogenesis 
(Klaunig et al., 1998). The extreme reactivity of the HO· makes it a particularly important 
player in free radical-mediated toxic processes. The reaction of HO· with aromatic ring 
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    +       OH· 
· 
structures can proceed by addition, and similar reactions occur with the purine and 
pyrimidine bases present in DNA and RNA (Halliwell and Gutteridge, 1989). For 
example HO· can add on across a double bond in the pyrimidine base thymine to form a 
thymine radical, as shown in figure 1.6. 
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Figure 1.6. The oxidation of thymine by HO· to form a thymine radical (Halliwell and 
Gutteridge, 1989). 
 
The thymine radical then undergoes a series of further reactions. For example, with 
oxygen it forms the fairly reactive thymine peroxyl radical (ROO·). Thus, HO· has the 
potential to severely damage DNA, even inducing strand breakage, which could lead to 
overactivation of PARP (section 1.2.1.3.1.1.) and thus, necrotic cell death.   
 
1.2.3.3.        Oxidation of Proteins 
Radical-mediated damage to proteins may be initiated by electron leakage, metal-ion-
dependent reactions and autoxidation of lipids and sugars (Dean et al., 1997). The 
consequent protein oxidation is O2-dependent, and results in reactive compounds, such as 
protein hydroperoxides and propagating alkoxyl radicals (Dean et al., 1997) which 
undergo further reactions, usually until the protein carbonyl is isolated. 
 
This whole process may alter protein functions, but this is not often quantitatively 
significant because of the sheer number of each type of protein (Grune et al., 1997). 
Except for enzymatic repair of oxidised thiols from S-alkyl derivatives, protein repair 
systems do not appear to exist, since it is apparently more efficient to either prevent the 
formation of oxidised proteins through the action of various cellular antioxidant systems, 
or to simply destroy the modified species and start over (Grune et al., 1997). Although 
O· 
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most oxidised proteins that are functionally inactive are rapidly removed, some can 
gradually accumulate with time and thereby contribute to the damage associated with 
ageing as well as various diseases including diabetes, atherosclerosis and 
neurodegenerative diseases (Kehrer, 2000). 
 
1.2.3.4. Lipid Peroxidation 
The brain is predisposed to LP, more so than most other organs, because it is rich in 
PUFA (Schafer et al., 2000). Peroxidation is initiated by the attack of a free radical that 
has sufficient reactivity to abstract a hydrogen atom from a methylene carbon in the side 
chain of an unsaturated fatty acid (Cheeseman and Slater, 1993). The removal of the 
hydrogen atom leaves behind an unpaired electron on the carbon atom to which it was 
originally attached (Gutteridge and Halliwell, 1990). The resulting carbon-centred radical 
undergoes molecular rearrangement (resonance stabilisation of the radical) followed by 
reaction with O2 to form a lipid ROO·. These radicals are capable of abstracting hydrogen 
from adjacent fatty acid side chains in a membrane and so cause propagation of LP. The 
resulting product is a lipid hydroperoxide (C in figure 1.7.) (Gutteridge and Halliwell, 
1990). The carbon-centred radical (A in figure 1.7.) formed during the initiation of LP 
may undergo minor reactions which include radical attack of membrane proteins and 
cross-linking of the side chain of the fatty acids should two of these radicals combine. 
The ROO· (B in figure 1.7.) could also attack membrane proteins and when they combine 
with each other, they form singlet oxygen, which is itself a highly reactive species 
capable of causing oxidative damage to macromolecules within a cell (Gutteridge and 
Halliwell, 1990). 
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Figure 1.7. Outline of the mechanism of LP (Gutteridge and Halliwell, 1990). 
 
The occurrence of LP in biological membranes causes impairment of membrane function 
in the following ways: (1) decreased fluidity and increased non-specific permeability to 
ions. (2) inactivation of membrane-bound receptors and enzymes (Gutteridge and 
Halliwell, 1990).  
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Lipid peroxides (ROOH) within the membrane have a devastating effect on membrane 
integrity because they alter membrane fluidity and permeability, thereby allowing ions 
such as calcium to leak into the cell (Halliwell, 1994). These ions then have a role to play 
in the cell death processes as discussed in section 1.2.2.4., creating a vicious cycle of 
deleterious events in and around neurons. 
 
In rat brain, LP decreases the specific binding of [3H] 5-HT and [3H] spiperone, 
indicating the loss of serotonergic binding sites of receptors (Muakkassah-Kelly et al., 
1982). Furthermore, the presence of phospholipids influences the binding of ligands to ß-
adrenergic receptors, suggesting that the interaction of the receptor with phospholipids is 
essential (Thang et al., 1980). NMDA and insulin receptors are known to have sulfhydryl 
groups that are damaged during LP (van der Vliet and Bast, 1992).  
 
LP is also known to affect the activities of a number of enzymes (Chan et al., 1985; 
Yeagle, 1989). Some of these enzymes are membrane-bound; others are found in the 
cytosol and become associated with the neural membrane during the activation process, 
whilst others such as sodium-potassium ATPase, protein kinase C, PLA2, guanylate 
cyclase, and 5'-nucleotidase require specific membrane phospholipids (Chan et al., 1985; 
Yeagle, 1989) for normal functioning. 
 
1.2.4.      Quinolinic Acid 
1.2.4.1. Introduction  
QA is a neurotoxic TRP metabolite, normally present at low concentrations in the CNS of 
man (Wolfensberger et al., 1983). However, in pathological states with signs of 
inflammation, these levels are markedly elevated (Heyes et al., 1992) because it is 
produced by immune activated macrophages (Pláteník et al., 2001). Increased CNS levels 
of QA have been found in patients with mental depression (Mangoni, 1974) and AD 
(Guillemin et al., 2003) and in mice with HSE (Reinhard, 1997).  
 
Literature Review_________________________________________________________ 
 27 
1.2.4.2. Biosynthesis of Quinolinic Acid 
1.2.4.2.1. Introduction 
In mammals, the vast majority of dietary TRP is metabolised via the KP (figure 1.10.), 
which is initiated by the oxidative opening of the indole ring and eventually produces the 
ubiquitous enzyme cofactor NAD. This pathway contains neuroactive intermediates, all 
of which derive from L-kynurenine (L-KYN), the primary degradation product of TRP. 
Most of the neuroactive metabolites including QA can produce neuronal damage via the 
overstimulation of NMDA receptors, whilst kynurenic acid, which has proved to be an 
antagonist at these same receptors, is neuroprotective (Schwarcz and Pellicciari, 2002).  
3-hydroxykynurenine (3-HK) and 3-hydroxyanthranilic acid (3-HA) can also produce 
neuronal damage, primarily by the induction of free radicals (Stone, 2000a).  
 
1.2.4.2.2.  Enzymes Involved in the Degradation of Tryptophan 
1.2.4.2.2.1. Tryptophan-2,3-Dioxygenase 
Tryptophan-2,3-dioxygenase (TDO) is one of the enzymes responsible for the 
degradation of TRP to L-KYN. It is a haeme-dependent enzyme, present in the livers of 
most mammals, including humans and rats. There is a considerable proportion of the 
enzyme that is present as the apoenzyme form, and is therefore inactive until the 
additional haeme is made available, either by the administration of haeme precursors in 
vivo or by the addition of haematin during incubation in vitro (Bender, 1983). Haeme is 
essential for activity and binds to the inactive apoenzyme in a reversible manner (step 1 
in figure 1.8.) (Feigelson et al., 1964a), to form the oxidised, inactive holoenzyme, 
containing ferrihaeme (Knox and Piras, 1966). TRP binds to the inactive holoenzyme 
(step 2 in figure 1.8.) and reduces it to the active holoenzyme, which contains haeme in 
the ferrous form. This results in TRP becoming a free radical. The new complex reacts 
with O2 (step 3 in figure 1.8.), during which O2 is reduced to O2·- and haeme iron is 
reoxidised to the ferric form. Still on the enzyme surface, the TRP radical and O2·- 
combine (Feigelson et al., 1964b), yielding indole peroxide as an intermediate (Hayaishi 
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et al., 1957). This intermediate then undergoes further reactions independent of TDO to 
form L-formylkynurenine, which hydrolyses to L-KYN.  
 
1. Apoenzyme + Haeme—Fe3+  Holoenzyme—Fe3+ 
  [inactive]    [inactive] 
 
2. Holoenzyme—Fe3+ + T                     Holoenzyme—Fe3+--T  
  [inactive]    [inactive] 
  
 
 
 
                                                                                 Holoenzyme—Fe2+--T· 
  [active] 
 
3.          Holoenzyme—Fe2+--T· + O2                      Holoenzyme—Fe2+--T· 
   
  O2 
 
  
                                                                                  Holoenzyme—Fe3+--T·  
     
  O2·- 
  
                         
                                                                                  Holoenzyme—Fe3+ + indole peroxide  
 
Figure 1.8. Activation and catalytic mechanism of TDO (modified from Feigelson et al., 
1964b). 
 
1.2.4.2.2.2. Indoleamine-2,3-Dioxygenase 
The second enzyme which catalyses the conversion of TRP to L-KYN in mammals is 
IDO. IDO has a broader specificity than TDO, as it can catalyse the oxidative cleavage of 
other indoleamines such as, 5-hydroxytryptophan, tryptamine, 5-HT and melatonin as 
well (Hirata and Hayaishi, 1972).  
 
IDO contains protohaeme IX as its prosthetic group (Hirata et al., 1977).The enzyme is 
only catalytically active in an oxygenated form. This active form of the IDO can be 
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formed by the interaction of either O2-· with the ferric form of the enzyme or O2 with the 
ferrous form of the enzyme (Hirata et al., 1977). The enzyme may then react with 
substrate to produce the product and the ferrous form of the enzyme. The ferrous form 
either undergoes oxidation to the ferric form or it can be oxygenated to regenerate the 
enzyme-O2 complex (figure 1.9.) (Hirata et al., 1977). 
 
The specific cofactor for IDO has not been identified. Dihydroflavin mononucleotide 
(FMNH2) has the capacity to activate O2 via a single electron donation to produce O2-· 
(Ozaki et al., 1987). Secondly, since it has another electron to donate, it may also 
function as a reducing agent converting [Fe3+-haeme] to a [Fe2+-haeme] state to which O2 
can bind to form a [Fe2+-O2-haeme] complex (Ozaki et al., 1987). These authors, after 
extensive work using FMNH2 on murine epididymal IDO, suggest that FMNH2 may 
therefore be the biological cofactor of IDO in vivo. 
 
 
Figure 1.9. Proposed mechanism of action of IDO (Hirata et al., 1977). 
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Figure 1.10. Graphical representation of the KP. (a) IDO; (b) TDO; (c) kynurenine 
formamidase; (d) kynurenine aminotransferase; (e) kynurenine-3-hydroxylase; (f) 
kynureninase; (g) 3-HAO; (h) picolinic carboxylase; (i) non-enzymatic cyclisation 
(spontaneous); (j) QA phosphoribosyltransferase (Heyes et al., 1997). 
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1.2.4.2.3. Enzymes Regulating the QA / Kynurenic Acid Balance 
Interference with the degradative enzymes of L-KYN, especially kynureninase and 
kynurenine-3-hydroxylase might favourably alter the kynurenic acid / QA ratio and thus 
correct pathophysiologically relevant chemical impairments in the brain (Schwarcz and 
Pellicciari, 2002). 
 
1.2.4.2.3.1. Kynurenine-3-Hydroxylase 
Kynurenine-3-hydroxylase is a flavin adenine dinucleotide (FAD)-dependent 
monooxygenase, which catalyses the hydroxylation of L-KYN to 3-HK (Schwarcz and 
Pellicciari, 2002). It catalyses the incorporation of one atom of O2 into kynurenine in the 
presence of nicotinamide adenine dinucleotide hydrogen (NADPH) as an electron donor 
(Breton et al., 2000). During the reaction, the prosthetic group FAD is reduced to 
dihydroflavin adenine dinucleotide (FADH2) by NADPH and is subsequently oxidised by 
O2 to FAD (Breton et al., 2000). 
 
1.2.4.2.3.2. Kynureninase 
Kynureninase is a pyridoxal phosphate-dependent enzyme that catalyses the hydrolysis of 
both L-KYN and 3-HK into alanine and anthranilic acid or 3-HA respectively (Schwarcz 
and Pellicciari, 2002). 
 
A Schiff base (I in figure 1.11.) forms between the pyridoxal phosphate enzyme and 
kynurenine. A proton from the α-carbon is eliminated. This results in the shifting of 
electrons and cleavage to form the o-aminobenzoyl radical (II in figure 1.11.) and the 
Schiff base of α-amino acrylic acid (III in figure 1.11.). Intermediate II (as its hydrate), 
either before or after stabilisation as o-aminobenzaldehyde, then undergoes a redox 
reaction with III to yield anthranilic acid and the Schiff base of alanine, which hydrolyses 
to alanine with regeneration of the phosphopyridoxal enzyme (Longenecker and Snell, 
1955). 
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Figure 1.11. Possible mechanism for the cleavage of kynurenine by kynureninase. For 
simplicity, the reactions are formulated with “pyridoxal” instead of “pyridoxal 
phosphate” (Longenecker and Snell, 1954). 
 
1.2.4.2.3.3. 3-Hydroxyanthranilic Acid Oxygenase  
3-Hydroxyanthranillic acid oxygenase (3-HAO) catalyses the conversion of 3-HA to an 
unstable intermediate, 2-amino-3-carboxymuconic semialdehyde, which in turn can 
spontaneously rearrange by non-enzymatic cyclisation and dehydration  (Schwarcz et al., 
1984) to QA or serve as a substrate for picolinic acid carboxylase to form picolinic acid. 
 
3-HAO is a non-haeme ferrous extradiol dioxygenase enzyme (Li et al., 2006). Key 
enzymes in the pathways of aromatic compounds are the metal-dependent ring cleavage 
dioxygenases, which act on the corresponding catechol-type derivatives, cleaving these at 
the intradiol position (ortho cleavage) or the extradiol position (meta cleavage) 
Literature Review_________________________________________________________ 
 33 
(Harayama et al., 1992). While intradiol dioxygenases typically depend on ferric ions 
(Fe3+), most extradiol dioxygenases depend on ferrous ion (Fe2+) (Andújar et al., 2000). 
A complete active site contains an Fe2+ ion (Zhang et al., 2005). The coordination ligands 
include two histidine residues (His51 and His95), a bidentate glutamate residue (Glu57), 
and a water molecule (Zhang et al., 2005). In this mechanism, the substrate binds to the 
active site Fe2+ by displacing one water molecule and the carbonyl oxygen of Glu57. This 
is followed by O2 binding and an electron transfer from Fe2+ to O2 to form an Fe3+-
containing product, 5 (figure 1.12.). Electron transfer from the electron rich aminophenol 
to the Fe3+ then produces the diradical, 6. Radical recombination would give a peroxide, 
7, followed by a Criegee rearrangement to form lactone, 8. Hydrolysis of 8 would then 
produce 10. The enzyme dissociates from the product, 2, which is 2-amino-3-
carboxymuconic semialdehyde (Zhang et al., 2005). It spontaneously rearranges to form 
QA (product 3). 
 
 
 
Figure 1.12. Proposed mechanism of action of 3-HAO (Zhang et al., 2005). 
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1.2.4.2.4. The Effect of QA Biosynthesis on Brain Indoleamine 
Metabolism 
In indoleamine metabolism (figure 1.13.), TRP is converted to 5-hydroxytryptophan by 
hydroxylation (Lovenberg et al., 1967). Decarboxylation of this indole derivative leads to 
the formation of 5-HT (Lovenberg, et al., 1962). Thus, the degradation of TRP by TDO 
and IDO, in the KP, during the biosynthesis of QA, reduces the amount of TRP available 
in the brain for conversion to 5-HT. Correlations between reduced levels of brain 5-HT 
and mental depression were discovered over twenty years ago (van Praag, 1982a). 
Depressed patients have a reduced level of plasma TRP (Delgado et al., 1990) and post-
mortem studies on brains of depressed or suicidal patients have shown reduced 
concentrations 5-HT (Gibbons and Davis, 1986). However, research findings thus far 
point to aberrant 5-HT synthesis and / or metabolism increasing the risk of depression 
(Jimerson et al., 1990), rather than being a cause of the disease. Postmortem brain studies 
on AD patients have reported loss of serotonergic neurons (Mann and Yates, 1983; 
Yamamoto and Hirano, 1985) and nerve terminals (Bowen et al., 1983; Palmer et al., 
1987) as well as reduced levels of 5-HT, its major metabolite 5-hydroxyindoleacetic acid 
(5-HIAA), and serotonergic receptor density (Adolfsson et al., 1979; Cross et al., 1984). 
In rabbits with experimental HSE, 5-HT levels are significantly reduced in the raphe 
nuclei (Päivärinta et al., 1993). 
 
5-HT may be acetylated to N-acetylserotonin (Weissbach et al., 1960), or oxidised by 
monoamine oxidase (MAO) to form 5-hydroxyindole acetaldehyde (figure 1.13.). 
Normally this is oxidised further to 5-HIAA by acetaldehyde dehydrogenase (Lerner and 
Case, 1960). Under some metabolic conditions, when the redox potential of the brain has 
shifted to a more reducing state than normal, a significant proportion of the aldehyde may 
be reduced to 5-hydroxytryptophol (Bender, 1983). All the 5-hydroxyindoles, namely,   
5-hydroxytryptophan, 5-hydroxytryptamine, 5-HIAA, 5-hydroxytryptophol and             
N-acetylserotonin can be methylated by hydroxyindole-O-methyl transferase (HIOMT) 
(Axelrod and Weissbach, 1960; Axelrod and Weissbach, 1961) to form                            
5-methoxytryptophan, 5-methoxytrytamine, 5-methoxyindoleacetic acid,                         
5-methoxytryptophol and melatonin, respectively (Klein and Notides, 1969). Melatonin is 
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an important neurohormone known to act against free radicals both directly and indirectly 
(Albarran et al., 2001). Patients with certain neurodegenerative disorders, such as AD 
have decreased levels of melatonin in the periphery (Monti and Cardinali, 2000). Ohashi 
et al., (1999) have suggested that this may be due to the neurodegenerative process of the 
disease. Moreover, previous studies have shown a reduction in melatonin secretion in 
patients with depression (Wetterberg et al., 1979, Miles and Philbrick, 1988), which may 
make these patients more susceptible to neurodegeneration. 
 
1.2.4.3. The Neurotoxicity of QA 
QA induced neurotoxicity has been associated with the overstimulation of NMDA 
receptors (Stone and Perkins, 1981). Thus, it would be expected to evoke a degenerative 
sequence of events within neurons, as shown in figure 1.5. In vivo, QA has been shown to 
impair learning and memory (He et al., 2002), induce apoptosis and necrosis (Ferrer et 
al., 1995), LP (Santamaria and Rios, 1993), DNA damage (Bordelon et al., 1999), and 
generate free radicals (Pérez-Severianoa et al., 2004). Furthermore, the fact that QA also 
has a lipid peroxidative potential in vitro (Rios and Santamaria, 1991) indicates a 
mechanism of generating free radicals independent of NMDA receptor activation. 
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Figure 1.13. Pineal Indole Metabolism (Young and Silman, 1982). 
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1.3.  NEUROPROTECTION 
1.3.1.  Introduction 
Neuroprotectants have a critical role to play in the therapeutic intervention of 
neurodegenerative disorders to partially reverse or slow their progression. 
Neuroprotective strategies should either aid neuronal regeneration or, ideally disrupt the 
cascade of events which eventually lead to apoptosis or necrosis at one or more points 
 
1.3.2.  Neuronal Regeneration 
1.3.2.1 Cellular Transplantation Therapy 
Cellular transplantation was one of the first neuroprotective approaches employed 
clinically and it has been tried extensively in human patients as an experimental treatment 
(Alexi et al., 2000). There are studies which have reported that foetal cortical tissue 
which has been transplanted 24 h after traumatic brain injury, survives and integrates into 
the injured brain. This has been shown to attenuate behavioural deficits and histological 
damage including hippocampal cell loss (Soares and McIntosh, 1991; Soares et al., 1995; 
Sinson et al., 1996). 
 
1.3.2.2. Neurotrophic Factors 
One of the most promising neuronal rescue strategies is treatment with neurotrophic 
factors. Neurotrophic factors influence cell survival and proliferation, differentiation, bio- 
chemical function, and morphological plasticity (Loughlin and Fallon, 1993; Hefti, 
1997). Indeed, endogenous levels of neurotrophic factors are often found to increase in 
response to neuronal injury, suggesting a physiological regenerative response (Connor 
and Dragunow, 1998; Hughes et al., 1999). Pharmacological application of many 
neurotrophic factors has been found to rescue injured neurons in animal models of 
Parkinson’s disease and Huntington’s disease (Alexi et al., 2000). Furthermore, 
intracerebroventricular administration of glial derived neurotrophic factor following brain 
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injury in rats decreased the post-traumatic neuronal loss in the hippocampus at one week 
postinjury (Kim et al., 2001). 
 
1.3.3.           Anti-Apoptotic Therapy 
Another strategy to prevent acute cell death may be to inhibit the caspase enzymes (Hara 
et al., 1997; Raghupathi, 2004) Several caspase inhibitors of varying specificity have 
been successfully evaluated in models of experimental traumatic brain injury including 
ketones such as the pan-caspase inhibitor z-VAD-fmk, the caspase-1 specific inhibitor 
acetyl-Tyr-Val-Ala-Asp-chloromethyl ketone and the caspase-3-specific z-DEVD-fmk 
(Raghupathi, 2004). In NMDA lesioned rats, intraventricular administration of the 
caspase inhibitor zVAD-fmk just prior to and 3 h after lesioning partially reduces the 
lesion volume (Hara et al., 1997). 
 
1.3.4.           Antioxidant Therapy 
1.3.4.1.         Introduction 
  
Halliwell and Gutteridge (1989) define an antioxidant as “any substance that, when 
present at low concentrations compared to those of an oxidisable substrate, significantly 
delays or inhibits oxidation of that substrate”. According to this definition, antioxidants 
can act at various levels in the oxidative sequence. 
 
1.3.4.2. Enzymes 
The antioxidant enzymes form an important part of the adaptation of organisms to protect 
themselves against free radical injury. These enzymes, as illustrated in figure 1.14., 
include catalase (CAT), glutathione peroxidase (GPx), glutathione reductase (GR) and 
superoxide dismutase (SOD) (Hung and Lee, 1998). SOD catalyses the dismutation of 
O2·- to H2O2 and in this way reduces the concentration of O2·- available i) to exert the 
deleterious effects described in section 1.2.2.2.1. ii) for the conversion to other toxic free 
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radicals such as OONO- and HOO· (Hung and Lee, 1998). CAT and GPx catalyse the 
conversion of H2O2 to water (H2O) thus slowing the progression of the Fenton reaction 
and the generation of the potent HO· (section 1.2.2.2.5.). GPx is the major enzyme for the 
detoxification of H2O2 in the brain since the brain has very low CAT activity (Bharath et 
al., 2002). Glutathione (GSH) serves as the reducing agent in this reaction (Hung and 
Lee, 1998). Antioxidant enzymes were found to be reduced in an animal model of AD 
(Marcus et al., 1998; Montilla-López et al., 2002). 
 
 
 
Figure 1.14. Schematic diagram of the antioxidant enzyme system, modified from Hung 
and Lee (1998). 
 
1.3.4.3. Iron Chelators 
Free or weakly bound ferrous iron is very sensitive to O2 and leads to the formation of 
ferric iron and O2·- which rapidly dismutates to H2O2. Ferrous iron can also react with 
H2O2, leading to HO· by Fenton chemistry. Moreover, in the presence of physiological 
reductants, iron can redox cycle between the two oxidation states, thereby generating the 
production of free radicals continuously (Galey, 1997). Increased iron content has been 
found in the substantia nigra of postmortem parkinsonian brains (Gerlach et al., 1994) 
and the toxicity of AP in AD toward some neural cells is mediated by H2O2 (Behl et al., 
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1994) Thus, agents with the ability to chelate iron and thus decrease its content in the 
brain may prove to be useful in oxidative stress-induced disorders of the CNS. By 
definition, chelation requires the presence of two or more electron donating groups, such 
as carboxylate and tertiary amine to form a coordinate bond with Fe2+ or Fe3+ (Galey, 
1997). Intramuscular injection of the well established iron chelator desferrioxamine was 
found to significantly reduce the brain iron content in a model of iron-loaded rats (Ward 
et al., 1995). 
 
1.3.4.4.      Scavengers of Free Radicals 
1.3.4.4.1. Introduction 
Scavengers of free radicals are antioxidants which act by being oxidised by free radicals 
in place of biomolecules (Halliwell and Gutteridge, 1989).The specific mechanism of 
action involves free radicals reacting with the antioxidant via hydrogen abstraction or 
addition to form an antioxidant radical (Halliwell and Gutteridge, 1989). Since most 
antioxidants have aromatic ring structures, the antioxidant radical so produced is itself 
insufficiently reactive to cause hydrogen abstraction or addition of biomolecules, because 
of delocalisation of the unpaired electron into the aromatic ring (Halliwell and 
Gutteridge, 1989). The antioxidant radical can however either undergo radical 
terminating reactions with other free radicals, further reducing the availability of these to 
initiate oxidative damage, or be regenerated by reducing agents. 
 
1.3.4.4.2. Endogenous Scavengers of Free Radicals 
Vitamin E and vitamin C are both endogenous scavengers of free radicals that work 
synergistically (Fang et al., 2002). Vitamin E can transfer its phenolic hydrogen to a 
ROO. of a peroxidised PUFA, thereby breaking the radical chain reaction and preventing 
the peroxidation of PUFA in membrane phospholipids (Fang et al., 2002). As a reducing 
agent, vitamin C reacts with a vitamin E radical to yield a vitamin C radical while 
regenerating vitamin E. The vitamin C radical is converted back to vitamin C by GSH 
(Fang et al., 2002). Peripheral levels of these vitamins have been found to be depleted in 
Literature Review_________________________________________________________ 
 41 
patients with AD (Rinaldi et al., 2003) and have shown promise in the prevention of this 
disease (Bradford and Gupta, 2005). Serum levels of vitamin E have also been found to 
be lower in patients suffering from major depression (Maes et al., 2000). 
 
1.3.4.5. Melatonin as an Antioxidant 
Melatonin is a neurohormone produced in the pineal gland of all mammalian species. 
This production is regulated by the photoperiodic environment, such that the daily period 
of light is associated with minimal release whereas during darkness, the synthesis and 
secretion is at a maximum (Reiter, 1991c). 
 
The functions of melatonin as an antioxidant are broad and thus it cannot be categorised 
as one specific type of antioxidant. Melatonin is able to detoxify free radicals via electron 
donation (Reiter et al., 1996). The indoyl cation that is formed is able to scavenge both 
the O2·- and ONOO- forming N-acetyl-N-formyl-5-methoxykynuramine. Limson et al., 
(1998) showed that melatonin can chelate iron. In addition, melatonin stimulates the 
synthesis of antioxidant enzymes including SOD, GPx and GR (Pablos et al., 1998; 
Albarran et al., 2001) suggesting that melatonin may act not only directly against free 
radicals, but also indirectly as an enzyme stimulator, although the specific induction 
mechanism is unknown (Albarran et al., 2001). 
 
1.3.5.  Anti-excitotoxin Therapy 
As described in section 1.2.2.4., excitotoxicity has a critical role to play in inducing 
neurodegeneration. Thus, it stands to reason that opposing or preventing excitotoxicity 
may have therapeutic potential in diseases, such as Parkinson’s (Alexi et al., 2000) AD 
and Huntington’s (Hynd et al., 2004), where the pathology is thought or known to 
include this phenomenon. There are various ways in which excitotoxicity can be 
curtailed. Memantine and zonampanel are antagonists at the NMDA and AMPA / kainate 
receptors respectively. Both these agents have been successful in treating experimental 
traumatic brain injury (Pitkanen et al., 2005), whilst the former has also been used in AD 
(Grossberg et al., 2006). There are also agents which modulate the release and uptake of 
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glutamate. Riluzole, which enhances glutamate uptake (Frizzo et al., 2004) and is an 
inhibitor of glutamate release has shown neuroprotective properties against hypoxic brain 
damage, MPTP-induced neurotoxicity, and both global and focal cerebral ischaemia in 
rodents (Mufson et al., 1999). In a clinical study, riluzole appears to slow the progression 
of amyotrophic lateral sclerosis (Pitkänen and McIntosh, 2006). 
 
1.3.6.  Bioenergetic Supplements 
Metabolic supplements such as nicotinamide diminish the neurotoxicity of metabolic 
poisons such as 3-nitropropionic acid and malonic acid in rodents. Nicotinamide is the 
precursor of NAD, an electron acceptor which releases energy when it is oxidised during 
phosphorylation of ADP to ATP. Thus it has the ability to possibly reverse ATP 
depletion during mitochondrial dysfunction. Nicotinamide provides neuroprotection from 
malonic acid lesioning when administered as four systemic injections beginning 30 min 
prior to malonic acid (Beal et al., 1994; Jenkins et al., 1996; Schulz et al., 1996).  
 
1.3.7.  Purine Nucleotides / Nucleosides  
Purine nucleosides and nucleotides are extensively released from degenerating cells, 
particularly under hypoxic/ischaemic conditions, thus it was suggested that these may 
have a role to play in regulating the response of nervous tissue to injury (Ciccarelli et al., 
2001). The interaction of guanine nucleotides with excitatory amino acid receptors, at the 
extracellular level, is already a well-established fact: both the common native 
nucleotides, guanosine triphosphate (GTP), guanosine diphosphate (GDP) and guanosine 
monophosphate (GMP), and the non-hydrolysable, synthetic analogues have been shown 
to displace agonists from both ionotropic receptors, including NMDA (Sharif and 
Roberts, 1981; Monahan et al., 1988) and non-NMDA (Souza and Ramirez, 1991; 
Gorodinsy et al., 1993) types, and metabotropic receptors (Tasca et al., 1995; Tasca et 
al., 1998). This is particularly relevant in the CNS, where this action may depress 
glutamatergic neurotransmission, thus reducing excitotoxic neuronal damage (Rudolphi, 
1991; Rudolphi et al., 1992). Moreover, it has been shown that guanosine is able to 
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induce neurite outgrowth of neuronal pheochromocytoma cells (Gysbers and Rathbone, 
1996) and to preserve glial cell viability (Jurkowitz et al., 1998). Recent data gave 
evidence that purines protect against oxidant-induced cell injury by inhibiting the 
activation of PARP (Virág and Szabo, 2001). 
 
These studies have encouraged the use of purines as therapeutic agents in neurological 
disorders. Unfortunately, the clinical use of naturally occurring molecules in humans is 
undermined by pharmacokinetic and pharmacodymanic problems (Ciccarelli et al., 
2001). The ubiquitous distribution of purine receptors results in numerous side effects 
when purines are administered systemically. Moreover, the widespread distribution of 
enzymes that metabolise purines implies that the half-life, and hence duration of action of 
these is very short. In contrast, synthetic purine derivatives that penetrate the blood brain 
barrier and enter the CNS are good candidates for clinical use, particularly if these are 
metabolised slowly. 
 
1.3.7.1. Acyclovir 
1.3.7.1.1.     Introduction 
A screening programme for antiviral drugs which began in the 1960s resulted in the 
discovery of acyclovir (AC) in 1974. Preclinical investigation brought the drug to clinical 
trials in 1977 and the first form of this antiviral drug was available to physicians in 1982 
(King, 1988). 
 
1.3.7.1.2. Pharmacology 
1.3.7.1.2.1. Indications 
AC is indicated for the treatment of infections due to HSV (types I and II) and varicella-
zoster viruses. 
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1.3.7.1.2.2. Adult Dosing 
Topical AC is used to treat the symptoms of HSV infections of the skin and mucous 
membranes by applying it to the affected area four to six times a day for up to 10 days 
(Gibbon, 2003). 
Oral treatment is 400 mg eight hourly or 200 mg five times daily, for ten days (primary 
episode) or 5 days (recurrent episode) (Gibbon, 2003). 
Parenteral AC is used in the treatment of severe primary herpes infections, disseminated 
herpes infections and in HSE. Intravenous (i.v.) infusion over one hour, 5mg/kg eight 
hourly for 5-7 days; 10mg/kg is recommended in HSE and in varicella-zoster (Gibbon, 
2003). 
 
1.3.7.1.2.3.  Drug Classification and Activation 
AC (figure 1.15.) is a deoxyguanosine analogue with an acyclic side chain that lacks the 
3-hydroxyl group of natural nucleosides (Wagstaff et al., 1994). After preferential uptake 
by infected cells, AC is monophosphorylated by virus-encoded thymidine kinase (TK); 
host cell TK is approximately 1 millionfold less capable of converting AC to its 
monophosphate derivative (Elion, 1982). Subsequent diphosphorylation and 
triphosphorylation are catalysed by host cell enzymes, resulting in the active form, AC 
triphosphate, the concentrations of which are 40 to 100 times higher in viral-infected cells 
than in uninfected cells (Elion, 1982). 
 
 
 
Figure 1.15. Structure of acyclovir (Herrero et al., 2001). 
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1.3.7.1.2.4.  Mechanism of Action 
AC triphosphate prevents viral DNA synthesis by inhibiting the viral DNA polymerase 
(Reardon and Spector, 1989; Kimberlin, 2001). In vitro, AC triphosphate competes with 
deoxyguanosine triphosphate as a substrate for viral DNA polymerase (Reardon and 
Spector, 1989). Because AC triphosphate lacks the 3-hydroxyl group required to elongate 
the DNA chain, the growing chain of DNA is terminated. In the presence of the 
deoxynucleoside triphosphate complementary to the next template position, the viral 
DNA polymerase is functionally inactivated (Reardon and Spector, 1989). In addition, 
AC triphosphate is a more suitable substrate for the viral polymerase than for cellular 
DNA polymerase, resulting in little incorporation of AC into cellular DNA (Kimberlin, 
2001). 
 
1.3.7.1.2.5. Adverse Effects 
AC is generally well tolerated (Gibbon, 2003). However, when administered i.v., it may 
cause inflammation and phlebitis at the injection site (Gibbon, 2003). Renal impairment 
may occur, although this appears to be reversible as it has reported to respond to 
hydration and / or dosage reduction or withdrawal (Harrington et al., 1981) If not 
controlled, it may progress to acute renal failure (Giustina et al., 1988; Eck et al., 1991). 
Occasionally, i.v. AC has caused neurological effects including lethargy, confusion, 
agitation, tremors and convulsions (Wade and Meyers, 1983). 
 
1.3.7.1.2.6. Drug Interactions 
Patients being treated with both zidovudine and AC together can develop severe 
somnolence and lethargy (Kimberlin, 2001). The likelihood of renal toxicity is increased 
when AC is administered with nephrotoxic drugs such as cyclosporine and amphotericin 
B (Kimberlin, 2001; Gibbon, 2003). Concomitant administration of probenicid decreases 
renal clearance of AC and prolongs its half-life; conversely, AC can decrease the 
clearance of drugs such as methotrexate that are eliminated by active renal secretion 
(Kimberlin, 2001). 
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1.3.7.1.3.     Pharmacokinetics 
1.3.7.1.3.1.  Absorption 
AC is slowly and poorly absorbed, as the time to reach peak concentrations is 1.5–2 hrs 
and the estimated bioavailability is 13–21 % (de Miranda and Blum, 1983). With multi-
dose administration, steady-state plasma concentrations are achieved by the second day. 
The mean plasma half-life is approximately 3.32 hrs and 3.03 hrs after oral and i.v. 
administration respectively (Blum et al, 1982). 
 
1.3.7.1.3.2.  Distribution 
AC is widely distributed in tissues and body fluids including the brain, kidney, lung, 
liver, muscle, spleen, uterus, vaginal mucosa and secretions, and the cerebrospinal fluid 
(CSF) (Blum et al., 1982). After multiple dose therapy, concentrations in the brain, spinal 
chord and CSF were 25–70 % of the plasma level (Blum et al., 1982). 
 
1.3.7.1.3.3.   Metabolism 
Radiolabelled disposition studies in individuals with normal renal function show that 
almost all of an administered i.v. dose is recovered from the urine. About 80 % is 
unchanged and a further 8.5–14 % appears as the oxidised metabolite, 
carboxymethoxymethyl guanine (de Miranda et al., 1981). Another minor metabolite,    
8-hydroxy-9-(2-hydroxyethoxymethyl guanine can be detected in urine at very low 
concentrations. Neither of these metabolites is known to be pharmacologically active (de 
Miranda et al., 1981).  
 
1.3.7.1.3.4. Excretion 
Renal excretion is the major route of elimination in individuals with normal renal 
function (de Miranda et al., 1981). The renal clearance of AC is approximately three 
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times greater than that of creatinine, thus indicating that the drug is removed by tubular 
secretion as well as glomerular filtration (de Miranda et al., 1981). 
 
1.4. RESEARCH OBJECTIVES 
Due to the activation of the immune response in the CNS during diseases such as AD, 
HSE and depression, the neurotoxin QA is produced. These diseases have the potential to 
impair learning and memory and hippocampal lesioning has been reported. Although QA 
may not be the sole cause of this neurodegeneration, it is likely to have some role to play, 
particularly if neurotoxic concentrations in the hippocampus are achieved. Numerous 
studies point to a neuroprotective potential for guanine, guanosine and their derivatives 
and analogues. AC, a guanosine analogue is of particular relevance in this regard because 
it is the current drug of choice in the treatment of one of these debilitating diseases, 
namely, HSE. 
 
The objective of this study is to determine whether AC has the ability to reduce QA-
induced spatial memory deficits and the neurodegeneration associated therewith. In 
addition, it also seeks to establish some of the mechanisms by which AC affords 
neuroprotection, if any, through the employment of various biological assays and 
inorganic studies. 
 
Since an increase in QA could enhance neuronal damage produced by a primary brain 
insult, the reduction in QA synthesis could limit the extent of CNS injury (Stone, 2000a). 
Thus, the effect of AC on the activity of some of the enzymes in the biosynthetic pathway 
of QA will be assessed to see if this drug could favourably regulate the KP. Due to the 
interplay between the cytokine activated KP and brain 5-HT, any profound effect 
exhibited by AC on the KP is expected to reflect in brain 5-HT and related 
neurotransmitter levels, thus changes in these levels will be investigated. Furthermore, 
preserving 5-HT levels within the brain may aid in preventing or alleviating mental 
depression, therefore the effect of AC on 5-HT metabolism will also be determined. 
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It is hoped that this study will provide more information on the neuroprotective potential 
of AC, which may contribute to the effectiveness of this antiviral in HSE. Furthermore, 
this work may provide a foundation for further research on structure-activity relationships 
of neuroprotective guanosine analogues to effectively harness maximal neuroprotective 
activity in one or some of these properties investigated. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Learning and Memory_____________________________________________________ 
 49 
CHAPTER 2 
LEARNING AND MEMORY 
 
2.1. INTRODUCTION 
The majority of studies on learning (Tsilovosky et al., 2004) include classical and 
instrumental conditioning. Classical conditioning is characterised by the contingent 
reinforcement of a specific signal, called a conditioned stimulus (CS) (Tsitolovsky et al., 
2004) with an unconditioned stimulus (US) to produce an unconditioned response (UR), 
resulting in the CS acquiring the ability to evoke a conditioned response (CR). This type 
of learning was first discovered by Pavlov who experimentally found that food as a US 
reflexively evokes salivation, the UR in dogs (Anderson, 2000). After repetitively giving 
the dogs food with the concomitant ringing of a bell (CS), the bell ringing could 
eventually evoke the salivation by itself (Anderson, 2000). On the other hand, the basis of 
instrumental conditioning is the contingent reinforcement of a specific type of behaviour 
(Tsitolovsky et al., 2004) with a stimulus. In 1898, Thorndike studied this type of 
learning by placing a hungry cat in a box with food outside (Anderson, 2000). If the cat 
hit an unlatching device, the door would open and the cat would escape and eat the food. 
After repeated trials, Thorndike found that the random behaviour of the cat diminished 
(Anderson, 2000) and when placed in the box, unlatching the door became instinct. Thus, 
in instrumental conditioning, the response (in this case, unlatching the door) to a stimulus 
(being placed in the box) is performed to obtain a reinforcer (escape and food).  
 
One of the most widely accepted ideas about memory is the distinction between short-
term memory and long-term memory (Atkinson and Shiffrin, 1968; Baddeley, 1976). 
More recently, it was suggested that long-term memory can be divided into two major 
components referred to as declarative or explicit and non-declarative or procedural 
memory (Schacter, 1987; Soliveri et al., 1992; Squire et al., 1993). While declarative 
memory relates to the ability to store and recall or recognise specific images, events, or 
facts, procedural memory is based on information which is accessible only by 
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improvement in performance and includes, for example, the cognitive and motor skill 
acquisition (Rammsayer et al., 2000) required to remember how to ride a bike. 
Declarative memory is generally conceived as a combination of episodic and semantic 
memory (Schacter and Tulving, 1994). Episodic memory involves the capacity to 
remember specific personal experiences (Eichenbaum, 2003). These memories contain 
the detailed sequence of events that constitute an experience and the spatial and temporal 
context in which the experience occurred (Eichenbaum, 2003). Semantic memory 
involves the acquisition of world knowledge, an organisation of information about the 
physical features of the world, about the content and meaning of language, social 
structure, geography and a multitude of other spheres of knowledge (Eichenbaum, 2003). 
 
Memory may further be classified according to purpose. Reference memory refers to the 
memory of information that remains constant over a relatively long period of time, 
whereas working memory refers to memory of information which is rapidly changing 
(Olton et al., 1979). 
 
Memory processing consists of an encoding phase, a consolidation phase and a retrieval 
phase. In the encoding phase, the stimulus material has to be learned (intentional) or 
processed deeply (incidental) (van der Veen et al., 2006). In the consolidation phase, the 
previously learned or encoded stimulus material is transformed into a permanent memory 
trace. In the retrieval phase, the stored information has to be retrieved from memory by 
using either recognition or recall (van der Veen et al., 2006). 
 
There is a well-established tradition of studying the effects of drugs using behavioural 
methods (Cook and Kelleher, 1963; Gollub and Brady, 1965). Defining behaviour in 
terms of underlying biological events is not a new concept (Bondy, 1985). Such 
correlations have been attempted in several areas ranging from learning and memory to 
neurological disease. Neurological disorders can formally be described as disturbances in 
structure or function of the nervous system resulting from a developmental abnormality, 
disease, injury, or toxin (http://www.alz.org/Resources/Glossary.asp#n). Increased 
information concerning the relationship between behaviour and neurobiological 
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mechanisms is important because it is often abnormal behaviour that is a first sign of 
exposure to a neurological disease and such changes may give clues as to the anatomical 
or chemical sites of attack on the nervous system (Bondy, 1985). Unfortunately, there 
appears to be a shortfall of literature reporting on both behavioural and biological 
disturbances caused by an agent of neurological disorders (developmental abnormality, 
disease, injury, or toxin) in the same experimental animal (Bondy, 1985). 
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2.2. THE EFFECT OF QA ALONE AND IN COMBINATION 
WITH AC ON RAT SPATIAL REFERENCE MEMORY 
 
2.2.1.  Introduction 
Declarative memory, in general, is highly dependent on the integrity of the hippocampus 
and anatomically related structures in the medial temporal lobe and diencephalon (Zola-
Morgan and Squire, 1993; Nelson, 1995). The hippocampal formation is particularly 
important in the development of episodic declarative memory (Squire et al., 1993; 
Schacter et al., 1996; Vargha-Khadem et al., 1997) and the working memory (Olton et 
al., 1979), necessary for the processing of cognitive mapping (O’Keefe and Nadel, 1978), 
or relational association (Eichenbaum et al., 1990; Bunsey and Eichenbaum, 1996). The 
hippocampus encodes the association or relation of numerous factors by representing 
sequences of multiple events or factors that compose the spatial and temporal context of 
an episode (Furusawa et al., 2006). Thus, many studies have suggested that the 
hippocampus is imperative for spatial memory. 
 
Rolls (1987) produced a theory of the hippocampus in which the dentate granule cells 
encode episodic memory input from the cortex by performing pattern separation so that 
the mossy fibres can act to set up different representations for each memory to be stored 
in the CA3 cells. The CA3 neurons then facilitate autoassociation. Autoassociation refers 
to the ability of a network of neurons to store information, after constant exposure to the 
same pattern of information (Hertz et al., 1991). When a distorted image of the same 
pattern (partial cue) is detected, the task is to retrieve the pattern. Rolls (1987) further 
suggested that the CA1 cells operate as a recoder for the information recalled from the 
CA3 cells so that the recalled information would be represented more efficiently to 
enable recall, via backprojection synapses to the neocortical areas similar to that which 
had been present during the original episode. As described in section 1.1.2., the CA3 
pyramidal neurons synapse on the CA1 pyramidal neurons via their axons known as the 
Schaffer collateral system. It is these synapses which undergo synaptic modification in 
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the form of LTP during learning (Morris, 1989), thus making it structurally possible for 
autoassociation to occur. By recording the firing patterns of hippocampal neurons of rats, 
Wood et al. (2000) showed that certain hippocampal neurons fire selectively and, 
therefore, likely undergo autoassociation when a rat is in a particular locus in its 
environment. This finding has been described as evidence that the hippocampus is 
dedicated to forming spatial maps (O’Keefe, 1979). 
 
Since the hippocampus plays such an important role in episodic memory, lesioning of this 
limbic structure after learning a spatial orientated task would induce spatial memory 
deficits (Winocur et al., 2005). QA is known to have the ability to cause lesioning in the 
hippocampus (Schwarcz et al., 1984 Speciale et al., 1987; Haberny et al., 1992), thus the 
aim of the experiment in this study is to investigate the effect of QA on spatial reference 
memory in male Wistar rats. Furthermore, since lesioning of the hippocampus commonly 
occurs during adult HSE and there is a link between HSE and QA (section 1.2.4.1.), it 
was also decided to assess whether AC, the current treatment of HSE could alter the 
effect, if any, of QA on spatial reference memory. This is deemed particularly relevant 
because AC belongs to the nucleoside class of guanosine analogues which have known 
neuroprotective effects (section 1.3.7.). The results of the study may also provide a 
foundation for further research into guanosine analogues and other potential memory 
impairing disorders, associated with QA, such as AD and depression (section 1.2.4.1.). 
 
Morris, (1981) first demonstrated that rats can rapidly learn to locate an object that they 
cannot see, hear, or smell provided it remains in a fixed spatial location relative to distal 
room cues. Instrumental associative learning is employed by training rats to escape from 
an opaque tank of water by swimming onto a platform, which is in a fixed location and 
submerged below the level of the water. Room cues are available to the rats to use for 
spatial orientation. After training, the hippocampi of the rats are lesioned and the rodents 
undergo a treatment regime. The effects thereof on the spatial memory of the water maze 
task experienced before the lesioning is determined by reintroducing the rats to the same 
Morris water maze and assessing the latency (time in seconds) to escape to the platform. 
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Since the location of the platform is not varied, this standard water maze task measures 
predominantly spatial reference memory, rather than spatial working memory. 
2.2.2.  Materials and Methods 
2.2.2.1. Animals 
Adult male Wistar rats were purchased from the National Health Laboratory Service 
(NHLS), Johannesburg, South Africa. The rats were randomly assembled into groups of 
five and housed in separate cages under artificial illumination with a daily photoperiod of 
12 hours (lights on at 06h00). The temperature of the animal house was maintained at  
20–24 ˚C, while an extractor fan ensured the constant removal of stale air. The rats   
(200–250 g) were provided with food and water ad libitum. All protocols for the 
experiments were approved by the Rhodes University Animal Ethics Committee. 
 
2.2.2.2.      Chemicals and Reagents 
AC sodium (Zovirax®, powder for injection) was obtained from Glaxo Wellcome, 
Midrand, South Africa. QA was purchased from Sigma Chemical Co, St. Louis, USA. 
Sodium phenobarbitone was purchased from Merck, Germany and was at a working 
concentration of 60 mg/ml. 
 
2.2.2.3.        Animal Training in the Morris Water Maze Task 
A black (opaque) platform, 12.5 cm in diameter and 31 cm in height, was placed on a 
marked position in a black circular water tank, 150 cm in diameter and 40 cm in height. 
Water at a temperature of 23 ˚C was filled in the tank to a height of 33 cm, thus the 
platform was submerged 2 cm below the level of the water. The tank was located in a 
room with colourful pictures (cues) external to the tank, which could be used by the rats 
for spatial orientation. The positioning of the cues remained unchanged throughout the 
study. During the training sessions, each rat was put into the water at the same starting 
point, and left to swim in the tank until they found the platform. If they failed to find the 
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platform within 90 s, they were gently guided to it. Training was conducted twice a day 
for 7 days, with each session consisting of two trials. 
 
2.2.2.4. Surgical Procedures 
Each rat was anaesthetised by an intraperitoneal (i.p.) injection of sodium phenobarbitone     
(60 mg/kg) and placed in a stereotaxic frame (Stoelting, IL, USA). The rat skull was 
orientated according to the stereotaxic atlas of König and Klippel (1963). After a sagittal 
cut in the skin of the skull, the bregma suture was located and bilateral holes were 
manually formed with a 21 gauge needle, at the following co-ordinates; 4.0 mm anterior, 
2.5 mm lateral of the suture. Care was taken not to damage the meninges. A Hamilton 
syringe with a 26 s gauge cannula with an outer diameter of 0.47 mm was used to inject 
120 nmoles of QA in 2 µl phosphate buffered saline (PBS), pH 7.4., 3 mm ventral of the 
dura. The rats in the control group were sham-lesioned with injections containing PBS 
only. Each injection was administered at a rate of 1 µl per minute and the cannula was 
left in situ for a further 2 minutes to allow for passive diffusion away from the cannula tip 
and to minimise spread into the injection tract. The cannula was then slowly removed and 
the scalp was closed with sutures. The rats were kept warm until recovery from the 
anaesthesia. 
 
2.2.2.5. Drug Treatment 
The rats were treated as described in table 2.1. The rats in the control group, which were 
sham-lesioned received an i.p. injection of saline (vehicle) twice a day for 5 days. The 
rats in the QA only group received this same treatment, whilst those in the QA + AC 
group received an i.p. injection of 5 mg/kg AC (dissolved in saline) twice a day for 5 
days.  
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Table 2.1. Treatment regime for each group of rats 
 
Treatment Group Intrahippocampal Injection 
 
Intraperitoneal Injection 
(Twice a day for 5 days) 
Control PBS Saline 
QA alone 120 nmoles QA Saline 
QA + AC 120 nmoles QA AC 5mg/kg 
 
2.2.2.6. Morris Water Maze Test of Spatial Reference Memory 
During these test runs, the rats were placed into the tank at the same starting point as 
during training, with their heads facing the wall of the tank. The time taken (latency to 
escape) for each rat to find the platform from the starting point was measured, using a 
stopwatch, by a person unaware of the experimental conditions. The test runs were 
performed once a day for 7 days. 
 
2.2.2.7. Brain and Hippocampi Removal 
On the 8th day after drug treatment, the rats were killed by cervical dislocation and 
decapitated. The brain was exposed by making an incision on either side of the parietal 
structure, from the foramen magnum to near the orbit. The calvarium was removed, 
exposing the brain, which was easily removed. The hippocampus was then dissected out 
from each hemisphere of the whole brain, rapidly frozen in liquid nitrogen and stored at 
-70 ˚C for use in chapter 5. 
 
2.2.2.8. Statistical Analysis 
All results were analysed using repeated measures analysis of variance (ANOVA) with 
group as a factor and latency to escape measured over 7 days. Student–Newman–Keuls 
multiple range test was used for post hoc analysis. The level of significance was accepted 
at p < 0.05 (Zar, 1974). 
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2.2.3.  Results 
The statistical analysis shows a significant difference in latency to escape between the 
groups (F = 20.39, p < 0.001). Post hoc tests (Student–Newman–Keuls’ Multiple Range 
tests) show that the latency to escape (over 7 days) of rats in the QA only group is 
significantly longer in comparison to the control group (p < 0.001). The QA + AC group 
has significantly faster escape times in comparison to the QA alone group (p < 0.001). 
There is no difference between the latencies to escape of the control group in comparison 
to the QA + AC group (p > 0.05). 
 
As shown in figure 2.1., it is evident that the latency to escape of the QA group decreases 
sharply between day 5 and day 7 on which the mean escape time was equal to that of the 
QA + AC. 
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Figure 2.1. Performance of the rats in the Morris water maze task. Each point represents 
the mean latency ± SD to escape of 10 rats. 
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2.2.4.  Discussion 
A previous study has shown that intrahippocampal injections of QA have the ability to 
impair memory (He et al., 2002). This is likely through the formation of lesions, which 
prevent the hippocampi from engaging in normal functioning. Lesioning by QA infusion 
occurred after memory encoding and consolidation (during training), but before memory 
retrieval (test runs), thus it is likely to be the last phase (memory retrieval) in the memory 
process which QA impairs. QA is an agonist at NMDA receptors (Stone and Perkins, 
1981; Pérez-Navarro et al., 2005), which are present in the glutamatergic synapses of the 
hippocampus and which are involved in LTP, the neuroplastic process which makes 
autoassociation possible (section 2.2.1.). It is this property of QA which may be involved 
in altering the ability of the rats to retrieve spatial reference memory. 
 
A signal-to-noise hypothesis has been proposed to be a consequence of enhanced activity 
of the glutamatergic system (Danysz and Parsons, 2003). Since QA is not metabolised in 
the synaptic cleft, it remains there for prolonged periods (Choi, 1988) and may thus cause 
continuous overstimulation of the NMDA receptors on the postsynaptic neuron. These 
receptors are usually only stimulated by glutamate released from the presynaptic neuron 
when it (the presynaptic neuron) receives an impulse (Danysz and Parsons, 2003). This 
normal physiological stimulation of the NMDA receptor evokes an influx of calcium 
ions, known as the calcium signal, required to induce LTP (section 1.1.3.1.). In the 
presence of QA, temporally uncoordinated, continuous pathological stimulation of 
NMDA receptors may occur, producing enhanced noise, decreasing the probability of 
detecting the relevant calcium signal (Danysz and Parsons, 2003) produced in response to 
firing of the presynaptic neuron. 
 
During the test trials (after the lesioning), the firing of hippocampal neurons occurs when 
partial cues are detected and the retrieval process of autoassociation is put in motion. All 
groups of rats have potentiated glutamatergic synapses between CA1 and CA3 subfields 
of the hippocampus, where the spatial information is stored and from which it needs to be 
retrieved. These potentiated synapses are formed by the induction and subsequent 
expression of LTP (section 1.1.3.1. and section 1.1.3.2.) in the encoding and 
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consolidation process during the 7 days of training. However, in these synapses in the 
hippocampi of rats lesioned with QA, the calcium signal generated as a result of an 
impulse is not detected. Therefore it is likely that the CA1 cells are unable to operate as 
recoders for the information recalled from the CA3 cells. This in turn suggests that the 
recalled information would not be represented more efficiently to enable recall, via 
backprojection synapses to the neocortical areas (section 2.2.1.). 
 
Overstimulation of ionotropic glutamate receptor sub-types, such as NMDA and AMPA 
may also lead to neurodegeneration via an excitotoxic mechanism described in section 
1.2.2.4. This implies that concentrations of QA which are high enough may cause 
degeneration of the postsynaptic neurons of the potentiated glutamatergic synapses. This 
poses a second mechanism by which QA impairs memory. If these neurons are destroyed 
then the information stored within them cannot be retrieved.  
 
It has been reported that intravenous AC treatment is able to improve the memory deficits 
in adult patients with HSE (Ishida et al., 2002; MacLean and Douen, 2002). This finding 
is coincident with a decrease in serum HSV DNA to undetectable levels (MacLean and 
Douen, 2002), suggesting that AC brings about this effect through its antiviral 
mechanism. However, in the present study AC appears to employ a mechanism 
independent of its antiviral activity, because it improves spatial reference memory 
deficits induced by QA, a product of the viral-induced immune response (Reinhard, 
1997). Thus AC either has the ability to reduce the noise-to-signal ratio or to protect the 
neurons against excitotoxicity-induced neurodegeneration, the two proposed mechanisms 
by which QA causes spatial memory deficits. AC appears to be very effective as it 
improves the memory to the extent that there is no significant difference in comparison to 
the control group (p>0.05). The ability of 120 nmoles of QA injected intrahippocampally, 
in the absence and presence of subsequent AC treatment, to cause neurodegeneration will 
be investigated in chapter 3. This will be the first step towards attempting to elucidate the 
neurobiological mechanisms which underlie this hitherto unreported effect of AC. 
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The improvement in memory of the QA alone group between days 5 and 7 shown in 
figure 2.1. may indicate that parts of the hippocampi were still able to function normally 
and that 120 nmoles QA did not lesion the entire hippocampus. This suggests that during 
the first few days of the test trials, the rats may undergo relearning, by encoding and 
consolidating the spatial information again, further strengthening the glutamatergic 
synapses through LTP in the unlesioned parts of the hippocampus. The autoassociative 
retrieval process and recall is therefore more easily achieved in the last few days (day 5–
day 7) of the test trials from these parts of the hippocampus than previously because the 
synapses are stronger. This increase in synaptic strength further implies that a more 
distorted (vague) partial cue may be detected, causing normal firing of the presynaptic 
neuron, which releases normal physiological levels of glutamate. The glutamate 
stimulates the NMDA receptors subsequently producing a signal great enough to activate 
the retrieval process. This concept of relearning shows the adaptability of neuroplastic 
processes in the brain.  
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CHAPTER 3 
NEURODEGENERATION 
 
3.1.  INTRODUCTION 
Necrosis and apoptosis cannot be taken as two completely distinct modes of cell death. 
Since these can be encountered in the same tissue and initiated by the same type of 
stimuli, it would appear possible that, at least some of the early events are common to 
both types of cell death, and that downstream controllers may decide the direction 
towards one outcome or another (Toescu, 1998). Necrosis, associated with extreme 
energy failure in mitochondria, may simply reflect the failure of neurons to carry out the 
"default" apoptotic death program used to dispose efficiently of aged or otherwise 
unwanted cells (Ankarcrona et al., 1995). The preservation of mitochondrial function 
may therefore be a decisive factor in determining the degree and progression of neuronal 
injury caused by excitotoxins (Ankarcrona et al., 1995) such as glutamate or QA. Both 
forms of cell death occur after exposure of brain regions which contain high 
concentrations of NMDA receptors for glutamate. These regions include the cerebral 
cortex and CA1 subfield of the hippocampus (Monaghan and Cotman, 1986). First, a 
rapid necrotic cell killing occurs during and immediately after glutamate exposure and is 
associated with loss of mitochondrial function. Second, a delayed apoptotic type of 
neuronal death occurs in the surviving neurons that recover their mitochondrial function 
and cellular energy levels (Ankarcrona et al., 1995). 
 
Histology is the anatomical study of the microscopic structure of animal and plant tissues. 
Histologic sections may be used to define the normal or abnormal appearance of brain 
tissue (Schmitz and Hof, 2005). Such descriptions, although subjective, are very useful to 
describe features of sections when there are distinct differences between pathologic and 
physiologic conditions (Schmitz and Hof, 2005). 
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Brain tissue consists of neurons, which are the impulse conducting cells of the nervous 
system and non-conducting, supporting glial cells, including astrocytes, oligodendrocytes 
and microglia, which nourish and protect the neurons. Glial cells are far more numerous 
than neurons and, unlike neurons, are capable of mitosis. 
 (http://en.wikipedia.org/wiki/Neuron) 
 
A typical neuron is shown in figure 3.1. It consists of a cell body, containing the nucleus 
and the surrounding cytoplasm, several short radiating processes (dendrites) and one long 
process (the axon), which terminates in twig-like branches. 
(http://en.wikipedia.org/wiki/Neuron) 
 
 
 
Figure 3.1. Structure of a typical neuron. (http://en.wikipedia.org/wiki/Neuron). 
 
The dendrites serve to collect incoming electrochemical signals either from the periphery 
or other neurons, to send them to the cell body. The axon is a long process that conducts 
an electrical impulse away from the neuronal cell body. At the other end of the axon, the 
axon terminals transmit the electrochemical signal across the synapse. Myelin, 
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manufactured by Schwann cells coats and insulates the axon (except for periodic breaks 
called nodes of Ranvier), increasing transmission speed along the axon.  
(www.med.mun.ca/anatomyts/nerve/neuron.htm). 
 
Neurons are metabolically very active and are thus involved in large amounts of protein 
synthesis. It is not surprising therefore that the most prominent organelle in the cell body 
is the rough endoplasmic reticulum (RER). RER is formed into large Nissl bodies and is 
responsible for protein synthesis (www.med.mun.ca/anatomyts/nerve/neuron.htm). The 
cell bodies of neurons also contain extensive neurofilaments and microtubules. These 
organelles are involved in the transport of materials synthesised in the cell body out into 
the processes. Neurons also generally have clearly observable nuclei. The Nissl bodies, 
neurofilaments and microtubules and clearly observable nuclei are the unique features of 
neurons in comparison to other cells. Other organelles present are common to most cells. 
(http://www.med.mun.ca/anatomyts/nerve/neuron.htm). 
 
Astrocytes are the largest and most abundant of all glial cells. These appear star shaped 
due to their large number of cytoplasmic processes that extend outwards from the cell 
body. The cytoplasm contains intermediate filaments that are composed of glial fibrillary 
acidic protein which serves to identify these cells (Björkland et al., 1984) 
 
Another salient feature of neurons in contrast to other cells of the body is that the nuclei 
of these do not possess centrioles. This is consistent with the amitotic nature of neurons 
in a developed brain and implies that degenerated neurons cannot be restored or replaced 
(http://training.seer.cancer.gov/module_anatomy/unit5_2_nerve_tissue.html).This is the 
primary challenge which neuroscientists are faced with in attempting to find treatments 
for neurodegenerative disorders.  
 
AD is a well established chronic progressive neurodegenerative disorder, in which brain 
regions involved in learning and memory, such as the hippocampus, are severely affected 
by QA produced in response to microglial activation, ultimately showing the highest rate 
of neurodegeneration (section 1.1.4.2.). The neurodegeneration in HSE is not as well 
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known and usually acute in nature. Increases in QA have been found in mice with 
experimental HSE (section 1.2.4.1.) and adult human HSE is pathologically characterised 
by necrotising lesions commonly found in the CNS structures implicated in learning and 
memory, including the amygdala, hippocampus, and entorhinal cortex (section 1.1.4.3.). 
QA production in the neurodegenerative hypothesis of depression is initiated through 
IDO activation by pro-inflammatory cytokines. The hypothesis has been supported by 
findings that hippocampal atrophy occurs in major depression (section 1.1.4.4.). 
 
Degeneration of the supporting glial cells may indirectly cause neurodegeneration as 
neurons are no longer supplied with the sustenance required to survive. This however is 
not likely to be a long term or major mechanism of neurodegeneration as the glial cells 
have the ability to undergo mitosis and therefore degenerated glial cells are rapidly 
replaced. 
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3.2. THE EFFECT OF QA ALONE AND IN COMBINATION 
WITH AC ON RAT HIPPOCAMPAL 
NEUROMORPHOLOGY AND CYTOARCHITECTURE 
 
3.2.1.  Introduction 
In section 1.1.2., the structure of the hippocampus was described. The important features 
of this description with respect to hippocampal neuromorphology and cytoarchitecture 
are aptly depicted in figure 3.2. 
 
 
 
Figure 3.2. Schematic diagram illustrating some aspects of the neuromorphology and 
cytoarchitecture of the rat hippocampus (Bear et al., 2001). 
 
Figure 3.2 shows the dentate gyrus and Ammon’s horn (only CA1 and CA3 are labelled) 
as two interlocking “C” shaped structures. It further indicates that the cell bodies of the 
neurons making up the primary cell layer of Ammon’s horn are pyramidally shaped, 
whilst those of the dentate gyrus are round and granular. Moreover, these primary strata 
Neurodegeneration________________________________________________________ 
 66 
of Ammon’s horn and the dentate gyrus both take on a characteristic band–like 
appearance. 
 
QA has been shown to cause dose–dependent selective pyramidal cell death in the 
hippocampal CA1, CA3 and CA4 regions (Behan et al., 1999) and results in the 
infiltration of microglial cells into the pyramidal cell layers and surrounding tissue (Stone 
et al., 2000). Thus, the present study aims to determine whether 120 nmoles QA has the 
ability to elicit such an effect in the CA1 and CA3 regions of the hippocampus, using 
histological analyses; and moreover, to assess the ability of AC to protect against 
pyramidal cell death, if any. This investigation will provide useful information on the 
degree to which the extent of neurodegeneration dictates the efficiency of spatial 
reference memory and therefore determine whether a correlation exists between the two 
processes. 
 
Histology as a technique relies on subjective visual assessment. Therefore, to improve the 
visibility of histologic sections, dyes and stains which react with tissue components are 
employed before examination under a microscope. The Nissl stain, introduced by the 
German neurologist Franz Nissl in the late nineteenth century, is commonly used to study 
neurons under the light microscope (Bear et al., 2001). This stain is extremely useful 
since it distinguishes neurons and glia from one another (Bear et al., 2001). This is 
because of the unique high Nissl body content of neurons which was described in section 
3.1. The elevated RNA content makes Nissl bodies highly basophilic. The bodies are thus 
sharply stained with basic aniline dyes, such as cresyl violet (figure 3.3.). 
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N
O +NH 2 N H 2
 
               
              Figure 3.3. Structure of cresyl violet, showing that it is an aniline 
              (http://www.coleparmer.com/catalog/large_image.asp?img=AGROS22963.jpg) 
 
3.2.2.  Materials and Methods 
3.2.2.1. Animals 
Adult male Wistar rats were purchased from the NHLS, Johannesburg, South Africa and 
cared for as described in 2.2.2.1. 
 
3.2.2.2. Chemicals and Reagents 
AC sodium (Zovirax®, powder for injection) was obtained from Glaxo Wellcome, 
Midrand, South Africa. QA and Cresyl violet acetate were purchased from Sigma 
Chemical Co, St. Louis, USA. Sodium phenobarbitone was purchased from Merck, 
Germany and was at a working concentration of 60 mg/ml. Paraffin wax was purchased 
from Lasec, South Africa and Distrene Plasticiser in xylene (DPX) was a donation from 
the Rhodes University Botany Department. Haupt’s Adhesive was prepared as follows: 1 
g gelatine, 100 ml water, 2 g phenol and 15 ml glycerol. Ethanol and xylene were 
purchased from Saarchem, Krugersdorp, South Africa. 
 
3.2.2.3. Surgical Procedures 
These procedures were conducted as described in section 2.2.2.4. 
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3.2.2.4. Drug Treatment 
This was performed as described in section 2.2.2.5. 
 
3.2.2.5. Brain Removal 
The rats were killed and the brains removed in the manner described in section 2.2.2.7. 
 
3.2.2.6. Histological Techniques 
3.2.2.6.1. Fixation of the Brain 
The brains were immediately stored in a fixative medium, which consisted of 
formaldehyde (30 %), glacial acetic acid and ethanol (2: 1: 7 v/v), for 48 hours. This 
process is necessary to preserve, as much as possible, the morphological and molecular 
structure of the tissue. Coronal sections were then cut from the forebrain. 
 
3.2.2.6.2. Tissue Processing 
Moisture was extracted from the tissue fragments by bathing these successively in graded 
series of ethanol for one hour each. This step was followed by the clearing process that 
involves the removal of ethanol by immersing the tissue in xylene twice for one hour 
each. The tissue was then submerged in molten paraffin wax at 57 ˚C twice for one hour 
each, which facilitated the removal of xylene and the thorough penetration of the tissue. 
This last step provides the hardness and support that the tissue requires for sectioning. An 
outline of the tissue processing is summarised in table 3.1.  
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Table 3.1. Outline of the steps in tissue processing. 
 
Step Processing Agent Time 
1 70 % ethanol 1 hour 
2 90 % ethanol 1 hour 
3 Absolute ethanol I 1 hour 
4 Absolute ethanol II 1 hour 
5 Xylene I 1 hour 
6 Xylene II 1 hour 
7 Molten wax (57 ˚C) 1 hour 
 
3.2.2.6.2. Blocking Out 
Blocking out was performed to form a support that would facilitate sectioning using a 
rotary microtome. This was done by fixing the brain material into a block using a mould. 
A plastic ice tray coated with lubricating gel was used as the mould.  Molten wax (10 ml) 
was added to the mould, the surface of which was allowed to harden. The brains were 
then removed from the final molten wax stage (step 7 in table 3.1) and placed carefully 
onto the mould with warmed forceps. Molten wax was then poured onto the brain so that 
it was completely submerged. Air was then gently blown over the surface of the wax to 
allow the top layer to solidify. The entire mould was then immersed in cold water 
overnight to facilitate quicker solidification and to prevent the formation of crystals that 
might disrupt the tissue. 
 
3.2.2.6.3. Sectioning 
The wax block was trimmed with a razor blade so that two of the sides were parallel to 
each other and the other two sides converged slightly. The sides were cut so as to leave 
about 2 mm of wax around the tissue. The entire wax block was attached to a small 
wooden block with a small amount of wax. Sectioning was done using a rotary 
microtome, set to cut sections with a thickness of 10 µm. As the sections were cut, these 
stuck together, forming long ribbons. When the part of the brain containing the 
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hippocampus was reached, the long ribbons were removed and placed in a water bath    
(40 ˚C) using warm forceps. 
 
3.2.2.6.4. Transferring Sections to Slides 
Each glass microscope slide was brushed with a thin layer of Haupt’s adhesive, using a 
thin paint brush, before being dipped into the water bath to allow 4–5 sections (1 long 
ribbon) to be mounted. The slides were left overnight in an oven set at 40 ˚C and 
saturated with formalin, to enable the section to adhere to the slide. 
 
3.2.2.6.5. Staining 
The sections were Nissl stained using cresyl violet. This stain stains Nissl substances 
intense purple, the nuclei purple, and leaves the background clear (Bauer et al., 1974). 
Since this dye is water soluble, the entire embedding process had to be reversed in order 
to remove the paraffin wax from the tissue and allow penetration of the dye. The paraffin 
was removed by running the slides through xylene twice for five minutes each, followed 
by immersion in a mixture of xylene and absolute ethanol (1:1) for three minutes. This 
step was followed by immersion in absolute ethanol for five minutes, and then re-
immersion in absolute ethanol overnight, at 30 ˚C. The procedure is outlined in table 3.2. 
 
Table 3.2. Outline of the procedure for dewaxing and rehydrating brain sections. 
 
Step Processing Agent Time 
1 Xylene I 5 minutes 
2 Xylene II 5 minutes 
3 Xylene: Absolute ethanol 
(1:1) 
5 minutes 
4 Absolute ethanol I 5 minutes 
5 Absolute ethanol II Overnight at 30 ˚C 
 
Neurodegeneration________________________________________________________ 
 71 
Sections were stained by placing the slides in 0.1 % cresyl violet solution for two hours. 
These were then differentiated rapidly by rinsing them in 95 % ethanol until the 
background was clear. The slides were then dehydrated again by placing them in absolute 
ethanol twice and xylene twice for five minutes each, as shown in table 3.3. 
 
Table 3.3. Procedure for dehydrating brain sections after staining. 
 
Step Processing Agent Time 
1 Absolute Ethanol I 5 minutes 
2 Absolute Ethanol II 5 minutes 
3 Xylene I 5 minutes 
4 Xylene II 5 minutes 
 
3.2.2.6.5. Mounting the Slides 
The stained section on the slide must be covered with a thin piece of plastic or glass to 
protect the tissue from external damage such as scratching, and to provide better optical 
quality for viewing under the microscope. The slides were removed from xylene (step 4 
in table 3.3.) and enough DPX was added to cover the stained tissue. A coverslip was 
placed over the stained tissue and pressed to remove air bubbles. The slides were allowed 
to dry on a flat surface for 48 hours. 
 
3.2.2.6.6. Photomicroscopy 
Slides were viewed using a bright light microscope. The CA1 and CA3 regions of the 
hippocampus were located and photographed with a digital Olympus camera. 
 
3.2.3.  Results 
Sections of the CA1 and CA3 regions of the control treated rats (figure 3.4 (a) and (b) 
respectively) show optimally sized, pyramidal shaped neurons which are grouped closely 
together to form the characteristic band-like appearance (section 3.2.1). The cells also 
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have clearly observable cell nuclei and continuous cell membranes. Thus these neurons in 
the CA1 and CA3 region appear to be undamaged.  
 
The hippocampal neuronal cells of both regions of the QA treated animals (figure 3.4 (c) 
and (d), respectively) have lost the pyramidal shape and are instead, round and swollen. 
These cells have also lost the band-like arrangement, appearing scattered, and 
furthermore, have little integrity of the cell membranes. There also appear to be fewer 
neurons indicating that lysis of some of the neurons has occurred.  
 
The majority of the hippocampal neuronal cells in the QA + AC treated rats (figure 3.4 
(e) and (f)) appear to have retained the pyramidal appearance, with better orientation, 
appearing closer to each other as though in an attempt to reconstruct the typical band-like 
appearance. These cells also show greater integrity of cell membranes in comparison to 
those of the QA only treated rats.  There are also fewer neurons which have undergone 
lysis. 
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Figure 3.4. Effect of QA alone and in combination with AC on rat hippocampal 
neuromorphology and cytoarchitecture. Figure 3.4 (a and b) show the CA1 and CA3 
regions of the control treated rats, respectively. The QA alone treated CA1 and CA3 
regions are evident as 3.4 (c and d), respectively while 3.4 (e and f) show the 
photomicrographs of the CA1 and CA3 regions of the QA + AC treated rats. Bar =        
10 µm. 
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 3.2.4. Discussion 
The cell damage and neurodegeneration occurring in the presence of an intrahippocampal 
injection of 120 nmoles QA without AC treatment, portrayed in figure 3.4 (c and d), fits 
the profile and characteristics of the various stages of necrotic cell death, described in 
section 1.2.1.2. The hypothesis that neurodegeneration is responsible for the spatial 
reference memory deficits induced by 120 nmoles QA (section 2.2.4) is therefore 
justified. Similarly, AC appears to protect against the QA-induced cell damage and 
neurodegeneration, which provides an explanation for the improvement in spatial 
reference memory (section 2.2.4). This is the first study to report on the neuroprotective 
effect of AC or any other guanosine analogue using a histological analysis.  
 
QA-induced necrosis has been associated with each of the three main mechanisms of 
neurodegeneration, namely, excitotoxicity (Stone and Perkins, 1981), mitochondrial 
dysfunction (Bordelon et al., 1997) and oxidative stress (Vega-Naredo et al., 2005), 
primarily through overstimulation of the NMDA receptor.  
 
Mitochondrial dysfunction may cause ATP depletion and therefore inevitably direct the 
neurons toward necrotic cell death rather than the more regulated apoptotic death, which 
is ATP-dependent. 
 
Excitotoxicity is a mechanism of neuronal cell death mediated by overstimulation of 
ionotropic glutamate receptor sub-types, such as NMDA and AMPA (Griffiths et al., 
2000). As described in section 1.1.3.1, in order for NMDA receptors to be activated, non-
NMDA glutamate receptors such as AMPA must be activated. This activation results in 
an influx of sodium ions into the cell causing a depolarisation of the membrane. The 
depolarisation results in the removal of the magnesium block on the NMDA receptor, 
allowing the opening of the calcium ion channel once QA has bound. Once opened, 
calcium ions move across the postsynaptic membrane and into the neuron. It has been 
suggested that two separate processes occur in the excitotoxic mechanism (Cotman et al., 
1989; Farooqui and Horrocks, 1991), namely acute toxicity and delayed toxicity.  
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The influx of sodium ions is accompanied by influx of chloride ions as well, creating an 
osmotic imbalance between the neuron and the extracellular environment (Rothman and 
Olney, 1987). Water flows into the cell, causing acute cell swelling, damage and possible 
lysis (Olney, 1969; Rothman, 1985; Choi, 1987, Tilson and Mundy, 1995), which is 
clearly observed in figure 3.4 (c and d).  
 
The massive calcium ion influx triggers the activation of intracellular calcium-dependent 
enzymes (Meldrum and Garthwaite, 1990). This causes a delayed toxicity in the round 
swollen cells that survive the osmotic crisis. The calcium ions activate various hydrolytic 
enzymes including PLA2 which cleave PUFA from lipid membranes. This may explain 
the loss of integrity of the cell membranes of the swollen round cells left after the acute 
QA insult (figure 3.4 c and d). The disintegration of the cell membranes may, in turn, 
result in the release of cytoplasmic content into the extracellular medium (Toescu, 1998). 
This triggers an important inflammatory response, which includes local cellular 
infiltration, vascular damage and oedema (Ankarcrona et al., 1995), which may account 
for the scattered arrangement of the cells and loss of the band-like appearance. 
 
QA in the hippocampus is known to elicit microglial cell infiltration (section 3.2.1) in 
response to the CNS injury. If neuronal death is induced by the injury, activated 
microglia are further transformed into phagocytic, and thus cytotoxic, cells known as 
microglia-derived brain macrophages (Mori and Kimura, 2001). These microglia kill 
injured (swollen) cells by releasing neurotoxic molecules, including free oxygen 
intermediates (section 1.1.4.1.) resulting in oxidative stress and therefore a rise in 
oxidative damage to DNA, proteins and lipids. The disintegration of the cell membranes 
may also be evidence of LP in conjunction with the action of PLA2. This will be 
investigated further in chapter 6. 
 
The neuroprotection offered by AC against the gross adverse changes in hippocampal 
neuromorphology and cytoarchitecture caused by QA (figure 3.4 e and f), may be related 
to an ability of this antiviral to interfere with one or more of the three mechanisms of 
neurodegeneration and the oxidative damage associated therewith. The ensuing chapters 
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will attempt to elucidate the neurobiological mechanisms which underlie the effect of AC 
on neurodegeneration. This includes direct effects on the mechanisms of 
neurodegeneration and the oxidative damage which correlates to it, as well as indirect 
effects. The latter includes the consequences of AC treatment on QA biosynthesis and the 
biosynthesis and metabolism of 5-HT, to assess whether AC could enhance an 
endogenous environment which challenges the neuroprotective-neurodegenerative 
balance such that the neuroprotective status of the cells is favoured. 
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CHAPTER 4 
EXCITOTOXICITY 
 
4.1. INTRODUCTION 
An increase in the concentration of a NMDA receptor agonist in the synaptic cleft of 
glutamatergic synapses may lead to excitotoxicity as a mechanism of neurodegeneration 
(section 3.2.4.). Figure 4.1., shows that this is a particularly important mechanism 
because the sequence of events it evokes effectively contributes to the other mechanisms 
of neurodegeneration as well, namely, oxidative stress and mitochondrial dysfunction.  
 
The arrival of the action potential to the presynaptic terminal (1) depolarises the plasma 
membrane and activates voltage-dependent calcium channels (2). Calcium influx induces 
the fusion of presynaptic vesicles with the presynaptic neuronal plasma membrane 
(synaptic exocytosis), (3) promoting glutamate release and increasing its concentration in 
the synaptic cleft (4). Glutamate will activate AMPA receptors on postsynaptic neurons 
(5), inducing sodium influx and depolarisation of the plasma membrane. In this 
condition, the magnesium ion that normally blocks the NMDA receptors is extruded (6), 
and the receptor activated by the binding of glutamate and its co-agonist glycine (7). The 
activation of the NMDA receptor induces sodium and calcium influx (8). Voltage-
dependent calcium channels (CCDV) also become activated (9) and in some 
circumstances calcium can also enter the cell through AMPA receptors (10). Calcium 
influx will induce cytoplasmic calcium overload and activation of diverse enzymes such 
as phospholipases (11), proteases (12) and nucleases, which drive the breakdown of 
phospholipids, proteins and nucleic acids (13). In addition, cytoplasmic calcium overload 
will lead to free radical production (14), thus oxidative stress, and impairment of 
mitochondrial function, which leads to energy failure (15) (Camacho and Massieu, 2006). 
As a result, neuronal death is likely to take place.  
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The detailed description of excitotoxicity above clearly illustrates that an understanding 
of the complexities of this process is crucial to finding ways to nullify it. The need for 
this is urgent since excitotoxicity is known to contribute towards the pathophysiology of 
several neurodegenerative disorders, such as AD (Olney, 1995; Hynd et al., 2004) and 
depression (Hayley et al., 2005; Yao and Reddy, 2005).   
 
 
 
Figure 4.1. Excitotoxic neuronal death induced by glutamate (Camacho and Massieu, 
2006). 
 
The extracellular concentration of glutamate after its synaptic release is highly regulated 
by Na+-dependent high affinity transporters located both in neurons and astrocytes 
(Storck et al., 1992; Kanai and Hediger, 2004; Maragakis and Rothstein, 2004). 
Glutamate transporter 1 is an astroglial transporter highly distributed in the entire 
forebrain (Danbolt et al., 1992; Pines et al., 1992; Furuta et al., 1997), whilst excitatory 
amino acid carrier 1 is a neuronal transporter abundantly expressed in the hippocampus, 
striatum and cerebellum (Olney et al., 1989; Schmitt et al., 2002).  
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As shown in figure 4.2., the activity of glutamate transporters depends on the sodium 
electrochemical gradient generated by the membrane Na+/K+ ATPases. One glutamate 
molecule is transported from the synaptic cleft across the neuronal cell membrane to the 
cytoplasm together with two sodium ions, while one potassium ion is extruded to the 
extracellular medium (Szatkowski et al., 1990; Attwell et al., 1993). Recovery of the 
sodium electrochemical gradient after the uptake of extracellular amino acids occurs at 
the expense of the ATP consumed by the membrane Na+/K+ ATPases (Bonvento et al., 
2002). Therefore, the maintenance of energy levels is essential for the control of 
glutamatergic transmission.  
 
 
 
Figure 4.2. Mechanism of extracellular glutamate uptake (Camacho and Massieu, 2006). 
 
Once glutamate is taken up into the presynaptic neuron, a low affinity sodium-
independent carrier located at the membrane of synaptic vesicles is responsible for 
vesicular glutamate uptake (Fykse and Fonnum, 1996; Wolosker et al., 1996). The 
coordinated actions of both systems (for neuronal and vesicular uptake) effectively 
maintain the glutamate concentration in the synaptic cleft at micromolar levels (Tavares 
et al., 2005).  From the mechanisms of the systems described above, it is evident that 
these rely on certain ionic and energy requirements, which if not met, may culminate not 
only in failure, but even possible reversal of the highly regulated processes through 
attempts by the neurons to maintain homeostasis.   
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4.2. THE EFFECT OF QA ALONE AND IN COMBINATION 
WITH AC ON GLUTAMATE RELEASE FROM RAT 
HIPPOCAMPAL SYNAPTOSOMES IN VIVO 
     
4.2.1.  Introduction 
Although microglia, astrocytes and neurons all express IDO, only microglia produce 
detectable amounts of QA. Conversely, astrocytes and neurons have the ability to 
catabolise this neurotoxin (Guillemin et al., 2005a). Astrocytes alone can thus be 
considered neuroprotective because these cells minimise QA production and maximise 
QA metabolism (Guillemin et al., 2001). However, QA selectively induces apoptosis of 
human astrocytes (Guillemin et al., 2005b) and hence effectively prolongs its own life 
and presence in the synaptic cleft. The availability of QA for perpetual NMDA 
stimulation is extended, thus aggravating excitotoxicity.  
 
In addition to eliciting a direct excitotoxic effect through NMDA overactivation, it has 
more recently been shown that in vivo, QA has the ability to inhibit vesicular and 
astrocytic glutamate uptake and to enhance synaptosomal glutamate release (Tavares et 
al., 2005). In this manner, QA indirectly enhances excitotoxicity through the elevation of 
glutamate levels in the synaptic cleft. Interestingly though, QA appears to have no effect 
on synaptosomal glutamate uptake (Tavares et al., 2005). Judging from the biological 
systems in place to regulate glutamate levels in the synaptic cleft and the inter-
relationship between these, it seems plausible to predict that QA may at least in part bring 
about these trends through exploitation of the above mentioned pathways and that any 
drug which counteracts this effect may have the ability to negate the QA-induced 
manipulation. Therefore, with the knowledge that QA has the ability to enhance 
synaptosomal glutamate release, and that this is reversed by guanosine (Tavares et al., 
2005), the effect of QA alone and in combination with AC, a guanosine analogue, on 
synaptosomal glutamate release was investigated. 
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4.2.2.  Materials and Methods 
4.2.2.1. Animals 
Adult male Wistar rats were purchased from the NHLS (Johannesburg, South Africa) and 
were cared for as described in section 2.2.2.1. 
 
4.2.2.2. Chemicals and Reagents 
AC sodium (Zovirax®, powder for injection) was obtained from GlaxoWellcome, 
Midrand, South Africa. [3H]-glutamate (specific activity of 42 Ci/mmole) was purchased 
from Amersham Biosciences, Buckinghamshire, United Kingdom. Sodium 
phenobarbitone was purchased from Merck, Germany and was at a working 
concentration of 60 mg/ml QA, Folin’s reagent, 4-(2-hydroxyethyl)-1- 
piperazineethanesulfonic acid (HEPES) and bovine serum albumin (BSA) were 
purchased from Sigma Chemical Corporation, St. Louis, MO, USA. All other bench 
reagents were of the highest quality and were purchased from Saarchem (PTY) Ltd, 
Krugersdorp, South Africa. 
 
4.2.2.3. Surgical Procedures 
These procedures were conducted as described in section 2.2.2.4. 
  
4.2.2.4. Drug Treatment  
This was performed as described in section 2.2.2.5. 
 
4.2.2.5. Brain and Hippocampi Removal 
The rats were killed and the brains and hippocampi removed in the manner described in 
section 2.2.2.7. However, the rats were killed the day after the last dose of the drug 
treatment.  
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4.2.2.6. Preparation of Synaptosomes 
Synaptosomes were prepared from each rat as previously described by Bonnet and 
Costentin (1989), with minor modifications. The hippocampi were homogenised in 20 
volumes of 0.32 M ice-cold sucrose in a pre-chilled manual glass Teflon homogeniser. 
The homogenates were then centrifuged at 1000 x g for 10 minutes at 4 ˚C to form a 
nuclear pellet. Supernatants were stored at 4 ˚C for 10 minutes and the pellet was 
resuspended in 20 volumes of 0.32 M sucrose and centrifuged for 10 minutes at 1000 x g. 
The two supernatants were then pooled and centrifuged at 17 500 x g for 30 minutes at    
4 ˚C, after which the supernatant was discarded and the pellets resuspended in Hepes/Cl 
buffered salt solution (HBSS), pH 7.4 (27 mM HEPES, 133 mM NaCl, 2.4 mM KCl,   
1.2 mM MgSO4, 1.2 mM KH2PO4, 1.2 mM glucose, 1 mM CaCl2), so as to obtain a 
protein concentration of 1.4 mg/ml. 
 
4.2.2.7. Protein Assay 
Protein estimation was done using the method previously described by Lowry et al., 
(1951). A calibration curve was generated using BSA which was prepared in Milli-Q 
water (1 ml) at concentration intervals of 60 µg/ml. The aliquots of BSA were incubated 
with copper reagent (6 ml) for 10 minutes at room temperature. Folin’s reagent (0.3 ml) 
was added and samples were left to stand for 30 minutes in the dark, at room temperature. 
The absorbance was then read at 500 nm on a GBC 916 UV/VIS spectrophotometer and 
the curve generated by plotting concentration against absorbance (Appendix I). 
 
4.2.2.8. L-[3H] Glutamate Release from Synaptosomes 
L-[3H] Glutamate release was measured according to Migues et al., (1999), with minor 
modifications. Synaptosomal preparations (1 ml) were incubated in the presence of        
L-[3H] glutamate (50 µl) at a final concentration of 500 nM. Samples were then 
centrifuged at 13 000 x g for 1 minute at 4 ˚C. The supernatants were discarded and the 
pellets washed three times with HBSS by centrifugation at 13 000 x g for 1 min at 4 ˚C. 
In order to measure the release of L-[3H] glutamate, the final pellet was resuspended in 
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HBSS and incubated for 60 s at 37 ˚C. Incubation was terminated by immediate 
centrifugation at 16 000 x g for 1 min at 4 ˚C. Radioactivity present in supernatants and 
pellets was determined separately in a Beckman, LS 2800 Scintillation Counter with a 
counting efficiency of 65 %. The results were initially expressed as L-[3H] glutamate         
(fmoles/mg protein). L-[3H] glutamate released (supernatant) was then calculated and 
expressed as a percentage of the total amount of L-[3H] glutamate (supernatant + pellet) 
in the synaptosomal preparations. 
 
4.2.2.9. Statistical Analysis 
The differences in the means were analysed using a one-way analysis of variance 
(ANOVA) for statistical significance. If the F values were significant, the Student–
Newman–Keuls test was used to compare the groups. The level of significance was 
accepted at p < 0.05 (Zar, 1974). 
 
4.2.3.  Results 
Figure 4.3. illustrates that intrahippocampal QA significantly enhances the percentage of 
[3H] glutamate released (p < 0.05). Administration of AC does not alter the effect induced 
by QA. 
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Figure 4.3. Effect of QA alone and in combination with AC on glutamate release from 
rat hippocampal synaptosomes in vivo. Each bar represents the mean ± SD; n = 5.   * (p < 
0.05) in comparison to control; ns (p > 0.05) in comparison to QA (ANOVA and 
Student–Newman–Keuls Multiple Range Test). 
 
4.2.4.  Discussion 
Bordelon et al., (1997) have shown that intrastriatal injections of QA in vivo produce 
progressive mitochondrial dysfunction, which may be a common and critical event in the 
cell death cascade. Mitochondrial dysfunction is likely to cause energy failure, during 
which ionic gradients are disrupted and the regulation of glutamate uptake is lost, leading 
to increased excitatory amino acid levels (Benveniste et al., 1984; Massieu et al., 2000). 
As shown in figure 4.2., recovery of the sodium electrochemical gradient occurs at the 
expense of ATP, thus a deficiency of this energy-bearing molecule will result in 
accumulation of intracellular sodium, which, in turn will drive the extrusion of 
osmotically active compounds, such as glutamate and aspartate for cell volume regulation 
(Phillis et al., 1997; Estevez et al., 1999). This process may also facilitate the reverse 
action of the sodium-dependent excitatory amino acid transporters, extruding glutamate 
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to the synaptic cleft (Longuemare et al., 1999; Phillis et al., 2000). This means that the 
mitochondrial dysfunction which occurs during excitotoxicity (figure 4.1.) may 
perpetuate itself and a cycle of deleterious effects predominates within the synapse. The 
finding that AC has no effect on the QA-induced increase in glutamate release could 
possibly indicate that AC is not able to salvage mitochondrial respiratory function after a 
QA-induced excitotoxic insult. 
 
Tavares et al., (2002) suggested that the increase in glutamate release induced by QA 
occurs through the activation of presynaptic NMDA receptors since MK-801 completely 
abolishes the effect. This hypothesis may explain further observations by these authors 
that this effect could be reversed by guanosine (Tavares et al., 2005), as this nucleoside is 
known to inhibit the binding of glutamate or its analogues to the NMDA receptor 
(Monahan et al., 1988; Souza and Ramirez, 1991). A study has demonstrated that 
activation of presynaptic NMDA autoreceptors may provide a positive rather than the 
usual negative feedback on presynaptic glutamate release in synaptosomal preparations 
(Breukel et al., 1998). These authors speculate that stimulation of these receptors causes 
depolarisation of the presynaptic membrane by sodium entry, inducing the same kind of 
homeostatic imbalance as previously described, which may induce reversal of amino acid 
transporters thereby releasing amino acids from a cytoplasmic pool. It was anticipated 
that AC, a guanosine analogue would have a parallel effect. A possible reason for this 
discrepancy is that Tavares and coworkers (2005) administered guanosine i.p. prior to the 
infusion of QA, thus, guanosine was already present to prevent the binding of QA, 
whereas in the present study, QA was infused 24 hours before initiation of the AC 
treatment and may therefore have more time to bind to presynaptic NMDA autoreceptors 
to elicit the response (glutamate release) before sufficient AC is present to inhibit the QA 
effect to a sufficiently substantial extent so as to pose a challenge. 
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CHAPTER 5 
OXIDATIVE STRESS 
 
5.1.  INTRODUCTION 
Oxidative stress is a state within cells where the generation of free radicals exceeds the 
capacity of the endogenous antioxidant defence system (Poston and Raijmakers, 2004). 
The brain, in comparison to the other organs of the body, is especially susceptible to this 
phenomenon as a result of its high consumption of total body O2, the primary source of 
free radicals, and its relatively low concentration of antioxidant enzymes (Coyle and 
Puttfarcken, 1993). 
 
The major reactions for the normal, regulated production of oxygen and nitrogen free 
radicals in the body are depicted in figure 5.1.  NO is formed from L-arginine by one of 
the three NOS isoforms, which all require oxygen, tetrahydrobiopterin, NADPH, 
calmodulin, FAD, flavin mononucleotide (FMN), and haeme for catalytic activity, whilst, 
in addition, nNOS found in neuronal tissue requires calcium (Wu and Morris, 1998).  
 
O2·- is generated from O2 by various metabolic pathways: 1) NADPH oxidation by 
NADPH oxidase; 2) oxidation of xanthine or hypoxanthine by xanthine oxidase; 3) 
oxidation of reducing equivalents (e.g., NADH, NADPH, and FADH2) via the 
mitochondrial electron transport chain; 4) auto-oxidation of monoamines (e.g., DA, 
epinephrine, and NE), flavins, and haemoglobin in the presence of trace amounts of 
transition metals; 5) one-electron reduction of O2 by cytochrome P-450 (Fridovich, 1999; 
Evans and Halliwell, 2001). 
 
The short lived, potent oxidant ONOO-, as described in section 1.2.2.2.3., is the 
biological reaction product of O2·- and NO. In addition, the H2O2 produced as a result of 
the auto-oxidation of monoamines or the dismutation of O2·- contributes to the formation 
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of ·OH, in the presence of reducing agents such as Fe2+ (Fenton reaction) or ascorbic acid 
(vitamin C) (Fang et al., 2002). 
 
 
 
Figure 5.1. Production of oxygen and nitrogen free radicals and other reactive species in 
mammalian cells (modified from Fang et al., 2002). 
 
The antioxidant defense system, outlined in figure 5.2. consists of enzymes, namely, 
SOD, CAT, GSH-Px, and GSH-R and antioxidant molecules such as reduced GSH,       
α-tocopherol (vitamin E) and vitamin C (Fang et al., 2002). 
 
SOD enzymes catalyse the removal of O2·- in a dismutation reaction where one O2·- 
radical is oxidised and another is reduced to form H2O2 and O2 (Fridovich, 1975). The 
H2O2 that is produced can be metabolised to H2O and O2 by CAT or GSH-Px. This latter 
enzyme uses GSH as a co-factor which is oxidised by H2O2 (Chance et al., 1979). The 
oxidised glutathione (GSSG) is recycled to its reduced form by GR (Barber et al., 2006). 
 
 
 
 
Oxidative Stress__________________________________________________________ 
 88 
Furthermore, GPx also detoxifies lipid hydroperoxides formed during lipid peroxidation 
to alcohols (Fang et al., 2002). These hydroperoxides are initially produced by the 
transfer of the phenolic hydrogen of vitamin E to a ROO· free radical, thereby breaking 
the radical chain reaction and preventing propagation of LP. A vitamin E radical is 
generated in this process, however it is not a highly reactive species because the unpaired 
electron is resonance stabilised (Fang, 2002). Vitamin C then reacts with the vitamin E 
radical to yield a vitamin C radical while regenerating vitamin E. The vitamin C radical is 
also not reactive and is converted back to vitamin C by GSH (Fang, 2002; Fang et al., 
2002). 
 
 
 
Figure 5.2. Removal of oxygen and nitrogen free radicals and other reactive species in 
mammalian cells (Fang et al., 2002). 
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The pathophysiology of neurodegenerative disorders further predisposes the brain to free 
radical attack as these either allow additional sources of free radicals to predominate, or 
alternately, exploit the usual sources of these reactive species mentioned above. 
Activated microglia and exaggerated calcium signalling in excitotoxicity (figure 4.1.) 
both stimulate NOS activity to enhance synthesis of NO (Kreutzberg, 1996). Figure 4.1. 
also shows that excitotoxicity may lead to mitochondrial dysfunction, another mechanism 
of neurodegeneration, the initial stages of which include depression of oxidative 
phosphorylation and thus the leakage of excess electrons which drive the production of 
the various free radicals. 
 
In AD, AP and NFT accumulate redox-active iron which, as described in section 
1.2.2.2.5., catalyses the formation of OH· via the Fenton reaction. Advanced glycation 
endproducts (AGE), a less well known morphological feature of AD (Steele et al., 2006), 
can also undergo redox recycling in the presence of redox active iron, thereby enhancing 
free radical production (Perry et al., 2002). Activated microglia, such as those 
surrounding senile plaques, can produce NO and O2·- (Kreutzberg, 1996) which can 
subsequently react to form ONOO- (Radi et al., 1991). AGE can further increase free 
radical formation by activation of specific receptors, such as the receptor for AGE 
(RAGE) and the class A scavenger-receptor (Gasic-Milenkovic et al., 2003). AP are also 
capable of this receptor activation. Mitochondrial metabolic abnormalities, such as 
changes in the mitochondrial genome or deficiencies in key metabolic enzymes, may also 
be a major initiating source of reactive oxygen species (ROS) in AD (Perry et al., 1998; 
Perry et al., 2002). 
 
The notion that oxidative stress is involved in the pathogenesis and pathology of AD now 
appears to be well established and unrefuted (Martins et al., 1986; Franceschi et al., 
1990; Butterfield et al., 1999a; Butterfield et al., 1999b; Ansari et al., 2006; Onyango and 
Khan, 2006). On the other hand it is a relatively new concept with respect to major 
depression, in which evidence of an imbalance in oxidant and antioxidant defence 
systems in favour of the pro-oxidant status has recently arisen (Khanzode et al., 2003). 
Similarly, oxidative stress has lately become recognised as a key feature of viral 
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infections including acute encephalitis caused by HSV-1 (Valyi-Nagy and Dermody, 
2005).  
 
The anomalous role of oxidative stress in any disease is that it is likely to lead to 
oxidative injury to the lipid, nucleic acid and protein biomolecules (Azbill et al., 1997; 
Sun and Chen, 1998; Bergamini et al., 2004), structures vital in the facilitation of normal 
functioning of the cell. The cells are thus steered towards degeneration (Bus and Gibson, 
1982), and moreover, the damage to some of these biomolecules may in turn further 
predispose the cells toward fatality. For example, the antioxidant enzymes and glutamate 
transporters (described in chapter 4) are protein molecules which may be structurally 
damaged during oxidative stress, thus rendering them dysfunctional (Mo et al., 1995; 
Camacho and Massieu, 2006) effectively enhancing oxidative stress and excitotoxicity 
respectively. Damage to DNA may cause mutations of genes and thus reduced and/or 
defective translation of proteins, including the antioxidant enzymes and glutamate 
transporters (Wei et al., 1998; Wei and Lee, 2002). 
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5.2. THE EFFECT OF QA ALONE AND IN COMBINATION 
WITH AC ON SUPEROXIDE ANION GENERATION IN 
RAT BRAIN HOMOGENATE IN VITRO 
 
5.2.1.  Introduction 
O2 is required for the generation of most free radicals (Fridovich, 1999), and since these 
are defined as molecules having an unpaired electron in the outer orbit (Gilbert, 2000), 
the simplest free radical to form is the O2·-, which is then the precursor of a diverse group 
of highly reactive species, including HO· (Fridovich, 1983), ONOO- (Radi et al., 1991) 
and HOO· (Halliwell and Gutteridge, 1989). 
 
Mitochondria are the major sites of the generation of free radicals (Curtin et al., 2002). In 
particular, it is the electron transport chain (ETC) which is a source of O2·-. Figure 5.3. 
shows that complex I, NADH ubiquinone oxidoreductase and Complex III, ubiquinol–
cytochrome C oxidoreductase are the two sites where O2·- is produced (Beyer, 1992).   
 
Electrons enter the ETC at either complex I (NADH-ubiquinone oxidoreductase) or 
complex II (succinate dehydrogenase) following the oxidation of NADH and succinate, 
respectively. Ubiquinone is a lipid-soluble electron carrier and carries the electrons from 
complex I and complex II to complex III (ubiquinol-cytochrome c oxidoreductase) 
(Beyer, 1992). In this process, a semiquinone anion, an intermediate in the oxidation of 
ubiquinol to ubiquinone is formed. This intermediate is responsible for the production of 
O2·- (Curtin et al., 2002) in the ETC because the electron which it surrenders upon 
oxidation back to ubiquinone is taken up by O2 to form O2·-. This free radical generated 
by the cycling of ubiquinol in the inner mitochondrial membrane, is produced primarily 
in the mitochondrial matrix (Raha et al., 2000). It is therefore plausible to predict that any 
agent capable of enhancing the activity of the ETC at complex I, II and at a point in 
complex III which is proximal to the formation of the semiquinone, will enhance O2·- 
production. Similarly, agents which inhibit the activity of complex III distal to the 
semiquinone formation and complex IV will probably also have such an effect.  
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Figure 5.3. Schematic diagram illustrating the major subunits of the ETC and sites of 
O2·- production (Curtin et al., 2002). 
 
Bordelon et al., (1997) have shown that intrastriatal injections of QA produce progressive 
mitochondrial dysfunction, thus the possibility of such an effect, specifically involving 
the ETC, on rat brain homogenate was investigated in vitro. The consequences, if any, of 
AC in combination with QA was also studied. 
 
The nitroblue tetrazolium (NBT) assay, generally accepted (Das et al., 1990; Sagar et al., 
1992) as a reliable method to assay for O2·-, was used. The principle behind the assay is 
that O2·- reduces NBT to the water insoluble nitroblue diformazan (NBD), which can be 
extracted using glacial acetic acid and quantified by spectrophotometric analysis. 
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5.2.2.  Materials and Methods 
5.2.2.1. Animals 
Adult male Wistar rats were purchased from the NHLS (Johannesburg, South Africa) and 
cared for as described in section 2.2.2.1. 
 
5.2.2.2. Chemicals and Reagents 
AC sodium (Zovirax®, powder for injection) was obtained from Glaxo Wellcome, 
Midrand, South Africa. NBD, QA and NBT were purchased from Sigma Chemical Co, 
St. Louis, USA. Ethanol and glacial acetic acid were purchased from Saarchem, 
Krugersdorp, South Africa.  
 
5.2.2.3. Removal of the brain 
Rats were killed and the brains removed as described in section 2.2.2.7. 
 
5.2.2.4. Preparation of Tissue 
Each brain was weighed and rapidly homogenised in a glass-teflon hand held 
homogeniser in ice cold 0.1 M PBS at pH 7.4 to obtain a homogenate concentration of  
10 % w/v. 
 
5.2.2.5. Preparation of the NBD Standard Curve 
A series of NBD standards (0–400 nmoles/ml) were prepared in triplicate using glacial 
acetic acid as the diluent to give a total volume of 1 ml. An NBD standard curve was 
generated by measuring the absorbances at 560 nm on a GBC UV/VIS 916 
spectrophotometer and plotting these against the molar equivalent weight of NBD 
(Appendix II). 
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 5.2.2.6. Nitroblue Tetrazolium Assay 
A modification of the NBT Assay as described by Das et al., (1990) was used.  
 
Samples of rat brain homogenate (1 ml), in triplicate, contained 1 mM QA (250 µl) in the 
absence and presence of increasing concentrations (0–2 mM) of AC (250 µl) and 0.4 ml 
NBT (0.1 % dissolved in ethanol and then made up to the required volume with milli-Q 
water). The samples were incubated in an oscillating water bath for an hour at 37 ˚C. 
Control samples did not contain QA or AC. 
 
The reaction was terminated and the NBD formed extracted by centrifuging the samples 
for 10 minutes at 2000 x g and resuspending the pellets with 2 ml glacial acetic acid. To 
remove insoluble debris, the samples were centrifuged for 5 minutes at 2000 x g. An 
aliquot of the supernatant (extracted NBD in glacial acetic acid) was read at 560 nm, 
using a GBC UV/VIS spectrophotomter. NBD levels were then determined from a 
standard curve generated as described in section 5.2.2.5. Final results were expressed as 
NBD (nmoles/mg tissue). 
 
5.2.2.7. Statistical Analysis 
This was performed as described in section 4.2.2.9. 
 
5.2.3.  Results 
Figure 5.4. shows that 1 mM QA has no significant effect on O2·-  generation in vitro. Co-
incubation with AC at low concentrations (≤ 0.5 mM) also produces no effect on the 
formation of this free radical. However, 1 mM AC (p < 0.05) and 2 mM AC (p < 0.01) 
are able to significantly reduce the amount of NBD that is already present. 
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Figure 5.4. Effect of QA alone and in combination with AC on O2·- generation in rat 
brain homogenate in vitro. Each bar represents the mean ± SD (n = 5). ns1 (p > 0.05) in 
comparison to control; ns2 (p > 0.05), * (p < 0.05) and ** (p < 0.01) in comparison to      
1 mM QA (ANOVA and Student–Newman–Keuls Multiple Range Test). 
 
5.2.4.  Discussion 
The results (figure 5.4.) show that QA has no direct effect on ETC activity as there was 
no difference in the generation of O2·- in comparison to control. This suggests that the 
ability of QA to cause mitochondrial dysfunction reported by Bordelon and coworkers 
(1997) is mediated by NMDA receptor overactivation (excitotoxicity). As described, in 
the previous chapter, it is the rise in intracellular calcium levels subsequent to NMDA 
stimulation in particular, which initiates the sequence of events. In the present 
experiment, QA is exposed to homogenised tissue in which the mitochondria remain 
intact, but the integrity of the outer neuronal cell membranes is destroyed. This may not 
have an adverse effect on receptor positioning and functioning within the cell 
membranes. However a compartmentalised intracellular environment to facilitate the 
cellular response (in this instance, increased intracellular calcium levels) to binding at the 
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receptor no longer exists. Thus the sequence of events leading up to mitochondrial 
dysfunction and a rise in O2·- does not occur. 
 
Even though QA does not enhance the formation of O2·-, it is important to note that at the 
higher end of the concentration range, AC is able to reduce the amount of O2·- present 
under those conditions. The presence of this O2-· is not influenced by the NMDA 
stimulation associated with QA, which implies that the reduction in O2-· brought about by 
AC must be through its ability to scavenge this free radical, rather than through 
prevention of its formation. 
 
Guanine is the most easily oxidisable nucleic acid base in DNA and is therefore a 
primary target of oxidative modification (Cadet et al., 2002). The ease with which free 
radicals react with guanine could thus possibly be exploited by the production of 
analogues, such as AC, as suitable free radical scavengers to alleviate oxidative stress. 
 
The interaction of O2-· with a guanine base is shown in figure 5.5.  The G (-H)· radical can 
be formed by H abstraction of the hydroxyl group at C-6. This abstraction could be 
carried out by the potent OH· radical which is known to be formed by QA activity in vitro 
(Pláteník et al., 2001) The G (-H)· radicals are usually considered to be O-centered 
radicals with the unpaired electron positioned on the O-6 atom (Hildenbrand and Schulte-
Frohlinde, 1990), which explains the low reactivity of this radical with O2 (Al-Sheikhly, 
1994). However, resonance stabilisation allows for the placement of the unpaired electron 
at C-5. The O2-· can react via an addition reaction at C-5 and at C-8 of both resonance 
structures (i.e. both forms of the G (-H)· radical) (Cadet et al., 1994). However, the 
former reaction is the major reaction (Misiaszek et al., 2003), which is depicted in figure 
5.5. Cadet and co-workers (1994) proposed that the addition of O2-· to the C-5 position of 
the G (-H)· radical is followed by a rapid protonation of the peroxide anion to form         
5-HOO-G-(H) Typically, hydroperoxides generated in the course of oxidative 
degradation of guanine bases are very unstable (Kang and Foote, 2002). Thus, according 
to the mechanism proposed by Cadet and co-workers (1994), the cleavage and 
decarboxylation of 5-HOO-G-(H) occurs via the opening of the pyrimidine ring at the C-
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5-HOO-G(-H) 
+ O2
-· 
G(-H)· 
+ H+ 
-CO2 
+ H2O 
-HCONH2 +H2O 
5—C-6 bond in 5-HOO-G(-H) leading to an unstable intermediate that is easily hydrated 
at the 7,8-C=N double bond. Ring chain tautomerisation and cleavage of the 
carbinolamine results in the opening of the imidazole ring with a subsequent 
intramolecular cyclisation of the guanidine residue forming imidazolone (Iz) which can 
be hydrated to oxazolone (Z). 
 
AC also has the purine ring involved in the mechanism of O2·- scavenging proposed for 
guanine, thus it probably acts in the same manner. The salient feature of this mechanism 
is that from unstable reactive radicals, namely ·OH, O2·- and G (-H)·, stable, non-reactive 
products, namely Iz and Z are formed, thus the propagation of free radicals is terminated 
and the progression of oxidative stress restrained. 
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Figure 5.5. Interaction of O2·- with a guanine base to form imidazolone (Iz) and 
oxazolone (Z) products (Misiaszek et al., 2003). 
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5.3. THE EFFECT OF QA ALONE AND IN COMBINATION 
WITH AC ON SUPEROXIDE ANION GENERATION IN 
RAT HIPPOCAMPAL HOMOGENATE IN VIVO 
 
5.3.1.  Introduction 
In the previous experiment, QA was found to not induce O2·- generation in vitro. The 
present study was therefore conducted to assess whether QA administered in vivo to 
intact cells in the hippocampus could generate increases in O2·-, through an insult on 
mitochondrial function, reported by Bordelon et al. (1994) through its long known, well 
established excitotoxic, NMDA receptor mediated, effect (Stone and Perkins, 1981). 
Furthermore, the investigation also sought to determine whether AC treatment in 
combination with QA could bring about any alterations to the effect of QA alone despite 
it not being successful at modifying glutamate release (chapter 4), an important 
aggravating factor of excitotoxicity. 
 
5.3.2.  Materials and Methods 
5.3.2.1. Animals 
Adult male Wistar rats were purchased from the NHLS (Johannesburg, South Africa) and 
cared for as described in section 2.2.2.1. 
 
5.3.2.2. Chemicals and Reagents 
As per section 5.2.2.2. In addition, sodium phenobarbitone was purchased from Merck, 
Germany and was at a working concentration of 60 mg/ml. 
 
5.3.2.3. Surgical Procedures 
These procedures were conducted as described in section 2.2.2.4. 
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5.3.2.4. Drug Treatment  
This was performed as described in section 2.2.2.5. 
 
5.3.2.5. Brain and Hippocampi Removal 
The hippocampi from the brains of the rats which were killed a day after their test trials 
(8 days after the last dose of the drug treatment) in the Morris Water Maze (chapter 2) 
were removed as described in section 2.2.2.6. 
 
5.3.2.6. Preparation of Tissue 
The preparation of each portion of the hippocampal tissue was performed as described for 
each whole brain in section 5.2.2.4. However, the homogenate concentration was             
5 % w/v instead of 10 % w/v.  
 
5.3.2.7. Preparation of the NBD Standard Curve 
This was performed as described in section 5.2.2.5. 
 
5.3.2.8. Nitroblue Tetrazolium Assay 
The NBT assay was performed as described in section 5.2.2.6. However, no exogenous 
QA and AC was added to the triplicate samples of rat hippocampal homogenate (0.5 ml).  
 
5.3.2.9. Statistical Analysis 
This was performed as described in section 4.2.2.9. 
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5.3.3.  Results 
Figure 5.6. illustrates that the intrahippocampal injection of QA (120 nmoles) has the 
ability to significantly enhance (p < 0.001) the generation of O2·-, in comparison to 
control, and that AC treatment significantly reduces (p < 0.001) QA-induced O2·-. 
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Figure 5.6. Effect of QA alone and in combination with AC on O2·- generation in rat 
hippocampal homogenate in vivo. Each bar represents the mean ± SD; n = 5.                    
# (p < 0.001) in comparison to control; *** (p < 0.001) in comparison to QA (ANOVA 
and Student–Newman–Keuls Multiple Range Test). 
 
5.3.4.  Discussion 
In cultured neurons, QA stimulation of the NMDA receptors is known to generate ROS, 
such as O2·-, H2O2 and NO· (Lysko et al., 1992; Lafon-Cazal et al., 1993; Gunasekar et 
al., 1995; Reynolds and Hastings, 1995; Küçükkaya et al., 1996). As in cultured neurons, 
QA injected intrastriatally (in vivo) causes NMDA stimulation (Giordano et al., 1990), 
thus it is expected that QA injected intrahippocampally is also able to induce a significant 
increase in O2·-. 
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The ability of QA to cause mitochondrial dysfunction (Bordelon et al., 1994), via its 
perpetuating excitotoxic mechanism (chapter 4) may account for the QA effect on O2·-, 
although this needs to be investigated further.  The dampening of the QA-induced 
increase in O2·- by AC is most likely primarily or even solely related to its capacity to 
scavenge this free radical, which was described in the previous experiment. This is 
argued in the light of the doubt cast on AC being able to restore mitochondrial function 
and to have a significant role to play as an anti-excitotoxin (discussed in chapter 4). Since 
QA impairs the activity of the O2·- detoxifying enzyme, SOD (Rodríguez-Martínez et al., 
2000), this ROS becomes longer-lived and therefore more readily available for 
conversion to other noxious free radicals (as described previously), ultimately 
augmenting oxidative stress. Furthermore, the direct toxicity of O2·- includes the 
inhibition of the calcineurin enzymes, which attenuates the expression of LTP (section 
1.2.2.2.1. Thus the enhanced generation of O2·- may be an additional mechanism by 
which QA induces spatial memory deficits (chapter 2). Through its capacity to scavenge 
O2·-, AC is therefore improving spatial memory deficits directly as well as indirectly by 
curbing oxidative stress.   
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5.4. THE EFFECT OF QA ALONE AND IN COMBINATION 
WITH AC ON TOTAL GLUTATHIONE LEVELS IN 
RAT HIPPOCAMPAL HOMOGENATE IN VIVO 
 
5.4.1.  Introduction 
The antioxidant properties of GSH, the most abundant thiol-containing peptide in the 
CNS (Hermann et al., 2002), are vast and include direct and indirect mechanisms. (1) 
GSH can react with a variety of xenobiotic electrophilic compounds in the catalytic 
reaction of glutathione-S-transferase (Baars and Breimer, 1980). (2) It effectively 
scavenges ROS (e.g., LOO·, ONOO- , and H2O2) directly and indirectly through 
enzymatic reaction with GPx (Fang et al., 2002). (3) GSH can conjugate with NO, 
resulting in the formation of an S-nitrosoglutathione, an adduct which has exhibited 
neuroprotective effects against iron-induced oxidative stress in the substantia nigra 
(Rauhala et al., 1998a). Although a pro-oxidant, GSH radical (GS•) is formed when GSH 
reacts directly with free radicals; it can be rapidly detoxified by reaction with another 
GS• to yield a non-radical GSSG (Fang et al., 2002). 
 
The additional versatility of GSH lies in its ability to regenerate from GSSG in the 
presence of GR and the reducing equivalent, NADPH (figure 5.2.), which is produced 
during glucose metabolism via the pentose phosphate pathway (PPP) (Puskas et al., 
2000). When the intracellular concentration of GSH decreases and that of GSSG 
increases, the cellular demand for NADPH increases markedly (Sies, 1999) and glucose 
utilisation is shunted towards the PPP. 
 
GSH is synthesised from glutamate, cysteine, and glycine (Sies, 1999), as shown in 
figure 5.2. Almost all dietary glutamate is subjected to first pass metabolism by the small 
intestinal mucosa (Wu, 1998). Thus, the hydrolysis of glutamine to glutamate by 
glutaminase and the production of glutamate from α-ketoglutarate and branched-chain 
amino acids via transamination is necessary for GSH synthesis, which is an energy-
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dependent process. GSH in the diet can be partly absorbed from the small intestine, thus 
it can be classified as an endogenous and exogenous antioxidant (Fang et al., 2002). 
 
The levels of GSH in the cerebral cortex of stress-induced depressed mice is appreciably 
depleted and different antidepressants were able to correct this to varying degrees, 
suggesting a close link between stress-induced depression, increased monoaminergic 
utilisation, oxidative stress and brain GSH (Pal and Dandiya, 1994). Adams and 
coworkers (1991) found that GSH levels were increased in the hippocampi, whereas Gu 
and coworkers (1998) found that these levels were reduced in the cingulate cortex of the 
brains of AD patients postmortem. The discrepancy lies in the unexpected increase in the 
former, which may suggest that after an initial decrease in GSH levels in the brain in AD, 
a compensatory response (Adams et al., 1991) increases the de novo synthesis and 
regeneration of GSH. Thus, whether a decrease or increase in the GSH levels in the 
brains of AD patients postmortem in comparison to controls is reflected depends on the 
progression of AD at the time of death. Intracellular endogenous GSH levels dramatically 
decreased in the first 24 h after virus adsorption after in vitro HSV-1 infection of cells 
with inhibition of viral replication upon addition of exogenous GSH (Palarama et al., 
1995).  
 
Rodríguez-Martinez et al., (2000) showed that striatal levels of GSH are reduced after 
intrastriatal injections of QA. This has raised the possibility that QA could have an 
analogous effect in the hippocampus. Thus the aim of this study was to assess the effect 
of QA in this regard and furthermore to probe whether AC could influence it. 
 
GSH is the most abundant intracellular low molecular weight, non-protein thiol (NP-SH) 
compound in mammalian cells (Sies, 1999), thus it is expected that it will account for 
most NP-SH in tissues. A rapid, simple spectrophotometric method for the determination 
of sulfhydryl groups in NP-SH in various tissues would be an appropriate technique to 
use to measure GSH levels in rat hippocampal homogenate. The technique is based on 
the principle that 5,5’-dithiobis-(2-nitrobenzoic acid) (DTNB) is reduced by SH groups to 
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form 1 mole of 2-nitro-5-mercaptobenzoic acid per mole of SH (Sedlak and Lindsay, 
1968). This reaction is illustrated in figure 5.7. 
   
R-S-S
COOH
NO2
SH
COOH
NO2
S NO2
COOH
S NO2
COOH
+
R-SH     +
 5,5'-dithiobis-(2-nitrobenzoic acid)  2-nitro-5-mercaptobenzoic acid (yellow)
 
Figure 5.7. Reaction of thiol-containing compounds (R-SH) with DTNB to produce  
2-nitro-5-mercaptobenzoic acid (Sedlak and Lindsay, 1968). 
 
5.4.2.  Materials and Methods 
5.4.2.1. Animals 
Adult male Wistar rats were purchased from the NHLS (Johannesburg, South Africa) and 
cared for as described in section 2.2.2.1. 
 
5.4.2.2. Chemicals and Reagents 
AC sodium (Zovirax®, powder for injection) was obtained from Glaxo Wellcome, 
Midrand, South Africa. QA (2, 3-pyridinedicarboxylic acid), GSH and DTNB were 
purchased from Sigma Chemical Co, St. Louis, USA. Methanol was purchased from 
Saarchem, Krugersdorp, South Africa. Sodium phenobarbitone was purchased from 
Merck, Germany and was at a working concentration of 60 mg/ml. 
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5.4.2.3. Surgical Procedures 
These procedures were conducted as described in section 2.2.2.4. 
 
5.4.2.4. Drug Treatment  
This was performed as described in section 2.2.2.5. 
 
5.4.2.5. Brain and Hippocampi Removal 
The hippocampi from the brains of the rats which were killed a day after their test trials 
(8 days after the last dose of the drug treatment) in the Morris Water Maze (chapter 2) 
were removed as described in section 2.2.2.6. 
 
5.4.2.6. Preparation of Tissue 
The preparation of each portion of the hippocampal tissue was performed as described for 
the whole brains in section 5.2.2.4., except that the homogenate concentration was  5 % 
w/v instead of 10 % w/v. 
 
5.4.2.7. Preparation of the GSH Standard Curve 
A series of GSH standards (0–10 nmoles/ml) were prepared in triplicate using PBS as the 
diluent to give a total volume of 0.5 ml. To these tubes, 1.5 ml 0.2 M tris HCl (pH 8.2), 
0.1 ml 0.01 M DTNB and 7.9 ml methanol were added and thereafter left to stand in the 
dark for 30 minutes. A standard curve was generated by measuring the absorbances at 
412 nm on a GBC UV/VIS 916 spectrophotometer and plotting these against the molar 
equivalent weight of GSH (Appendix 3). 
 
5.4.2.8. Glutathione Assay 
GSH levels were estimated by measuring NP-SH using the method previously described 
by Sedlak and Lindsay (1968).  
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To 1 ml of rat hippocampal homogenate, 0.5 ml TCA (25 % in milli-Q water) was added 
to precipitate proteins and thus separate protein bound thiol containing compounds from 
non-protein-bound thiol-containing compounds (Sedlak and Lindsay, 1968), the 
predominant one being GSH (Sies, 1999; Hermann et al., 2002).  These samples were 
centrifuged at 2000 x g for 15 minutes. Aliquots of the supernatant (0.5 ml) were 
transferred to a clean set of test tubes and 1.5 ml 0.2 M tris-HCl (pH 8.2), 0.1 ml DTNB 
(0.01 M in methanol) and 7.9 ml methanol were added. All the samples were incubated 
for 30 minutes at room temperature. The tris-HCl buffer (pH 8.2) was necessary to 
maintain a final pH of the complete reaction mixture above 8.0 since the intensity of the 
colour of 2-nitro-5-mercaptobenzoic acid varies with pH below pH 8 (Sedlak and 
Lindsay, 1968). The incubation mixture was then centrifuged at 2000 x g for 15 minutes 
and the supernatant was read at 412 nm. The GSH levels were determined from a 
standard curve generated from GSH as described in section 5.4.2.7. Final results were 
expressed as GSH (nmoles/mg tissue). 
 
5.4.2.9. Statistical Analysis 
This was performed as described in section 4.2.2.9. 
 
5.4.3.  Results 
Figure 5.8. illustrates that the intrahippocampal injection of QA (120 nmoles) has the 
ability to significantly reduce (p < 0.001) GSH levels in the rat hippocampus, in 
comparison to control, and this effect is blunted by treatment of the rats with AC            
(p < 0.01). 
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Figure 5.8. Effect of QA alone and in combination with AC on GSH levels in rat 
hippocampal homogenate in vivo. Each bar represents the mean ± SD; n = 5. *** (p < 
0.001) in comparison to control; ** (p < 0.01) in comparison to QA (ANOVA and 
Student–Newman–Keuls Multiple Range Test). 
 
5.4.4.  Discussion 
From the nature of the antioxidant defense system, it appears that it is possible that an 
inverse relationship exists between O2·- levels and GSH levels. After the dismutation of 
O2·- to H2O2, this substrate of the Fenton reaction and thus ·OH formation, is reduced to 
H2O by GPx with GSH as a reducing agent (figure 1.14 and figure 5.2). Increased O2·- 
generation exhibited by QA in vivo in the rat hippocampus (section 5.3.) should then 
drive increased production of  H2O2 and this in turn should enhance GPx activity and thus 
GSH consumption. This at least may explain in part the diminished GSH levels present in 
the rat hippocampus after an intrahippocampal injection of QA.  Furthermore, GSH is 
known to have its own direct free radical scavenging properties (Kavanagh et al., 1993) 
and may thus also become depleted by the free radicals generated during an excitotoxic 
insult by QA (Ganzella et al., 2006).  
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The ability of QA to cause mitochondrial dysfunction has been referred to previously. 
This may reduce the production of ATP which is the energy-bearing molecule required 
for GSH synthesis (figure 5.2), thus reducing GSH levels in comparison to control rat 
hippocampi where ATP production is not adversely affected. 
 
A potential O2·-scavenging property of AC has already been discussed and implies that 
AC treatment could swing the inverse relationship between O2·- and GSH in the opposite 
direction to that brought about by QA in the absence of such treatment. The O2·- levels 
are reduced by AC, thus less H2O2 is formed, thereby decreasing the activity of GPx and 
the requirement for GSH associated therewith. Moreover, the loss of ·OH by hydrogen 
abstraction from AC means that less GSH is required for its direct free radical scavenging 
activity. The unlikelihood of AC restoring mitochondrial function was articulated in the 
previous chapter, indicating that it cannot aid the increased generation of ATP needed to 
overcome the deficit of de novo production of GSH induced by QA. 
 
The significance of the conservation of GSH levels by AC is largely related to the 
alleviation of oxidative stress in the potential neurodegenerative disorders, AD, HSE and 
depression. In HSE, this, in turn, may not only limit oxidation of biomolecules and 
neurodegeneration directly, but also reduce activation of nuclear factor kappa B (NFκB), 
a nuclear transcription factor known to be activated in response to oxidative stress and 
thus suppress HSV-1 replication (Palamara et al., 1995). Moreover, GSH appears to have 
direct anti-HSV-1 activity by inhibition of viral glycoprotein B synthesis which is 
necessary for the production of enveloped (i.e. infectious) virus particles (Palarama et al., 
1995). These antiviral effects brought about by GSH may aid in reducing CNS injury 
during HSE, by dampening the direct viral invasion of neurons and the subsequent viral 
induced immune response (section 1.1.4.1.).  
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CHAPTER 6 
LIPID PEROXIDATION 
 
6.1.  INTRODUCTION 
PUFAs, such as arachidonic, docosatetraenoic, and docosahexaenoic acids are essential 
for normal cell functioning because many membrane properties such as fluidity and 
permeability are closely related to their presence. LP results in a loss of membrane 
PUFA, which increases membrane rigidity (Choe et al., 1995). Furthermore, ROOH 
within the membrane have a devastating effect on membrane integrity because these too 
alter membrane fluidity and permeability (Halliwell, 1994). This alteration in membrane 
integrity due to LP, in turn, markedly affects the functioning of membrane bound 
enzymes and receptors (Farooqui and Horrocks, 1994). 
 
Oxidative damage to lipids rather than the other biomolecules is of particular significance 
in neuroscience, because the brain is rich in peroxidisable PUFAs (Floyd, 1999). The 
products of LP are increased in the plasma of depressed patients (Bilici et al., 2001) and 
in the brains of AD patients post-mortem (Sultana et al., 2006; Williams et al., 2006). In 
HSE, LP is thought to be part of the phagocytic function of macrophage, through the 
release of neurotoxic oxidative agents such as QA (Reinhard, 1997). However, the extent 
to which oxidative damage plays a beneficial role for the host by limiting viral replication 
is largely unknown (Valyi-Nagy and Dermody, 2005), since inevitably, surrounding 
healthy tissue is also damaged. 
 
It has not been determined unequivocally whether LP is a cause of cell death or merely a 
consequence of cell damage by some other mechanism (Smith et al., 1983). It was 
established many years ago that disrupted tissues undergo peroxidation more rapidly than 
healthy ones due to the inactivation of some antioxidants and the release of metal ions, 
especially iron from storage sites within cells (Barber, 1963, Gutteridge and Stocks, 
1976). This finding provides supporting evidence that increased LP often occurs as a 
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result of cell damage or death and not vice versa (Halliwell and Gutteridge, 1984a). 
However, whether LP occurs before or after cell death, it remains a biomarker for 
oxidative cell damage, which may result in neurodegeneration.  
 
LP can be assayed by quantifying malondialdehyde (MDA), which is a product of LP. 
The test material is heated at low pH with thiobarbituric acid (TBA) and the resulting 
pink chromogen, formed by a MDA-TBA complex (figure 6.1.) is extracted into butanol 
and measured by absorbance at 532 nm or by fluorescence at 553 nm (Gutteridge and 
Halliwell, 1990). Some of the MDA detected in the TBA test is formed from the 
hydroperoxides during the peroxidation process itself, but most is generated during the 
acid-heating stage of the test (Gutteridge and Halliwell, 1990). 
 
O
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Figure 6.1. Reaction between 1 molecule of MDA and 2 molecules of TBA to form an 
MDA-TBA complex (modified from Mead et al., 1986). 
 
The value of the TBA test is that the peroxidation process beginning in the reaction 
mixture is effectively amplified in the assay itself, hence making it fairly sensitive 
(Gutteridge and Halliwell, 1990). A problem with the assay is that added metal ions, 
antioxidants and chelating agents may interfere with peroxide decomposition (Gutteridge 
and Quinlan, 1983). 
 
MDA is produced from ring LOOH, as shown in figure 6.2. These peroxides can only be 
formed during the oxidation of methylene-interrupted polyunsaturated systems with three 
or more double bonds (Dahle et al., 1962). The reason for this is that lipid ROO· with an 
unsaturation β, γ with respect to the ROO· function are required (Dahle et al., 1962). This 
MDA TBA 
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is illustrated in figure 6.3., using the fatty acid linolenate as an example. Hydrogen 
abstraction of linolenate can give rise to four different isomeric lipid ROO·. Of the four 
radicals, only two possess an unsaturation β, γ with respect to the ROO· function (Dahle 
et al., 1962). The β, γ unsaturated lipid ROO· undergo cyclisation to form five-membered 
ring peroxides (Dahle et al., 1962). If the β, γ-unsaturated free radical is stabilised by 
addition of a hydrogen atom to become a hydroperoxide, it could again yield a peroxide 
radical upon loss of hydrogen to either RO· or HO· .The latter radicals could be formed 
from ROOH under the acidic conditions of the TBA assay (Dahle et al., 1962). In 
contrast, figure 6.4. shows that ring peroxides cannot be formed from linoleate, which 
only has two double bonds. 
 
The TBA test is particularly useful in neuroscience because neural membranes contain 
large amounts of phospholipids that are characterised by their high content of 
arachidonic, docosatetraenoic, and docosahexaenoic acids (Farooqui and Horrocks, 
1994). All these fatty acids contain three or more double bonds, thus MDA can be formed 
and used as a marker for LP. The amount of MDA present is directly proportional to the 
incidence of LP. 
 
Figure 6.2. Mechanism of formation of MDA from cyclic ring peroxides (Dahle et al., 
1962). 
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Figure 6.3. The formation of ring peroxides during LP of linolenate (Dahle et al., 1962). 
 
 
 
Figure 6.4. No ring peroxides formed during LP of linoleate (Dahle et al., 1962).  
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6.2. THE EFFECT OF QA ALONE AND IN 
COMBINATION WITH AC ON LIPID 
PEROXIDATION IN RAT BRAIN 
HOMOGENATE IN VITRO 
 
6.2.1.  Introduction  
Rios and Santamaria, 1991 first described the lipoperoxidative effect of QA in vitro in rat 
brain homogenates and concluded that lipid peroxidation may be a damaging process 
involved in the neurotoxicity of QA. 
 
AC was able to protect against QA-induced necrosis of hippocampal cells and the loss of 
integrity of hippocampal cell membranes (chapter 3). In the previous chapter, AC was 
found to have the ability to attenuate oxidative stress. Theoretically then, attenuation of 
oxidative stress should diminish oxidative damage to lipids (LP). Hence, the effect of QA 
on LP in rat brain homogenate in vitro, in the absence and presence of AC was 
investigated.  
  
6.2.2.  Materials and Methods 
6.2.2.1. Animals 
Adult male Wistar rats were purchased from the NHLS (Johannesburg, South Africa) 
were cared for as described in section 2.2.2.1. 
 
6.2.2.2. Chemicals and Reagents 
AC sodium (Zovirax®, powder for injection) was obtained from Glaxo Wellcome, 
Midrand, South Africa. 1, 1, 3, 3-tetramethoxypropane (98%), QA, Butylated 
Hydroxytuolene (BHT) and TBA and trichloroacetic acid (TCA) were purchased from 
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Sigma Chemical Co, St. Louis, USA. Ascorbic Acid, ethanol and butanol were purchased 
from Saarchem, Krugersdorp, South Africa. 
 
6.2.2.3. Removal of the brain 
This was performed as described in section 5.2.2.3.  
 
6.2.2.4. Preparation of Tissue 
This was performed as described in section 5.2.2.4. 
 
6.2.2.5. Preparation of the MDA Standard Curve 
Preparation of the calibration curve is complicated by the fact that MDA is unstable. 
Thus, MDA must be prepared immediately before use, by hydrolysing one of its 
derivatives, either 1,1,3,3-tetramethoxypropane or 1,1,3,3-tetraethoxypropane (Halliwell 
and Gutteridge, 1989). A series of 1, 1, 3, 3-tetramethoxypropane standards (0–20 
nmoles/ml) were prepared in triplicate using PBS as the diluent to give a total volume of 
1 ml. To these tubes 0.5 ml BHT (0.5 % in ethanol) and 1 ml TCA (15 % in milli Q 
water) were added. An aliquot of 2 ml of this solution was added to 0.5 ml TBA (0.33 %) 
and incubated for 1 hour. A standard curve was generated by measuring the absorbances 
at 532 nm on a GBC UV/VIS 916 spectrophotometer and plotting these against the molar 
equivalent weight of MDA in the complexes formed (Appendix IV). 
 
6.2.2.6. Lipid Peroxidation Assay 
A modification of the TBA Assay as described by Placer et al. (1966) was used.  
 
Triplicate samples of rat brain homogenate (1 ml) contained 1 mM QA (100 µl) in the 
absence and presence of increasing concentrations (0–2 mM) of AC (100 µl). The 
samples were incubated in an oscillating water bath for an hour at 37 ˚C. Control samples 
did not contain QA or AC. 
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The reaction was terminated at the end of the incubation period by the addition of 1 ml 
TCA (15 % in milli-Q water) and 0.5 ml BHT (0.5 % in ethanol) to each sample. The 
samples were heated at 95 ˚C for 15 minutes in a water bath to release protein-bound 
MDA. Following this, samples were cooled and centrifuged at 2000 x g for 20 minutes to 
yield a protein-free supernatant. This supernatant (2 ml) was then transferred to a clean 
set of test tubes and 0.5 ml TBA (0.33 % in milli-Q water) was added. All samples were 
heated at 95 ˚C for an hour in a water bath to allow for the formation of the MDA-TBA 
complex. After rapidly cooling the test tubes on ice, 2 ml butanol was added to extract the 
pink complex. The samples were then centrifuged at 2000 x g for 15 minutes. An aliquot 
of the top layer (extracted complex in butanol) was read at 532 nm, using a GBC UV/VIS 
spectrophotomter. MDA levels were then determined from a standard curve generated 
from 1, 1, 3, 3-tetramethoxypropane as described in section 6.2.2.5. Final results were 
expressed as MDA (nmoles/mg tissue). 
 
6.2.2.7. Statistical Analysis 
This was performed as described in section 4.2.2.9. 
 
6.2.3.  Results  
Figure 6.5. illustrates that 1 mM QA increases the amount of MDA in comparison to 
control approximately six-fold, and that AC blunts the 1 mM QA-induced LP. The latter 
response proceeds in a concentration-dependent manner and the suppression of MDA is 
highly significant for each concentration used (p < 0.001) in comparison to samples 
containing QA alone.  
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Figure 6.5. Effect of 1 mM QA alone and in combination with AC on LP in rat brain 
homogenate in vitro. Each bar represents the mean ± SD (n = 5). # (p < 0.001) in 
comparison to control and *** (p < 0.001) in comparison to 1mM QA (ANOVA and 
Student–Newman–Keuls Multiple Range Test). 
 
6.2.4.  Discussion 
Štípek et al., 1997 found that the effect of QA on LP in the rat brain in vitro, reported by 
Rios and Santamaria (1991) depends on Fe2+ and that this mechanism is likely to involve 
Fe2+-chelation by QA. In this experiment, QA was added to homogenised and therefore 
disrupted tissues. The homogenising action results in the release of metal ions especially 
iron from storage sites within cells (Barber, 1963, Gutteridge and Stocks, 1976). Ultra-
violet (UV) absorption spectra have shown that QA has the ability to chelate the Fe2+ ion. 
This was also observed with 2,6-pyridinedicarboxylic acid, which like QA, contains a 2-
pyridinecarboxylic acid moiety (figure 6.6) (Iwahashi et al., 1999). 
 
Lipid Peroxidation________________________________________________________ 
 117 
 
 
Figure 6.6. Binding of Fe2+ by the 2-pyridine carboxylic acid moiety (Iwahashi et al., 
1999) 
 
The UV spectral wave so generated disappeared upon addition of H2O2, indicating that 
the Fe2+ ions in the complex may have been oxidised by H2O2 to Fe3+ (Iwahashi et al., 
1999), with the subsequent formation of the potent HO· radical, shown in Equation 6.1. 
This free radical is potent enough to initiate LP. 
 
Fe2+-2,6-pyridinedicarboxylic acid + H2O2   
 
Fe3+ + OH- + HO· + 2,6-pyridinedicarboxylic acid                        Equation 6.1.  
 
It has also been reported that the QA-Fe2+ complex is able to inhibit the auto-oxidation of 
Fe2+ (Murakami, et al. 1998), implying that iron is kept in the ferrous form which 
participates in the Fenton reaction. Thus, it appears that, through weak chelation of Fe2+, 
QA may enhance the Fenton reaction. Furthermore, the ability of Fe3+ to undergo rapid 
redox recycling to Fe2+ (Gutteridge, 1994) in the presence of O2·- provides a constant 
supply of Fe2+ for the Fenton reaction.  
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Štípek, et al., (1997) further found that upon addition of the iron chelator, desferoxamine, 
the increase in QA-induced LP is abolished. It is thus evident that the ability of AC to 
ameliorate QA-induced LP is possibly related to an ability to strongly bind Fe2+ and/or 
Fe3+. If AC binds strongly to endogenous Fe2+ in rat brain homogenate, reduction of these 
ions will not occur even in the presence of H2O2 and fewer of these ions will be available 
to bind to QA to form the QA-Fe complex. Similarly, strong binding of Fe3+ by AC 
would prevent redox recycling of this ion and thus the perpetual formation of Fe2+. AC 
has been reported to bind various other 3d metal ions, including nickel, copper and 
platinum (Herrero et al., 2001). The ability of AC to bind the 3d metal ions Fe2+ and Fe3+ 
shall be investigated in chapter 7.  
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6.3. THE EFFECT OF IRON (II) ALONE AND IN 
COMBINATION WITH AC ON LIPID PEROXIDATION 
IN RAT BRAIN HOMOGENATE IN VITRO 
 
6.3.1.  Introduction  
In addition to having a high content of peroxidisable PUFAs, the brain also contains high 
levels of transition metals (Floyd, 1999). In biological systems, the formation of the LP 
initiating HO· radical, is catalysed by the Fenton reaction, which occurs between H2O2 
and the transition metals, iron or copper in a low valence state (Halliwell and Gutteridge, 
1986), as shown in the equation 6.2. below: 
 
Metaln+
   
+    H2O2       Metaln+1   +   HO·     +    OH-        Equation 6.2 
 
The Fenton reaction has gained such prominence in neuroscience that the two transition 
metals have been classified as mediators of oxidative stress in a number of 
neurodegenerative disorders (Sayre et al., 1999; Thompson et al., 2001). 
 
This reaction may be accelerated by a reducing agent such as ascorbic acid, which 
promotes the redox cycling of soluble iron complexes (Rauhala et al., 1998b). 
Ethylenediamine tetraacetate (EDTA) is an anionic hexadentate ligand which has the 
ability to bind Fe3+. Upon chelation with ferric ions, a soluble complex ion is formed. 
This prevents the formation of neutral insoluble complexes which cannot be reduced even 
in the presence of a reducing agent such as ascorbic acid. It has been shown that ferric 
complexes with EDTA can generate HO· radicals and initiate LP in the presence of 
reducing agents such as ascorbate (Rauhala et al., 1998b). 
 
In section 6.2.4., evidence that the Fenton reaction is implicated in the lipoperoxidative 
effect of QA in vitro was explored. Thus, in this experiment, the direct effect of the 
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Fenton reaction on LP was investigated by simulating, as accurately as possible the 
conditions under which this reaction occurs. 
 
6.3.2.  Materials and Methods 
6.3.2.1. Animals 
Adult male Wistar rats were purchased from the NHLS (Johannesburg, South Africa) and 
cared for as described in section 2.2.2.1. 
 
6.3.2.2. Chemicals and Reagents 
Chemicals and reagents used were as described in section 6.2.2.2., with the exception of 
QA. In addition, ferrous sulphate (FeSO4.7H2O) was obtained from Merck, Darmstadt, 
Germany. EDTA was obtained from Holpro Chemical Corp., Johannesburg, South 
Africa. H2O2 was obtained from BDH Laboratory Supplies, Poole, England and ascorbic 
acid was obtained from Saarchem, Krugersdorp, South Africa. 
 
6.3.2.3. Brain Removal 
This was performed as described in section 5.2.2.3. 
 
6.3.2.4. Preparation of Tissue 
The tissue was performed as described in section 5.2.2.4.  
 
6.3.2.5. Preparation of the MDA Standard Curve 
This was performed as described in section 6.2.2.5.  
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6.3.2.6. Lipid Peroxidation Assay 
The assay was performed as described in section 6.2.2.6. However, triplicate samples of 
rat brain homogenate (1 ml) containing 1 mM Fe2+ (100 µl) in the absence and presence 
of increasing concentrations (0–2 mM) of AC (100 µl), together with 100 µM H2O2     
(100 µl), 100 µM EDTA 100 µl and 10 µM (100 µl) ascorbic acid were incubated at      
37 ˚C for an hour. Control samples contained no Fe2+and no AC. 
 
6.3.2.7. Statistical Analysis 
This was performed as described in section 4.2.2.9.  
 
6.3.3.  Results 
Figure 6.7. illustrates that 1 mM Fe2+ increases the amount of MDA produced in 
comparison to the control by approximately seventy five times. AC has the ability to 
significantly reduce 1 mM Fe2+-induced LP. This effect does not appear to be entirely 
concentration dependent as the difference between the amount of MDA formed by co-
incubation of 1 mM QA and 1 mM AC (0.97 nmoles/mg tissue) and that formed by co-
incubation of 1 mM QA and 2 mM AC (0.95 nmoles/mg tissue) is insignificant. 
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Figure 6.7. Effect of 1 mM Fe2+ alone and in combination with AC on LP in rat brain 
homogenate in vitro. Each bar represents the mean ± SD; n = 5. # (p < 0.001) in 
comparison to control; ** (p < 0.01) and *** (p < 0.001) in comparison to 1 mM Fe2+ 
alone (ANOVA and Student–Newman–Keuls Multiple Range Test). 
 
6.3.4.  Discussion 
The finding that 1 mM Fe2+ produced a significantly higher amount of MDA compared to 
control indicates that the Fenton reaction has the potential to play a major role in LP. Fe2+ 
ions catalyse the formation of HO· from H2O2 (Halliwell and Gutteridge, 1989). These 
radicals are sufficiently reactive to abstract H· (Halliwell and Gutteridge, 1989) from 
membrane PUFA to initiate LP. Furthermore, ferrous and ferric ions also react with lipid 
hydroperoxides already formed as by-products of LP, decomposing them to ROO· and 
alkoxyl radicals that can reinitiate LP (Halliwell, 1994). A reduced iron complex (e.g. 
EDTA- Fe3+ or QA- Fe2+) reacts with these lipid hydroperoxides in a similar way to its 
reaction with H2O2, i.e. it causes fission of an O-O bond. This forms an alkoxyl radical 
(Halliwell and Gutteridge, 1989), as shown in equation 6.3. 
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ROOH   +   Fe2+-complex             Fe3+-complex + OH- +   R-O·                   Equation 6.3. 
lipid peroxide                         alkoxyl radical   
 
A Fe3+ complex can form both ROO· and alkoxyl radicals (Halliwell and Gutteridge, 
1989) according to the overall equation 6.4. 
 
R-OOH + Fe3+-complex             R-O-O·   +     H+    +   Fe2+-complex           Equation 6.4. 
        peroxyl      further reaction to    
                              radical                 alkoxyl radical 
 
The reaction of Fe2+ with R-OOH is faster than the reaction with H2O2 (Halliwell and 
Gutteridge, 1989). Thus, if both substrates are available, the reaction with R-OOH will be 
favoured. When cells are injured, LP is more likely to occur and traces of R-OOH are 
formed enzymatically in tissues by cyclo-oxygenase and lipoxygenase enzymes 
(Halliwell and Gutteridge, 1989). When these are decomposed, in the presence of ferrous 
and ferric ions, alkoxy and peroxy radicals are generated which can abstract H· and 
stimulate LP further.  
 
Since AC is able to reduce Fe2+-induced LP, the argument that AC may be binding Fe2+ 
and/or Fe3+ is strengthened. However, it is possible that a maximum effect is achieved 
when the ratio of AC to Fe2+ is 1 to 1 because LP was not suppressed by much more 
when the ratio of AC to Fe2+ was greater than 1. This may suggest that the concentration-
dependent decrease in QA-induced LP (section 6.3) may be attributed to other factors 
aside from iron binding, such as the scavenging of free radicals, particularly those 
associated with Fe2+-induced LP, such as HO·, O2·- and alkoxyl radicals. The ability of 
AC to scavenge O2·- has been elucidated in chapter 5. 
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In general, of all the various biomolecule monomers, the guanine base is particularly 
sensitive to oxidation and these products are often used as a biomarker for oxidative 
injury (Halliwell and Gutteridge, 1989). Guanine reacts with the HO· as illustrated in 
figure 6.8., to form 8-hydroxyguanine. 
 
 
Figure 6.8. Reaction of guanine base with HO· to form 8-hydroxyguanine (Halliwell and 
Gutteridge, 1989). 
 
Figure 6.9. Proposed reaction of AC with HO· to form 8-hydroxyAC. 
 
Analogous to guanine, AC, a guanosine analogue may also be sensitive to oxidation and 
react with HO· in a similar manner as proposed in figure 6.9., and therefore reduce the 
availability of this radical for reaction with lipid membranes, effectively diminishing the 
occurrence of LP in rat brain homogenate. 
 
HO· may also be inactivated by AC through the abstraction of H· from the hydroxyl group 
at position 5 of AC, to form a guanine radical which scavenges O2·-. This is described in 
section 5.2.4., as part of the O2·- scavenging of AC. 
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6.4.   THE EFFECT OF QA ALONE AND IN COMBINATION 
WITH AC ON LIPID PEROXIDATION IN THE RAT 
HIPPOCAMPUS IN VIVO 
 
6.4.1.  Introduction 
The disruption of the structure and integrity of the lipid membranes of the cell bodies in 
the CA1 and CA3 regions of the hippocampi of QA only treated rats (chapter 3) may 
occur due to the cleavage of arachidonic acid and related PUFA by calcium-dependent 
PLA2 release after an excitotoxic insult (section 3.2.4.), or otherwise LP which may occur 
as a result of QA-induced oxidative stress (chapter 5). Therefore, the improvement in this 
structure and integrity observed in the hippocampi of QA + AC treated rats may be 
through protection of AC against QA-induced LP in rat hippocampal homogenate in vivo. 
 
Ultimately, this section aims to assess the deleterious effect, if any, of the mechanisms of 
neurodegeneration, such as excitotoxicity (chapter 4) and oxidative stress (chapter 5), 
initiated by QA in vivo, on lipid biomolecules and to determine if AC could alter this. To 
reiterate what was mentioned in section 1.2.3.4. and 6.1., the importance of maintaining 
the structure and integrity of lipid membranes lies in its role in normal cell functioning. 
Impairment of this arrangement may (1) decrease fluidity and increase non-specific 
permeability to ions. (2) inactivate membrane-bound receptors and enzymes (Gutteridge 
and Halliwell, 1990).  
 
6.4.2.  Materials and Methods 
6.4.2.1. Animals 
Adult male Wistar rats were purchased from the NHLS (Johannesburg, South Africa) and 
cared for as described in section 2.2.2.1. 
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6.4.2.2. Chemicals and Reagents 
Chemicals and reagents used were as described in section 6.3.2.2. Sodium 
phenobarbitone was purchased from Merck, Germany and was at a working 
concentration of 60 mg/ml. 
 
6.4.2.3. Surgical Procedures 
These procedures were conducted as described in section 2.2.2.4. 
 
6.4.2.4. Drug Treatment  
This was performed as described in section 2.2.2.5. 
 
6.4.2.5. Brain and Hippocampi Removal 
The rats were killed and the brains and hippocampi removed in the manner described in 
section 2.2.2.7. However, the rats were killed the day after the last dose of the drug 
treatment.  
 
6.4.2.6. Preparation of Tissue 
The preparation of each portion of the hippocampal tissue was performed as described for 
each whole brain in section 5.2.2.4. However, the homogenate concentration was             
5 % w/v instead of 10 % w/v.  
 
6.4.2.7. Preparation of the MDA Standard Curve 
This was performed as described in section 6.2.2.5. 
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6.4.2.8. Lipid Peroxidation Assay 
The LP assay was performed as described in section 6.2.2.6. However, no exogenous QA 
or AC was added and the first incubation at 37 ˚C for one hour was omitted. The assay 
resumed with the termination of LP by addition of TCA and BHT to the triplicate 
samples of rat hippocampal homogenate (1 ml).  
 
6.4.2.9. Statistical Analysis 
This was performed as described in section 4.2.2.9. 
 
6.4.3.  Results 
As shown in figure 6.10, it appears that the intrahippocampal injection of QA (120 
nmoles) causes approximately a three-fold increase (p < 0.001) in MDA levels in 
comparison to the control treated rats. However, the twice daily i.p. injections of AC 
(5mg/kg) for five days are able to significantly reduce the QA-induced MDA production 
(p < 0.001). 
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Figure 6.10. Effect of QA alone and in combination with AC on LP in rat hippocampal 
homogenate in vivo. Each bar represents the mean ± SD; n = 5. # (p < 0.001) in 
comparison to control; *** (p < 0.001) in comparison to QA (ANOVA and Student–
Newman–Keuls Multiple Range Test). 
 
6.4.4.  Discussion 
The effect of QA on the formation of LP products from hippocampal tissue in this study 
is in agreement with the results of Behan et al., (1999). These authors found that 
melatonin, a potent free radical scavenger and a stimulant of antioxidant enzyme 
synthesis (section 1.3.4.5.), is able to reduce 120 nmoles QA-induced LP in rat 
hippocampus in vivo and thus suggest that free radical formation contributes significantly 
to QA-induced damage. In Chapter 5, the ability of AC to reduce QA-induced oxidative 
stress in rat hippocampus in vivo was demonstrated. Therefore, through this mechanism, 
there will be fewer free radicals available to attack lipids and initiate LP, which may 
explain the amelioration of QA-induced LP by AC in rat hippocampus in vivo. 
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As expected, these results exhibit an inverse relationship to the degree of integrity of the 
cell membranes of the cell bodies of the hippocampal neurons in section 3.2. QA alone 
produced a decrease in the integrity of the cell membranes which was coupled with an 
increase in LP, in comparison to the control. In contrast, QA + AC treatment had an 
improved integrity of cell membranes and reduced LP in comparison to QA alone. It can 
therefore be concluded that the integrity of neural membranes in general is highly 
dependent on the degree of LP. As explained in section 6.1., LP may often occur as a 
result of cell damage or death, thus a correlation between the extent of cell damage and / 
or death and the extent of LP exists and these results may serve to confirm the findings of 
chapter 3. 
 
NMDA and insulin receptors are known to have sulfhydryl groups which are damaged 
during LP (van der Vliet and Bast, 1992). Thus, the LP induced by the intrahippocampal 
injection of QA may inactivate the NMDA receptors of the glutamatergic system in the 
hippocampus, reducing the incidence of LTP at the glutamatergic synapses which have 
survived the excitotoxic insult. The amelioration of LP may therefore be an additional 
mechanism by which AC treatment improves the spatial memory deficits (Chapter 2) 
after intrahippocampal injections of QA.  
 
It may be argued that if the NMDA receptors are inactivated during LP, excitotoxicity 
should also be dampened and the further effects thereof, such as LP should diminish over 
time.  However, instead, hippocampal LP was enhanced 5 days after an intrahippocampal 
injection of QA. This points to the possibility that other mechanisms are involved in QA-
induced LP in vivo. Shoham et al., (1992) have shown that after single unilateral 
injections of QA into the rat ventral-striatal region, iron accumulates in high 
concentrations in the basal ganglia area such as globus pallidus and substantia nigra pars 
reticulate. Hence, it is possible that the intrahippocampal injection of QA has a similar 
effect on iron accumulation in the hippocampus, consequently forming the QA-iron 
complex which may also have a role to play in enhancing the production of the HO· in 
vivo and in this manner initiate LP independent of excitotoxicity (NMDA stimulation). 
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CHAPTER 7 
IRON CHELATION STUDIES 
 
7.1.  INTRODUCTION 
Iron is an essential constituent of a number of proteins involved in oxygen transport or 
metabolism (Winterbourn, 1995). It is transported in the body, stored and made available 
for synthesis of these iron proteins (Brock, 1994; De Jong et al., 1990). The ability of 
iron to undergo cyclic oxidation and reduction is an important aspect of its function. 
However, as described in sections 1.2.2.2.5., 6.2. and 6.3., such redox activity can 
generate free radicals and other strongly oxidising species capable of causing a wide 
range of biological injuries (Winterbourn, 1995), particularly via the Haber-Weiss and 
Fenton reactions (Halliwell and Gutteridge, 1984b). 
 
Iron has also been associated with the pathological lesions of AD (Smith et al., 1997). 
Accumulation of iron has been shown to be associated with AP and NFT, indicating 
alterations of iron homeostasis in AD, which is further supported by the elevated serum 
levels of the iron binding protein p97 found in patients with AD (Kennard et al., 1996). 
Moreover, iron greatly increases the vulnerability of neurons to amyloid toxicity, which 
involves membrane LP resulting in the production of the aldehyde 4-hydroxynonenal, 
which, in turn, impairs the function of membrane ATPases and glucose and glutamate 
transporters (Goodman and Mattson, 1994; Mark et al., 1997a,b). 
 
Iron is also essential for the biosynthesis of the deoxyribonucleotides required for DNA 
synthesis and repair (Aisen et al., 1999). DNA viruses, such as HSV-1 are directly 
dependent on iron for their proliferation since iron plays a role in the catalytic centre of 
ribonucleotide reductase (Cooper et al., 1996; Lamarche et al., 1996; Chabes et al., 
2000). Therefore, the presence of free iron may enhance HSV-1 replication, thereby 
facilitating increased viral infectivity in HSE. 
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Depression may be accompanied by the induction of an immune response which includes 
the production of pro-inflammatory cytokines (section 1.1.4.4.). Other features of this 
inflammatory process include alterations in iron metabolism (Fairbanks and Beutler, 
1988; Brock, 1994), such as decreased serum iron and transferrin (Fairbanks and Beutler, 
1988; Brock, 1994), the iron protein transporter, which delivers an iron supply to the 
tissues (Brock, 1994; De Jong et al., 1990). Thus, in such patients, the provision of iron 
for the synthesis of iron proteins is reduced and may contribute to  “sickness behaviour” 
consisting of psychomotor retardation, anorexia, weight loss, lethargy and sleep disorders 
(Kleesiek and Greiling, 1984; Kent et al., 1992). These signs and symptoms are common 
in patients with major depression (Maes et al., 1993). 
 
Iron deprivation and/or the removal of free iron from plasma and cells may be beneficial 
in neurodegenerative disorders which are associated with iron-catalysed oxidative stress, 
particularly if the accumulation of iron is prevalent, as in AD. In HSE, reduction in the 
replication of HSV-1 is an additional advantage. However, such therapy cannot afford to 
be drastic as it may aggravate iron-related “sickness behaviour”, in neurodegenerative 
disorders, such as HSE or depression where serum iron levels are low or normal. 
 
By definition, chelation requires the presence of two or more atoms on the same molecule 
capable of forming a coordinate bond, an interaction between the electron donor 
(chelating ligand) and an electron acceptor (metal) to form a complex metal ion (Galey, 
1997). Depending on the number of donor groups associated with the chelating ligand, 
varying ligand to metal ratios may occur to satisfy the coordination requirements of the 
metal ion. Both ferrous and ferric ions have a coordination number of 6 (Galey, 1997). 
Bidentate ligands therefore form 3 to 1 iron complexes, whereas tridentate ligands form 2 
to 1 complexes. 
 
There exists an ambiguous relationship between iron and its interaction with compounds 
with which it forms co-ordinate bonds. For example, many ferrous chelates, such as the 
QA-iron complex referred to in chapter 6 react with hydrogen peroxide to produce an 
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oxidising species, namely HO· (Winterbourn, 1995). On the other hand, other chelates, 
such as the ATP-iron complex are not effective at driving the Fenton reaction 
(Winterbourn, 1995). The former category of chelates would enhance oxidative stress and 
oxidation of biomolecules whilst the latter would prevent the participation of iron in 
redox reactions, thus limiting its physiological and pathological activity. 
 
Using qualitative analytical techniques, this chapter aims to firstly determine whether an 
interaction exists between AC and iron, in both the ferrous and ferric oxidation states. 
Secondly, an attempt will be made to characterise the interactions, if any, particularly 
with respect to the strength of the AC-Fe2+ complex in relation to the QA-Fe2+. The 
results of these studies will predict whether the hypothesis that AC binds iron in the 
ferrous and ferric forms holds true or not. Such an effect would diminish the redox 
activity of iron and therefore its ability to catalyse the formation of HO· and induce LP 
(chapter 6). 
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7.2. ULTRAVIOLET AND VISIBLE SPECTROSCOPIC 
ANALYSIS OF AC ALONE AND IN COMBINATION 
WITH IRON (II) AND IRON (III) 
 
7.2.1.  Introduction 
The fundamental principle underlying spectrophotometric techniques is that all chemicals 
to some extent absorb electromagnetic radiation of specific wavelengths (Newman, 
1964). These techniques measure the extent to which electromagnetic radiation is 
absorbed by any chemical substance. Ultraviolet and visible (UV/VIS) spectroscopy 
specifically measures the absorption of electromagnetic radiation in the UV/VIS range of 
the electromagnetic spectrum, which extends from 200 nm to 800 nm. 
 
Electromagnetic radiation absorbed in the UV region produces changes in the electronic 
energy of the molecule resulting from transitions of valence electrons in the molecule 
(Silverstein et al., 1981). These transitions consist of the excitation of an electron from an 
occupied molecular orbital, usually a non-bonding p or bonding π orbital to the next 
higher energy orbital, an antibonding π*  or σ* orbital  (Silverstein et al., 1981). As a 
result, unsaturated organic compounds in particular absorb UV light (Newman, 1964). 
 
Different chemicals may absorb light at different wavelengths so a qualitative analysis of 
an unknown chemical may be made by determining the absorption spectrum of that 
chemical (Newman, 1964). The principle characteristics of any absorption band in an 
absorption spectrum are its position and intensity (Silverstein et al., 1981). The position 
of absorption corresponds to the wavelength of radiation whose energy is equal to that 
required for an electronic transition. The intensity of absorption is dependent on two 
factors: (a) the probability of interaction between the radiation energy and the electronic 
system and (b) the difference between the ground and excited state (Silverstein et al., 
1981). Therefore, any change in structure or composition of a compound will result in a 
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change in the electronic system, thereby introducing alterations in the spectrum; either a 
shift in wavelength or a change in the intensity of the absorbance (Newman, 1964). 
 
7.2.2.  Materials and Methods 
7.2.2.1. Chemicals and Reagents 
AC sodium (Zovirax®, powder for injection) was obtained from Glaxo Wellcome, 
Midrand, South Africa. Hydrated ferrous sulphate (FeSO4.7H2O) and anhydrous ferric 
chloride (FeCl3) were purchased from BDH Laboratory Supplies, Poole, England. All 
solutions were prepared in deaerated Milli-Q water to prevent autooxidation. 
 
7.2.2.2. UV/VIS Spectroscopy 
The interaction between AC and Fe2+ and Fe3+ was studied by comparing the absorption 
spectrum of AC alone in solution to those of AC in equimolar combinations with each 
metal ion (0.125 mM-0.5 mM). All the samples were analysed on a GBC UV/VIS 916 
spectrophotometer, using quartz cuvettes with a pathlength of 0.1 cm. 
 
7.2.3.  Results 
Figures 7.1 and 7.2 show that free AC has an absorption band from 227.2 nm to        
298.4 nm, with a λmax of 252.8 nm and a shoulder extending from 262.4 nm to 298.4 nm. 
Upon the addition of Fe2+ (figure 7.1), there is an increase in the absorption intensity and 
a blue shift of λmax by 2.4 nm from 252.8 nm to 250.4 nm. In the presence of Fe3+ (figure 
7.2.), a blue shift of the band at 252.8 nm to 250.4 nm is also observed with a greater 
increase in absorption intensity. The observations are also noted at the other 
concentrations (0.25–0.5 mM). 
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Figure 7.1. UV spectroscopic analysis of AC alone and in the presence of an equimolar 
concentration (0.125 mM) of Fe2+. 
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Figure 7.2. UV spectroscopic analysis of AC alone and in the presence of an equimolar 
concentration (0.125 mM) of Fe3+. 
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7.2.4.  Discussion 
The λmax absorption band of free AC at 252.8 nm is due to an aromatic, π  π* electronic 
transition (Silverstein et al., 1981). The absorption of sulphides, disulphides, thiols, 
amines, bromides and iodides frequently appear only as a shoulder or an inflection 
(Silverstein, 1981), thus the shoulder in the spectra (figures 7.1 and 7.2) most likely 
represents the amine group in AC (figure 1.15).  
 
Possible complexation on addition of both Fe2+ and Fe3+ is evidenced by the increase in 
the intensity of the absorbance and by the blue shift of λmax by 2.4 nm, which indicate that 
a change in the electronic system of AC has occurred (section 7.2.1). In co-ordinate 
bonding with metals, it is the ligand which provides both electrons for each bond. Thus, a 
good ligand is likely to be a compound which has a number of non-bonding electrons. 
AC (figure 1.15) has auxochromic substituents such as N and O-containing functional 
groups which have non-bonding electrons. The blue shift to a wavelength of higher 
energy may result from an increase in the energy required for an electronic transition to 
occur because of the reduced availability of non-bonded electrons in a possible AC-iron 
complex.  
 
As mentioned previously, the intensity of absorption is largely dependent on two factors: 
(a) the probability of interaction between the radiation energy and the electronic system 
and (b) the difference between the ground and excited state (section 7.2.1.). The 
probability of transition [(a) above] is proportional to the change in the electronic charge 
distribution occurring during excitation, therefore a greater intensity of absorption is 
reflected on the absorption spectrum when the electronic transition during excitation is 
accompanied by a larger change in the electronic charge distribution (Silverstein et al., 
1981). During co-ordinate bonding, the electrons of the ligand move towards the metal 
ion, therefore any charge on the free ligand or metal ion is no longer isolated but spread 
over the entire complex, known as a complex ion. This change in the electronic structure 
may effect a larger change in the electronic charge distribution during the electronic 
transition and may thus explain the increase in absorption intensity on addition of the 
ferrous or ferric ions. The larger intensity of absorption of AC in combination with Fe3+ 
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than with Fe2+ may indicate that the interaction between AC and Fe3+ is stronger than that 
of AC and Fe2+. 
 
It has been suggested that purines act as chelating ligands of metals through the N(7) and 
the exocyclic atom attached to C(6) (Turel et al., 1998). However, in aqueous systems, 
true chelation has only been observed in 6-thiopurines. Acyclovir is a 6-oxopurine (figure 
7.3.), in which the typical bonding pattern in the metal complexes can be best described 
as indirect chelation where a water molecule in the coordination sphere forms interligand 
hydrogen bonds to the exocyclic substituent at C(6) (Turel et al., 1998). In some cases, 
metal-AC bonds may also form through the hydroxylic oxygen atoms of a bridging AC 
molecule bound via the N (7), as in the cadmium complex (Garcia-Raso et al., 1999). The 
proposed metal-ligand bonding of AC is shown in figure 7.4.  
 
 
 
Figure 7.3. Structure of AC with atoms numbered (Turel et al., 1998). 
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Figure 7.4. Proposed metal-AC chelation, showing the functional groups involved in the 
coordinate bonding. 
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7.3. AN ELECTROCHEMICAL ANALYSIS OF IRON (III) 
AND IRON (II) ALONE AND IN THE PRESENCE OF AC 
OR QA 
 
7.3.1.  Introduction 
A chemical reaction in which one or more electrons are transferred from one species to 
another is the basis for electrochemical analysis (Pecsok et al., 1968). Electrochemical 
cells usually consist of three electrodes, namely, a working, a reference and an auxilliary 
electrode (Bard and Faulkner, 1980). The electron transfer reactions occur at the surface 
of the working electrode. These reactions are monitored in relation to a reference 
electrode, which maintains a constant potential. The current passes between the working 
electrode and the auxilliary electrode, the latter serving to complete the circuit (Bard and 
Faulkner, 1980). 
 
Metal ions in solution are able to accept and donate electrons. This electroactive nature 
makes both qualitative and quantitative analysis possible. For a trace metals in solution it 
is necessary to employ a preconcentration step to isolate it at the working electrode where 
the reactions take place (Limson, 1998). This may be performed electrolytically or 
spontaneously. Adsorptive stripping voltammetry (ASV) is an electrochemical technique 
in which natural tendency of analytes to preconcentrate at the electrode is exploited 
(Limson, 1998). This extends the use of stripping voltammetry to organic compounds 
which cannot be electrolytically deposited (Wang, 1989). Furthermore, in metal analysis, 
ASV allows for the preconcentration of any oxidation state and not only the metallic state 
(Limson, 1998). 
The first step in ASV is the formation of a metal-ligand complex (equation 7.1), followed 
by controlled interfacial accumulation (adsorption) of the complex onto the electrode at a 
fixed deposition potential during the deposition step (equation 7.2) (Limson et al., 1998). 
The third phase is the electrochemically active stripping step (Limson et al., 1998). It 
involves the application of a potential in the negative direction, during which reduction of 
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the adsorbed metal complex occurs, releasing the metal and ligand back into solution 
(equation 7.3) (Limson et al., 1998). Thus, the third step further specifies the technique as 
adsorptive cathodic stripping voltammetry. The flow of electrons during the last step 
produces a cathodic current which peaks at the reduction potential of the complex. This 
current is a direct measure of the rate at which reduction occurs (Limson, 1998). The 
resulting current potential plot is a voltammogram. 
Mn+     +     x(Ligand)aq                               M(Ligand)x,aq     +     xnH+     Equation 7.1. 
M(Ligand)x,aq                                               M(Ligand)x,ads                        Equation 7.2. 
M (Ligand)x,ads     +     xnH+     +     ne-        Mn+     +     x(Ligand)aq            Equation 7.3.  
 
A metal species will produce a characteristic voltammogram, with current being 
proportional to the concentration of the species, due to the linear relationship between 
current, the amount of species adsorbed onto the electrode and the bulk concentration of 
the species in the electrolyte (Limson, 1998). When a suitable ligand is added to a metal 
solution, the ligand facilitates movement of the metal to the surface of the electrode, 
possibly due to the field dipole interactions between the electrode double layer and 
functional groups of the ligand. (Limson, 1998). Theoretically then, a ligand which forms 
a bond with a metal should bring about an increase in current response observed. There 
may also be a shift in potential resulting from the reduction of a new species, the metal-
ligand complex at the electrode.  
 
The affinity of the ligand toward the metal is expressed by the extent of an increase in 
current response of the metal on addition of the ligand, while the extent of a shift in the 
reduction potential is a measure of the stability of the complex (Limson et al., 1998). A 
lowering in current response at relatively high ligand concentrations indicates possible 
competition by free ligand with the metal-ligand complex for binding sites at the 
electrode, thereby decreasing the space available for adsorption of the metal-ligand 
complex (Limson, 1998). At low ligand concentrations, this is more likely due to the 
formation of strong metal-ligand bonds where the metal is not easily reduced (Limson, 
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1998) thus impeding cathodic current flow and decreasing the rate at which reduction 
occurs. A shift in potential may also be indicative of metal-ligand bond strength (Limson, 
1998). Since reduction potential is the tendency of a chemical species to acquire electrons 
and become reduced, a negative potential shift indicates that the metal-ligand complex 
has a lower tendency to become reduced. A large shift to more negative potentials may 
occur as a result of a strong metal-ligand interaction. The converse may be ascribed to a 
large positive shift, which is associated with a weaker metal-ligand interaction.  
 
7.3.2.  Materials and Methods 
7.3.2.1. Chemicals and Reagents 
As described in section 7.2.2.1. QA was purchased from Sigma Chemical Co., St. Louis, 
USA. 
 
7.3.2.2. Apparatus 
Adsorptive cathodic stripping voltammograms (AdCSVs) were recorded on an Autolab 
PGSTAT 30 voltammeter equipped with a Metrohm VGA cell stand. A 3 mm glassy 
carbon electrode (GCE) was employed as a working electrode for voltammetric 
experiments. A silver/silver chloride (KCl = 3 M) and a platinum wire were employed as 
reference and auxilliary electrodes respectively. Prior to use and between scans, the GCE 
was cleaned by polishing with alumina on a Buehler pad, followed by washing in nitric 
acid and rinsing in Milli-Q water. 
 
7.3.2.3. Adsorptive Stripping Voltammetry 
An appropriate concentration of either FeSO4.7H2O or FeCl3 was introduced into the 
electrochemical cell containing the electrolyte, 0.2 M tris-HCl buffer, pH 7.4 which was 
then deaerated for 5 minutes. Thereafter, an optimum deposition potential for each metal 
was identified and applied for 60 s to effect the formation and adsorption of the metal ion 
onto the GCE. A potential scan in the negative direction from the deposition potential to 
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at least 0.50 V beyond the reduction potential of the metal was applied, at a scan rate of 
0.1 V.s-1, to strip the adsorbed metal species from the electrode. During the stripping step, 
current responses due to the reduction of the metal species were measured as a function 
of potential to generate voltammograms. The GCE was then cleaned as described in 
section 7.3.2.2. The procedure was repeated between successive additions of an 
appropriate concentration of the ligand (0–0.06 mM) to the electrolyte containing the 
metal ion in the electrochemical cell.  
 
Current vs concentration and potential vs concentration plots were constructed to 
measure the extent of shifts in current response and reduction potential of the metal 
species with increasing concentrations of the ligand. 
 
7.3.3. Results 
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Figure 7.5. AdCSVs of Fe3+ (0.01 mM) alone and in the presence of increasing          
(0.01–0.06 mM) concentrations of AC. 
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In figure 7.5., the AdCSV for 0.01 mM Fe3+ alone in 0.2 M tris-HCl, pH 7.4 buffer shows 
a peak reduction potential of 1.952 x 10-6 A at -401.8 mV. The addition of increasing 
concentrations of AC causes a significant concentration-dependent shift in the reduction 
potential and decrease in current response (figure 7.5). 
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Figure 7.6. AdCSVs of Fe2+ (0.02 mM) alone and in the presence of increasing          
(0.02–0.04 mM) concentrations of AC. 
 
In figure 7.6., the AdCSV for 0.02 mM Fe2+ alone in the electrolyte shows a peak 
reduction potential of 2.582 x 10-6 A at -322.4 mV. In the presence of 0.02 mM and     
0.03 mM AC, there is a concentration-dependent decrease in the current response with a 
slight shift in the reduction potential of 1.2 mV to a more positive potential, which 
remains constant at both concentrations (figure 7.6). However, upon addition of 0.04 mM 
AC, where the metal to ligand ratio is 1 to 2, there is a slight increase in current response 
of 0.027 x 10-6 A and a very slight shift of 0.2 mV in the reduction potential to a more 
negative potential, in comparison to 0.03 mM AC.   
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Figure 7.7. AdCSVs of Fe2+ (0.02 mM) alone and in the presence of increasing (0.01–
0.04 mM) concentrations of QA. 
 
Figure 7.7. shows that QA elicits a concentration-dependent decrease in the current 
response of 0.02 mM Fe2+. At a metal to ligand ratio of 2 to 1, there is a slight shift of   
0.6 mV in reduction potential to more negative potentials. A positive shift back to that of 
Fe2+ alone occurs at a metal to ligand ratio of 1 to 1. Finally, at a metal to ligand ratio of 1 
to 2, there is a comparatively large shift of 3 mV to more negative potentials.  
 
Figures 7.8. and 7.9. aptly illustrate the concentration-dependent decrease in reduction 
potential and peak current response respectively of 0.01 mM Fe3+, exhibited by AC. The 
gradients of the curves are -6.638 (∆Ep) and -0.1227 (∆IA) respectively.  
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Figure 7.8. Effect of increasing concentrations of AC on the reduction potential of      
0.01 mM Fe3+. 
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Figure 7.9. Effect of increasing concentrations of AC on the peak current response of 
0.01 mM Fe3+  
 
Iron Chelation Studies_____________________________________________________ 
 147 
y = -0.72x - 318.44
y = 0.2686x - 322.15
-325
-324
-323
-322
-321
-320
-319
-318
-317
-316
-315
0 1 2 3 4 5
Fe2+(0.02 mM) and ligand (x 0.01 mM)
Po
te
n
tia
l (m
V)
AC
QA
Linear (QA)
Linear (AC)
 
 
Figure 7.10. Effect of increasing concentrations of AC and QA on the reduction potential 
of 0.02 mM Fe2+ 
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Figure 7.11. Effect of increasing concentrations of AC and QA on the peak current 
response of 0.02 mM Fe2+ 
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Figure 7.10. depicts an overall decrease in reduction potential of Fe2+ with a gradient 
(∆Ep) of -0.72 in the presence of increasing concentrations of QA. A converse effect with 
∆Ep of 0.2686 is observed with AC. Figure 7.11. shows that both ligands produce an 
overall reduction in peak current response of Fe2+ with concomitant increases in 
concentration. This effect is greater for AC (∆IA = -0.212), than for QA (∆IA = 0.1353). 
 
7.3.4.  Discussion 
Chelators affect the reduction potential of iron, and therefore its effectiveness as a 
catalyst (Winterbourn, 1995). Equation 1.1 of the Fenton reaction (section 1.2.2.2.5.) 
involves the reduction of Fe3+ to Fe2+ and drives equation 1.2 (section 1.2.2.2.5.) in which 
H2O2 is reduced to HO· with a concomitant oxidation of Fe2+ back to Fe3+. Therefore, 
chelators which alter the reduction potential of Fe2+ and/or Fe3+, such that it favours the 
reduction of Fe3+ or the oxidation of Fe2+, will likely enhance the production of the potent 
HO·. Similarly, chelators which have the opposite effect will curb its formation. 
 
The reduction potential is an indication of the ease with which a species is reduced. AC 
has the ability to form a complex with Fe3+ which has a more negative reduction potential 
than Fe3+ alone (figure 7.5.). Therefore, AC forms a strongly bonded complex with Fe3+ 
which is more difficult to reduce, but easier to oxidise than Fe3+ alone and is likely to 
curtail the reduction of Fe3+ to Fe2+. Figure 7.8. emphasises that AC has a concentration 
dependent effect on the decrease in reduction potential. The gradient of figure 7.8. is an 
estimation of the magnitude of the reduction potential shift over the AC concentration 
range. This in turn is a measure of the stability of the AC-Fe3+ complex. The gradient of   
-6.6638 is relatively large and thus indicates that a stable complex has been formed. 
Through this strong binding of Fe3+, AC prevents the reduction of Fe3+ to Fe2+ in        
Fe2+-induced and QA-enhanced Fe2+-induced LP, thereby diminishing this detrimental 
effect (Chapter 6). 
 
Štípek et al., 1997 found that the effect of QA on LP in the rat brain in vitro, reported by 
Rios and Santamaria (1991) depends on Fe2+ and that this mechanism is likely to involve 
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Fe2+-chelation by QA. In section 6.2.4., it was suggested that through weak chelation of 
Fe2+, QA enhances equation 1.2 of the Fenton reaction. QA has the ability to form a 
complex with Fe2+ which has a more negative reduction potential than Fe2+ alone except 
at a metal-ligand ratio of 1 to 1 (figure 7.7.). However, figure 7.10. shows that despite 
this deviation, overall there is a shift to more negative potentials. Thus, the QA-Fe2+ 
complex is more difficult to reduce, but easier to oxidise than Fe2+ alone. This result 
confirms and explains the enhancement of the oxidation of Fe2+ by QA in the Fenton 
reaction. The gradient of -0.72 of the QA graph in figure 7.10., which is very small, 
indicates that the QA-Fe2+ complex is unstable. 
 
In contrast, AC forms a complex with Fe2+ which has more positive reduction potentials 
than Fe2+ alone except at a metal to ligand ratio of 1 to 2 (figure 7.6.). The AC graph of 
figure 7.10. shows that overall, there is a shift to more positive potentials. The AC-Fe2+ 
complex is easier to reduce, but more difficult to oxidise than Fe2+ alone, thus, in the 
presence of AC, the oxidation of Fe2+ in the presence of H2O2 to produce LP initiating 
HO· is likely to be suppressed. This may explain why AC is efficient at ameliorating 
Fe2+-induced LP (chapter 6). However, the gradient of the AC graph in figure 7.10. of 
0.2686 is small indicating that the complex, like that of QA-Fe2+ is not stable. The 
instability of both complexes suggests that the results discussed so far are insufficient to 
determine which of the two ligands, QA and AC has the greater chelating activity of Fe2+. 
This information is crucial to determine whether equation 1.2 of the Fenton reaction is 
enhanced by QA or inhibited by AC in the presence of both ligands. 
 
Since low ligand concentrations were used, the decrease in the peak current response of 
the free metal after the formation of metal-ligand complex, observed in figures 7.5., 7.6. 
and 7.7., most likely indicates that the rate of reduction of the complexes is lower than 
the rate of reduction of the metal species. Figure 7.9. and 7.11. show that this was a 
concentration dependent effect for the AC-Fe3+ and QA-Fe2+ complexes respectively. 
This implies that the complexes are strong enough to hinder the reduction reaction and 
thus slow the cathodic current flow. This is expected for the AC-Fe3+ and QA-Fe2+, 
which have negative ∆Ep’s and are consequently more difficult to reduce than the 
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respective free metal ion. However the effect appears to be contradictory with respect to 
the AC-Fe2+ complex, which has a positive ∆Ep. As mentioned previously, a lowering in 
current response may be a result of competition by free ligand with the metal-ligand 
complex for binding sites at the electrode at relatively high ligand concentrations, thereby 
decreasing the space available for adsorption of the metal-ligand complex. Despite the 
overall decrease in peak current response of the free Fe2+, in the presence of increasing 
concentrations of AC (AC graph of figure 7.11) this argument should be ruled out 
because figure 7.6. shows that upon addition of the final concentration of AC (0.04 mM), 
a slight increase in peak current response was observed. It can therefore be concluded 
that the electrode is not saturated with free ligand at the metal to ligand concentrations 
achieved in this experiment. This may indicate that the affinity of AC for Fe2+ is only 
enhanced once a metal to ligand ratio of 1 to 2 or greater is achieved in the 
electrochemical cell. At lower metal to ligand ratios, it may be that although the complex 
requires less energy to be reduced than free Fe2+, the complex is so unstable that the rate 
of reduction is lower. 
 
The results of the electrochemical study are in agreement with that of the UV/VIS study 
in that it appears that AC forms a stronger bond with Fe3+ than with Fe2+. The 
electrochemical study has shown that the oxidation of the QA-Fe2+ complex is easier, 
whilst that of the AC-Fe2+ complex is more difficult than free Fe2+. The former would 
therefore enhance the Fenton reaction (equation 1.1) and the latter would ameliorate it. 
However, the results were insufficient to predict the nature of, if any, the competition 
between AC and QA for binding of Fe2+. This would provide the necessary evidence to 
determine whether Fe2+ is more likely to be bound by QA or AC and therefore, whether 
the Fenton reaction (equation 1.2) is enhanced or inhibited in the presence of both 
ligands. This needs to be investigated further. 
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7.4. A COMPARISON OF THE EFFECT OF AC, QA AND 
POSITIVE CONTROL EDTA ON THE INHIBITION OF 
THE FERROZINE-IRON (II) COMPLEX 
 
7.4.1.  Introduction 
Ferrozine (figure 7.12.) can form purple complexes with Fe2+ (figure 7.13.) in a 
quantitative manner (Decker and Welch, 1990) with a metal to ligand ratio of 1 to 3. 
(figure 7.13.). It is the lone pairs of electrons in the nitrogen atoms adjacent to each other, 
but on different aromatic rings which are involved in the co-ordinate bonding to Fe2+ 
(figure 7.13.) 
 
 
 
Figure 7.12. Representations of the ligand ferrozine. The figure on the left is a stick 
representation and the figure on the right is a ChemDraw® representation of the ligand. 
The carbon atoms are green, the hydrogens are white, the nitrogen atoms are blue, the 
oxygen atoms are red, and the sulphur atoms are yellow.  
(http://www.chemistry.wustl.edu/~edudev/LabTutorials/Ferritin/ferrozine.html). 
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Figure 7.13. Molecular stick representation of Fe2+-ferrozine complex. The carbon atoms 
are green, the hydrogens are white, the nitrogen atoms are blue, the oxygen atoms are red, 
the sulphur atoms are yellow and the Fe2+ is purple. 
(http://www.chemistry.wustl.edu/~edudev/LabTutorials/Ferritin/feferr.html). 
 
In the presence of agents, which also have the ability to chelate Fe2+, the formation of the 
Fe2+-ferrozine complex is inhibited or reduced resulting in a decrease in the colour of the 
complex. EDTA is a well established metal chelator known to inhibit the Fe2+-ferrozine 
complex (Que et al., 2006). The greater the Fe2+ chelating activity of a chelator, the 
greater the inhibition of the complex. Therefore, measurement of the inhibition of the 
Fe2+-ferrozine complex may be an ideal approach to elucidate which ligand, AC or QA, 
has a stronger affinity for Fe2+. To reiterate, this is important because it would determine 
whether Fe2+ is more likely to be bound by QA or AC and therefore, whether the Fenton 
reaction (equation 1.2) is enhanced or inhibited in the presence of both ligands.   
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7.4.2.  Materials and Methods 
7.4.2.1. Chemicals and Reagents 
AC sodium (Zovirax®, powder for injection) was supplied by Glaxo Wellcome, Midrand, 
South Africa. FeSO4.7H2O and EDTA were purchased from Merck, Darmstadt, 
Germany. QA and ferrozine, was purchased from Sigma Chemical Co., St. Louis, USA. 
 
7.4.2.2. Chelating Activity of AC and QA 
The chelating activity of AC and QA on Fe2+ was assessed by measuring the percentage 
(%) inhibition of the Fe2+-ferrozine complex using the method of Decker and Welch 
(1990). A 1 ml solution containing increasing concentrations (0, 1.56, 3.13, 6.25, 12.5, 
25, 50, 100 µg/ml) of the test compound (QA or AC) was added to 3.7 ml of Milli-Q 
water. This mixture was reacted with 0.1 ml of 2 mM FeSO4.7H2O and 0.2 ml of 5 mM 
ferrozine for 20 minutes. The absorbance was read at 562 nm in a GBC 916 UV/VIS 
spectrophotometer. Lower absorbance of the reaction mixture indicated higher chelating 
activity. The percentage inhibition of ferrozine–Fe2+ complex formation was calculated 
by the following formula:  % inhibition of the ferrozine–Fe2+ complex = {(A1-A0)/A1} x 
100, where A1 was the absorbance of 0 µg/ml test compound and A0 was the absorbance 
in the presence of each of the other concentrations of the test compound. EDTA, at the 
same concentrations as the test compounds, was used as the positive control.  
 
7.4.3.  Results 
Figure 7.14. shows that EDTA, AC and QA inhibit the Fe2+-ferrozine complex in a 
concentration-dependent manner. However this concentration-dependent effect is 
negligible for QA. At 100 µg/ml, EDTA, AC and QA inhibited 99.98 %, 99.08 % and 
11.98 % of the Fe2+-ferrozine complex respectively. At 100 µg/ml, EDTA and AC have 
similar % inhibitions of the Fe2+-ferrozine complex, but EDTA is still more potent than 
AC at lower concentrations. At concentrations between 1.5625 µg/ml and 6.25 µg/ml, 
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QA has greater % inhibitions of the Fe2+-ferrozine complex than AC, whilst at higher 
concentrations, the opposite is observed. 
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Figure 7.14. Percentage inhibition of Fe2+-ferrozine complex by EDTA, AC and QA. 
Each point represents the mean ± SD (n = 10). 
 
7.4.4.  Discussion 
The knowledge that EDTA is a well established metal chelator known to inhibit the Fe2+-
ferrozine complex (Que et al., 2006) is confirmed and AC was found to be nearly as 
potent. The results clearly indicate that overall, AC has a greater ability to inhibit the 
Fe2+-ferrozine complex and therefore a greater affinity and chelating activity of Fe2+ than 
QA. It may thus be concluded that Fe2+ is more likely to be bound by AC than by QA and 
therefore, the Fenton reaction (equation 7.2) is more likely to be impeded rather than 
enhanced in the presence of both ligands. This provides an adequate explanation for the 
inhibition of QA-induced LP by AC (Chapter 6).  
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This study provides supporting evidence of a metal-ligand interaction between the metal 
ion, Fe2+ and the ligands, QA and AC alluded to by the UV/VIS spectroscopic and 
electrochemical analyses. Moreover, it provides some substantiation on the nature of the 
interplay between these interactions. 
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CHAPTER 8 
THE BIOSYNTHESIS OF QUINOLINIC ACID 
 
8.1.  INTRODUCTION 
The KP contains neuroactive intermediates, all of which are derived from L-KYN, the 
primary degradation product of TRP (Schwarcz and Pellicciari, 2002). However, the KP 
does not only occur in the CNS, but in the periphery as well and as shown in figure 8.1., 
the dynamics of the KP is such that there is interplay between KP metabolism in the 
periphery and the brain (Schwarcz and Pellicciari, 2002). Although L-KYN can be 
produced in the brain to a moderate degree, under normal circumstances, the cerebral KP 
is driven mainly by blood-borne L-KYN, which enters from the circulation using the 
large neutral amino acid transporter (Fukui et al., 1991). 3-HK can also penetrate the 
brain, using the same uptake mechanism (Reinhard et al., 1994). The subsequent 
intracellular degradation of these substrates appears to be dictated primarily by the 
distribution of individual enzymes in astrocytes and microglial cells (Schwarcz and 
Pellicciari, 2002). For example, because of the efficiency of 3-HAO, which converts 3-
HA to QA, as opposed to the low activity of the degradative enzyme of QA, quinolinic 
acid phosphoribosyltransferase, the extracellular CNS levels of QA are governed largely 
by the bioavailability of 3-HA (Schwarcz and Pellicciari, 2002). 
 
In severe regional CNS inflammatory disease, the contribution of systemic L-KYN to QA 
pools is negligible (Kita et al., 2002). However, in less severe regional CNS 
inflammatory disease or when local CNS inflammation is accompanied by systemic 
disease as well, the possibility remains that circulating L-KYN may make consequential 
contributions to the CNS QA pools (Kita et al., 2002). 
 
An increase in QA levels in the CNS could enhance the amount of neuronal damage 
produced by a primary brain insult; therefore the reduction of QA synthesis could limit 
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the amount of brain damage (Stone, 2000b). Chapters 2–6 have shown the deleterious 
actions of QA on the rat hippocampus and the neuroprotective effect of AC associated 
therewith. Thus, the aim of this chapter is to assess the ability of AC to ameliorate the 
activity of the enzymes which catalyse the first and last steps in the conversion of 
tryptophan to QA. As shown in figure 1.10., these enzymes are TDO, IDO and 3-HAO. 
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Figure 8.1. Dynamics of cerebral and extracerebral kynurenine pathway metabolism. L-
TRP, L-tryptophan; L-KYN, L-KYN; 3-HK, 3-HK; 3-HANA, 3-hydroxyanthranilic acid; 
QUIN, quinolinic acid; NMDA-R, NMDA receptor; 7-nACh-R, 7 nicotinic acetylcholine 
receptor. Broken arrows: brain entry/cellular uptake (red), release (blue). Solid arrows: 
enzymatic conversion (black), receptor agonist (red), receptor antagonist (blue) 
(Schwarcz and Pellicciari, 2002). 
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8.2. THE EFFECT OF AC ON TDO ACTIVITY IN RAT 
LIVER HOMOGENATE IN VITRO AND IN VIVO 
 
8.2.1.  Introduction 
The major site of TRP catabolism is the liver (Salter et al., 1986). The liver cytosolic 
enzyme, TDO is the major determinant of the levels of peripheral, circulating TRP 
(Badawy and Evans 1981). Thus, the untoward effect of enhanced activity of TDO is not 
only an increase in blood-borne L-KYN for the biosynthesis of the neurotoxin QA, but it 
also reduces the availability of TRP for uptake into the brain. As shown in figure 1.13., 
TRP is required for 5-HT synthesis, the rate-limiting step of which is the conversion of 
TRP to 5-hydroxytryptophan by TRP hydroxylase (Knowles and Pogson, 1984). 
Therefore the cerebral concentration of TRP is an important factor in brain 5-HT 
synthesis (Fernstrom and Wurtman, 1971). 5-HT appears to be an important mood-
enhancing neurotransmitter (section 1.1.4.3.), with decreased levels reported in patients 
with, and in animal models of, depression, AD and HSE (section 1.2.4.2.4.). 
 
Glucocorticoids are potent inducers of TDO activity (Salter and Pogson, 1985). Most 
patients suffering from depression have elevated cortisol levels (Curzon, 1988). Because 
TRP hydroxylase is approximately 50% saturated with TRP in vivo, 5-HT levels will be 
more sensitive to decreases in TRP than increases in TRP (Pogson et al., 1989). Elevated 
cortisol levels in depressed patients may, therefore, contribute to mood status by 
producing a TDO-induction dependent decrease in brain 5-HT (Salter et al., 1994).  
 
The hippocampal formation forms part of the limbic-hypothalamic-pituitary-adrenal 
(LHPA) axis; a negative feedback loop where increased glucocorticoid (mainly cortisol 
in humans) levels are “shut-off” by activation of receptors at one or several levels of this 
axis. Activation of these receptors also influences neurochemistry, neuronal excitability 
and structural plasticity (McEwen 2000). Notably, excessive glucocorticoid exposure to 
hippocampal neurons impairs neuronal plasticity and may contribute to or worsen 
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neurodegeneration in AD. This has been suggested to result in a vicious circle, where loss 
of neurons in the hippocampus leads to further loss of feedback inhibition leading to 
hypercortisolism with progressive hippocampal damage (Sapolsky et al., 1986; Seckl and 
Olsson 1995). Part of this progressive hippocampal damage may be due the induction of 
liver TDO by the glucocorticoids. This enhances blood-borne L-KYN which is taken up 
into the brain where it can be converted to the neurotoxic QA.  
 
There is much controversy surrounding the use of corticosteroids in combination with AC 
in the treatment of HSE. Corticosteroids could have an important role in the management 
of this disease because the anti-inflammatory action reduces cerebral oedema (Thompson 
et al., 2000). However the use of these anti-inflammatory drugs has been limited by 
concerns that their immunosuppressive actions could increase viral replication and spread 
(Thompson et al., 2000). Data published by Thompson et al., (2000) suggest that 
corticosteroids are not detrimental in this regard when combined with AC in the 
management of HSE. However, by virtue of the fact that glucocorticoids have the ability 
to induce the activity of TDO, it is reasonable to argue that these agents may indirectly 
contribute to neuronal damage through increased biosynthesis of QA, an action which is 
totally independent of its effect on viral replication. 
 
Thus, due to the potential of enhanced TDO activity and the detrimental role of this 
phenomenon in neurodegeneration and the alteration of mood in AD, depression and 
HSE, the effect of AC on the activity of the Holo- and Apoenzyme of TDO was 
determined. 
 
8.2.2  Materials and Methods 
8.2.2.1. Animals 
Adult male Wistar rats were purchased from the NHLS (Johannesburg, South Africa) and 
cared for as described in section 2.2.2.1. 
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8.2.2.2. Chemicals and Reagents 
AC (Zovirax®, powder for injection) was obtained from Glaxo Wellcome, Midrand, 
South Africa. Haeme (porcine), BSA, TCA and Folin’s reagent were purchased from 
Sigma Chemical Co, St. Louis, U.S.A. L-TRP was obtained from Merck, Darmstadt, 
Germany. Sodium hydroxide was obtained from Saarchem, Krugersdorp, South Africa. 
 
8.2.2.3. In vitro Exposure of Rat Liver to AC 
8.2.2.3.1. Removal of the Liver 
Rats were killed by cervical dislocation and rapidly decapitated. To remove the liver, a 
mid-ventral incision was made through the abdominal musculature from the pelvic region 
to the posterior edge of the sternum. A transverse cut was made anteriorly to expose the 
liver, which was removed carefully. The liver was immediately perfused with cold 0.9 % 
saline to remove all endogenous haeme, frozen in liquid nitrogen and stored at -70 ˚C. 
 
8.2.2.3.2. Preparation of the Tissue 
The livers were thawed, weighed and chopped into fine pieces using a blade. The pieces 
of liver were then rapidly homogenised with a hand-held homogeniser in 0.01 M PBS pH 
7.4, to give a final concentration of 10 % w/v. The homogenate was then sonicated for a 
period of two minutes at thirty second intervals for complete removal of the enzyme from 
cells. The entire procedure, where possible, was conducted on ice. 
 
 
8.2.2.3.3. Determination of TDO Activity 
A modification of the method described by Badawy and Evans, (1975) was used. 
 
Homogenate (15 ml) and water (12.5 ml) was added to each of two flasks. To one flask, 
haematin (100 µl) was added, to make a final concentration of 2 µM. This flask was 
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stirred and allowed to stand for one minute to allow for activation of the enzyme by 
haematin. An aliquot of 2.5 ml 0.03 M L-TRP was then added to each flask. The flasks 
were stirred before aliquots of 2 ml were transferred to test tubes in triplicate. Thereafter, 
AC (1 ml) was added such that incubation concentrations of 100 µM and 10 µM were 
achieved. No drug was added to control samples. The test tubes were incubated for 60 
minutes at 37 ˚C in an oscillating water bath. To stop the reaction, 0.9 M TCA (2 ml), 
was added to each test tube. The resulting precipitate was then centrifuged at 4500 x g for 
15 minutes. The supernatant (2.5 ml) was transferred to a new set of test tubes and 0.6 M 
sodium hydroxide (1.5 ml) was added to each. An aliquot from each test tube was 
removed for analysis. The absorbance was read at 365 nm, which is the λmax of N-
formylkynurenine. The extinction co-efficient of N-formylkynurenine, ε =  4540 M-1.cm-1 
was used to determine the concentration of N-formylkynurenine. The activity of TDO 
was expressed as pmoles N-formylkynurenine/mg protein/min. The results from test 
tubes which contained haematin represent total activity, whilst the results from those 
which did not contain haematin represent holoenzyme activity. Apoenzyme activity is 
calculated as the difference between the total activity and holoenzyme activity. 
 
8.2.2.3.4. Protein Assay 
The determination of protein was performed as described in section 4.2.2.7. 
 
8.2.2.4. In vivo Administration of AC 
8.2.2.4.1. Drug Treatment 
Ten rats were randomly divided into two groups.  The animals in the first group (control) 
received i.p. injections of saline (0.25 ml) twice a day (at 0830 and 1630 hours) for five 
days. The animals in group two (treatment) received injections of AC (5 mg/kg) twice a 
day for five days, in the same manner and at the same times. 
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8.2.2.4.2. Removal of the Liver 
On the morning of the sixth day, the rats were killed and the livers removed as described 
in section 8.2.2.3.1. 
 
8.2.2.4.3. Preparation of the Tissue  
This was performed as described in 8.2.2.3.2. 
 
8.2.2.4.4. Determination of TDO Activity 
This was conducted as described in section 8.2.2.3.3. However, after addition of 0.03 M 
L-TRP (2.5 ml) to each flask, aliquots of 3ml instead of 2ml were transferred in triplicate 
to test tubes. AC not added to any of the test tubes. 
 
8.2.2.4.5. Protein Assay 
The determination of protein was performed as described in section 4.2.2.7. 
 
8.2.2.5. Statistical Analysis 
This was performed as described in section 4.2.2.9. 
 
8.2.3.  Results 
Figure 8.2. shows that 100 µM AC significantly reduces the total activity and apoenzyme 
activity of TDO (p < 0.05), whilst 10 µM AC produces no effect on either form of the 
enzyme. AC at a concentration of 100 µM has no significant effect on holoenzyme 
activity.  
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As shown in figure 8.3., it is evident that AC, administered 5 mg/kg twice a day for five 
days induces a significant (p < 0.001) decrease in the total apoenzyme and holoenzyme 
activity of TDO. 
 
0
50
100
150
200
250
300
Total Enzyme
Activity
Holoenzyme
Activity
Apoenzyme
Activity
TD
O
 
Ac
tiv
ity
 
(p
m
o
l N
-
fo
rm
yl
ky
n
u
re
n
in
e
/m
g 
pr
o
te
in
/m
in
) Control
100 µM AC
10 µM AC
*
*
ns
 ns
 ns
ns
 
 
Figure 8.2. Effect of AC on TDO enzyme activity in rat liver homogenate in vitro. Each 
bar represents the mean ± SD (n = 5). * (p < 0.05) and ns (p > 0.05) in comparison to 
controls (ANOVA and Student–Newman–Keuls Multiple Range Test). 
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Figure 8.3. Effect of AC on TDO enzyme activity in rat liver homogenate in vivo. Each 
bar represents the mean ± SD (n = 5). # (p < 0.001) in comparison to control (ANOVA 
and Student–Newman–Keuls Multiple Range Test). 
 
8.2.4.  Discussion 
The already active holoenzyme does not require the addition of exogenous haeme for 
demonstration of its activity in vitro, whereas the haeme-free predominant apoenzyme 
does (Badawy and Evans, 1975). Therefore, apoenzyme activity represents the activity of 
TDO which is in the apoenzyme form at the time of removal of the liver. This implies 
that it first has to be activated by exogenous haeme to become the active holoenzyme. 
Holoenzyme activity represents the activity of TDO which is already in the active 
holoenzyme form at the time of removal of the liver. 
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There are two mechanisms by which compounds may inhibit TDO:  
 
(a) Some agents may interfere with the conjugation of the apoenzyme and its co-factor, 
haeme (Badawy and Evans, 1981), thus inhibiting the formation of new holoenzyme from 
the apoenzyme (step 1 of figure 1.8). Thus, effectively, apoenzyme activity is inhibited.  
 
(b) An indole amine (indole–NH) group is required for substrate binding to the catalytic 
site of TDO, whilst a secondary amine [CH(NH2)COOH] group ensures that the substrate 
takes up the correct configuration appropriate to the catalytic reaction (Uchida et al., 
1992). Thus, compounds which possess at least an indole–NH should competitively 
inhibit the binding of TRP to the inactive holoenzyme (step 2 of figure 1.8.), thereby 
inhibiting holoenzyme activity. Uchida et al., (1992) further suggest that compounds 
without the indole -NH may inhibit TDO at this level by non-competitive inhibition, that 
is, interference with TRP binding through interaction at a site other than that designated 
for TRP.  
 
In vitro, 100 µM AC could only inhibit apoenzyme activity and not holoenzyme activity, 
which implies that AC does not interfere with TDO when it is already in its active form. 
Instead, it is probably interfering with the conjugation of haeme to the apoenzyme. The 
relationship between this hypothesis and the finding that 10 µM AC does not have an 
effect on apoenzyme activity may be that this concentration is not sufficiently high to 
inhibit the haeme added exogenously. The type of inhibition displayed by AC may be 
competitive rather than non-competitive because it consists of functional groups and 
rings found in the structure of haeme. However, this needs to be investigated further. 
 
Since in vivo AC was administered before removal of the liver, competition between 
endogenous haeme and AC may occur up to the time of liver removal. Holoenzyme 
activity represents the specific activity of TDO which is already in the active holoenzyme 
form at the time of removal of the liver. Thus, such competitive inhibition of TDO by AC 
might lead to decreased active holoenzyme and therefore decreased holoenzyme activity 
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in the livers of rats which received in vivo administration of AC. Any free AC still 
present in the liver at the time of its removal and which is not taking part in the 
competition with endogenous haeme may be available to compete with exogenous haeme 
and thus also cause competitive inhibition, resulting in decreased apoenzyme activity. 
 
The inhibition of TDO by AC should decrease the catabolism of systemic TRP, raising its 
concentration not only in the blood but also in the brain. An increased availability of TRP 
will increase the activity of TRP hydroxylase, and therefore increase the synthesis and 
vesicular stores of 5-HT (Schaetchter and Wurtman, 1989). Furthermore, inhibition of 
TDO by AC will reduce the peripheral L-KYN levels thereby decreasing the 
consequential contributions to CNS QA levels, particularly as a result of TDO induction 
by endogenous and administered glucocorticoids implicated as described in section 
8.2.1., in AD, HSE and depression. 
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8.3. THE EFFECT OF AC ON IDO ACTIVITY IN RAT 
SMALL INTESTINAL HOMOGENATE IN VITRO AND 
IN VIVO 
 
8.3.1.  Introduction 
IDO is ubiquitously distributed in various organs including the brain, lung, spleen and 
alimentary tract (Hayaishi et al., 1975).  
 
The pro-inflammatory cytokine IFN-γ induces the enzyme IDO in a variety of cells, both 
in vitro and in vivo (Wirleitner et al., 2003). IDO activation limits availability of TRP. 
Because TRP is required for protein synthesis, withdrawal of this essential amino acid 
from the micro-environment arrests protein biosynthesis and subsequent growth of 
pathogens and proliferating cells (Schröcksnadel, et al., 2006). Consequently, TRP 
depletion is regarded as a defence mechanism induced by IFN-γ in immunocompetent 
cells during an immune response (Schröcksnadel, et al., 2006). 
 
In addition however, the activation of IDO results in an increase in the biosynthesis of the 
intermediates of the kynurenine pathway, including the neurotoxic 3-HK, 3-HA and QA. 
As described in section 1.1.4.1., these TRP catabolites may also contribute to the immune 
mechanism by killing already injured neurons. However, at the same time, surrounding 
healthy tissue is compromised by oxidative damage. For example, in HSE, QA could be 
part of the macrophage's phagocytic function, by degrading lipid membranes, but it is 
also possible that the increased QA could augment the toxicity of HSV-1 by degrading 
the lipid membranes of cells in proximity to the virus (Reinhard, 1997). A similar and 
likely analogy may be drawn to AD and depression as well, where IDO activation and 
increased QA levels are also prevalent (sections 1.1.4.2., 1.1.4.4., 1.2.4.1.). Thus, the aim 
of this section is to investigate the effect of AC, an antiviral used in HSE, on the activity 
of IDO. 
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It has been shown that IDO utilises O2·- in the catalytic process in vivo (Taniguchi et al., 
1977) and in vitro (Hirata and Hayaishi, 1971, Hayaishi et al., 1977). O2·- can be 
generated in situ enzymatically by xanthine oxidase or GR with their respective 
substrates or chemically by ascorbic acid and methylene blue (Hirata and Hayaishi, 
1975). 
 
8.3.2.  Materials and Methods 
8.3.2.1. Animals 
Adult male Wistar rats were purchased from the NHLS (Johannesburg, South Africa) and 
cared for as described in section 2.2.2.1. 
 
8.3.2.2. Chemicals and Reagents 
AC sodium (Zovirax® powder for injection) was obtained from Glaxo Wellcome, 
Midrand, South Africa. CAT (specific activity of 2.250 units/mg protein), BSA, TCA and 
Folin’s reagent were purchased from Sigma Chemical Co, St. Louis, U.S.A. L-TRP was 
purchased from Merck, Darmstadt, Germany. Ascorbic acid and methylene blue were 
purchased from Saarchem, Krugersdorp, South Africa. 
 
8.3.2.3. In vitro Exposure of Rat Small Intestine to AC 
8.3.2.3.1. Removal of the Small Intestine 
Rats were killed by cervical dislocation and rapidly decapitated. To remove the small 
intestines, a mid-ventral incision was made through the abdominal musculature from the 
pelvic region to the posterior edge of the sternum. A transverse cut was made anteriorly 
to expose the small intestine, which was removed carefully. Food and faeces were 
removed, using PBS pH 6.0. The small intestines were frozen in liquid nitrogen and 
stored at -70˚C. 
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8.3.2.3.2. Preparation of the Tissue 
The small intestines were thawed, weighed and chopped into fine pieces using a blade. 
The pieces of small intestine were then rapidly homogenised with a hand-held 
homogeniser in 0.01M PBS pH 6.0, so as to give a final concentration of 10 % w/v. A pH 
of 6.0 was found to be the optimal pH for stability of IDO when assayed with either L- or 
D-TRP as substrate (Shimizu et al., 1978).  The homogenate was then sonicated for a 
period of two minutes at thirty second intervals for complete removal of the enzyme from 
cells. This procedure was, where possible, performed on ice. 
 
8.3.2.3.3. Determination of IDO Activity 
A modification of the method described by Shimizu et al., 1978 was used. 
 
Reaction mixtures containing 0.01 M PBS pH 6.0 (0.75 ml), 10 µg catalase (0.15 ml),   
10 µM or 100 µM AC (0.15 ml), 25 µM methylene blue (0.15 ml), 10 mM ascorbic acid 
(0.15 ml) and 5 mM L-TRP (0.15 ml), in that order, were prepared. IDO is easily 
inactivated by H2O2 formed by ascorbic acid, in the presence of methylene blue in the 
reaction mixture (Hirata et al., 1977), hence CAT is included in the reaction mixture 
(Hirata and Hayaishi, 1975), to degrade any H2O2 produced. Four groups were prepared 
in triplicate. The first group (control) did not contain AC, methylene blue or ascorbic 
acid. The second group did not contain AC, whilst the third and fourth group contained 
10 µM and 100 µM AC respectively. Homogenate (1.5 ml) was then added to the 
reaction mixture in each test tube. The test tubes were incubated for 60 minutes at 37 ˚C 
in an oscillating water bath. After incubation, 2ml TCA (0.9 M) was added to each test 
tube to terminate the reaction. The test tubes were then shaken for a further 30 minutes at 
50˚C to hydrolyse N-formylkynurenine to L-KYN. The resulting precipitate was then 
centrifuged at 4500 x g for 10 minutes. An aliquot of the supernatant from each test tube 
was then removed for analysis. The absorbance was read at 335 nm, the isosbestic point 
of N-formylkynurenine and L-KYN. An extinction co-efficient, ε of 3500 M-1cm-1 was 
used to determine the concentration of the two kynurenines. The activity of IDO was 
expressed as pmoles kynurenines/mg protein/min. 
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8.3.2.3.4. Protein Assay 
The determination of protein was performed as described in section 4.2.2.7. 
 
8.3.2.4.   In vivo Administration of AC 
8.3.2.4.1. Drug Treatment 
Ten rats were randomly divided into two groups and treated as described in section 
8.2.2.4.1. 
 
8.3.2.4.2. Removal of the Small Intestine 
On the morning of the sixth day, the rats were killed and the small intestines removed as 
described in section 8.3.2.3.1. 
 
8.3.2.4.3. Preparation of the Tissue  
The tissue was prepared as described in section 8.3.2.3.2. 
 
8.3.2.4.4. Determination of IDO Activity 
This assay was performed as described in section 8.3.2.3.3. However, there were two 
groups each for the small intestines from control and AC treated rats. AC was excluded 
from all reaction mixtures. Group one contained no methylene blue or ascorbic acid, 
whilst group two did. 
 
8.3.2.4.5. Protein Assay 
This was performed as described in section 4.2.2.7. 
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8.3.2.5.  Statistical Analysis 
This was performed as described in section 4.2.2.9. 
 
8.3.3.  Results 
Figures 8.4. and 8.5. show that the activity of IDO is significantly greater (p < 0.001) in 
the presence of in situ generation of O2·-. Furthermore, 10 µM and 100 µM AC (figure 
8.4.) significantly reduce the specific activity in comparison to 0 µM AC (p < 0.01 and p 
< 0.001 respectively), in a concentration dependent manner. 
 
Figure 8.5. shows that AC, administered 5 mg/kg twice a day for five days induces a 
significant decrease in the specific activity of IDO in both the absence and presence of in 
situ generation of O2·- (both p < 0.001). 
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Figure 8.4. Effect of AC on IDO enzyme activity in rat small intestinal homogenate in 
vitro. Each bar represents the mean ± SD (n = 5). # (p < 0.001) in comparison to control; 
** (p < 0.01) in comparison to 0 µM AC; *** (p < 0.001) in comparison to 0 µM AC 
(ANOVA and Student–Newman–Keuls Multiple Range Test). 
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Figure 8.5. Effect of AC on IDO enzyme activity in rat small intestine homogenate in 
vivo. Each bar represents the mean ± SD (n = 4). *** (p < 0.001) in comparison to no in 
situ O2·- generation (control and AC treated animals); # (p < 0.001) in comparison to 
control (no in situ O2·- generation and in situ O2·- generation) (ANOVA and Student–
Newman–Keuls Multiple Range Test). 
 
8.3.4.  Discussion 
IDO contains haeme as a prosthetic group and it is the oxygenated form of the enzyme 
which is catalytically active (Hirata et al., 1977; section 1.2.4.2.2.2.). Unlike TDO, the 
active form of the enzyme can be produced not only by the interaction of O2 with the 
ferrous form of the enzyme, but also by the interaction of O2·- with the ferric form of 
enzyme (Hirata et al., 1977; figure 1.9). This explains why, as shown in both figures 8.4 
and 8.5, the presence of in situ O2·- generated by methylene blue and ascorbic acid 
increases the activity of IDO. Both interactions mentioned could occur under these 
conditions, therefore producing more IDO in the active form. In contrast, only the 
interaction of O2 with the ferrous form of the enzyme could occur in the absence of 
methylene blue and ascorbic acid. 
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The success of AC at inhibiting the activity of IDO in vitro (figure 8.4.) is likely to be 
related to its ability to scavenge O2·-, a property of AC which was demonstrated in 
Chapter 5. By scavenging O2·-, there are fewer of these free radicals available to bind to 
the ferric form of the enzyme, thus reducing the formation of active IDO. This effect of 
AC is concentration dependent because a higher concentration of AC is able to scavenge 
more O2·- in comparison to lower concentrations. 
 
The effect of AC on IDO activity in vivo may be two-fold. In the presence of in situ O2·-
generation, the role of AC is likely to be the scavenging of this free radical, as described 
for the in vitro inhibition of IDO. In the absence of in situ O2·- generation, AC may have 
scavenged endogenous O2·- , thus reducing active IDO. In addition, in the absence or 
presence of in situ O2·- generation, AC may be preventing the binding of endogenous 
haeme, the prosthetic group of IDO, reflecting a potential property of AC which was 
proposed for the inhibition of TDO in section 8.3.4. Thus, in vivo, there are two possible 
mechanisms by which AC may suppress the activation of the IDO enzyme. 
 
Through inhibition of IDO activity in the small intestine, AC may counter the rise in 
peripheral L-KYN brought about by the induction of peripheral IDO by pro-
inflammatory cytokines in diseases such as HSE where local CNS inflammation is 
accompanied by systemic disease. Furthermore, qualitatively, the characteristics of 
enzymes along the QA branch of the KP do not differ between the brain and the 
periphery (Schwarcz and Pellicciari, 2002), therefore AC is likely to inhibit CNS IDO as 
well, and thus may also be effective in diseases, such as AD and depression, which are 
primarily associated with neuroinflammation. Inherently then, AC has the potential to 
reduce the biosynthesis of QA. 
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8.4. THE EFFECT OF AC ON 3-HAO ACTIVITY RAT 
LIVER HOMOGENATE IN VITRO AND IN VIVO 
 
8.4.1.  Introduction 
Since QA, in contrast to its bioprecursors tryptophan and L-KYN, does not cross the 
blood brain barrier, it can reasonably be assumed that in the brain it is synthesised locally 
by its anabolic enzyme, 3-HAO (Foster et al., 1986). In the frontal cortex, striatum and 
hippocampus, 3-HAO activity is relatively high, whilst the activity of QA 
phosphoribosyltransferase, which catabolises QA, is low in these same areas (Perkins and 
Stone, 1983; Schwarcz and Köhler, 1983) This is particularly undesirable, as these 
cerebral structures are highly susceptible to the excitotoxic effects of QA (Perkins and 
Stone, 1983; Schwarcz and Köhler, 1983). These effects have been shown to impair 
spatial reference memory (Chapter 2), induce neurodegeneration (Chapter 3), enhance 
excitotoxicity (Chapter 4), oxidative stress (Chapter 5) and LP (Chapter 6) in the rat 
hippocampus. Thus, QA released during neuroinflammation in diseases such as AD, HSE 
and depression (sections 1.1.4.2., 1.1.4.3., 1.1.4.4.) has the potential to initiate a plethora 
of deleterious CNS effects.  
 
The administration of kynurenine hydroxylase inhibitors appear to be the most logical 
way to decrease the amount of QA beyond TDO and IDO in the cerebral KP because the 
production of the neurotoxic precursors of QA, namely 3-HK and 3HA are also inhibited, 
with a simultaneous rise in the neuroprotectant, kynurenic acid (Stone, 2000b). However, 
being an NMDA receptor antagonist at the glycine binding site, kynurenic acid may 
block the induction of LTP, which would impair learning and memory. This has been 
illustrated in the CA1 region of the hippocampus, employing 7-chlorokynurenic acid, the 
potent analogue of kynurenic acid, (Izumi et al., 1990). An alternative approach to 
preventing the synthesis of QA is to inhibit 3-HAO (Stone, 2000b). Since 3-HAO is 
distant from the branching point of the KP, enzyme inhibition provides a method to 
selectively attenuate QA formation without a concomitant rise in kynurenic acid. 
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(Schwarcz and Pellicciari, 2002). Thus, there being a good rationale for manipulation of 
the KP at this point, the effect of AC on 3-HAO activity was investigated. 
 
There appears to be general accordance between 3-HAO in the brain and from peripheral 
sources with regard to dependency on the cofactor Fe2+, substrate specificity, the Km for 
3-HA and cytosolic localisation (Foster et al., 1986). 3-HAO has been studied primarily 
in the liver and kidney as these organs contain large amounts of the enzyme (Foster et al., 
1986). Therefore, rat liver 3-HAO activity was measured as a model of rat brain 3-HAO 
activity. 
 
8.4.2.  Materials and Methods 
8.4.2.1. Animals 
Adult male Wistar rats were purchased from the NHLS (Johannesburg, South Africa) and 
cared for as described in section 2.2.2.1. 
 
8.4.2.2. Chemicals and Reagents 
AC sodium (Zovirax®, powder for injection) was obtained from Glaxo Wellcome, 
Midrand, South Africa. 3-HA, BSA and Folin’s reagent were purchased from Sigma 
Chemical Co, St. Louis, U.S.A. FeSO4.7H2O was obtained from Merck, Darmstadt, 
Germany. Ascorbic acid, hydrochloric acid (HCl) and sodium hydroxide were obtained 
from Saarchem, Krugersdorp, South Africa. 
 
8.4.2.3. In vitro Exposure of Rat Liver to AC 
8.4.2.3.1. Removal of the Liver 
This was performed as described in section 8.2.2.3.1. 
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8.4.2.3.2. Preparation of the Tissue 
This was performed as described in section 8.2.2.3.2. 
 
8.4.2.3.3. Determination of 3-HAO Activity 
A modification of the method described by Mehler, 1956 was used. 
 
Reaction mixtures were prepared containing 0.01 M PBS pH 7.4 (0.5 ml), 10µM 3-HA 
(0.25 ml), 100µM ascorbic acid (0.25 ml), 100 µM FeSO4.7H2O (0.25 ml) and 10 µM or 
100 µM AC (0.25 ml), in that order. Four groups were prepared in triplicate. The first 
group (control) did not contain AC, FeSO4.7H2O or ascorbic acid. The second group did 
not contain AC, whilst the third and fourth groups contained 10 µM and 100 µM AC 
respectively. Homogenate (1.5 ml) was then added to the reaction mixture in each test 
tube. The test tubes were incubated for 30 minutes at 37˚C in an oscillating water bath. 
After incubation, 2 ml HCl (3 M) was added to each test tube to terminate the reaction. 
The resulting precipitate was then centrifuged at 4500 x g for 10 minutes. An aliquot of 
the supernatant from each test tube was then removed for analysis. The absorbance was 
read at 360 nm, which is the λmax of 2-amino-3-carboxymuconic semialdehyde, the 
unstable intermediate which spontaneously rearranges to form QA. An extinction co-
efficient, ε of 47500 M-1.cm-1 was used to determine the concentration of 2-amino-3-
carboxymuconic semialdehyde. The activity of 3-HAO was expressed as pmoles of 2-
amino-3-carboxymuconic semialdehyde /mg protein/min. 
 
8.4.2.3.4. Protein Assay 
This was performed as described in section 4.2.2.7. 
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8.4.2.4. In vivo Administration of AC 
8.4.2.4.1. Drug Treatment 
This was performed as described in section 8.2.2.4.1. 
 
8.4.2.4.2. Removal of the Liver 
On the morning of the sixth day, the rats were killed and the livers removed as described 
in section 8.2.2.4.2. 
 
8.4.2.4.3. Preparation of the Tissue  
This was performed as described in section 8.2.2.4.3. 
 
8.4.2.4.4. Determination of 3-HAO Activity 
This was performed as described in section 8.4.2.3.3. However, there were two groups 
each for the livers from control and treated rats. AC was excluded from all reaction 
mixtures. Group one contained no FeSO4.7H2O, whilst group two did. 
 
8.4.2.4.5. Protein Assay 
This was performed as described in section 4.2.2.7. 
 
8.4.2.5. Statistical Analysis 
This was performed as described in section 4.2.2.9. 
 
8.4.3.  Results 
Figures 8.6. and 8.7. show that the activity of 3-HAO is greater in the presence of Fe2+   
(p < 0.001). Furthermore, 10 µM and 100 µM AC significantly reduce the activity of     
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3-HAO (figure 8.6.), in comparison to 0 µM AC (p < 0.05 and p < 0.01 respectively), in a 
concentration dependent manner. Figure 8.7. shows that AC, administered 5 mg/kg twice 
a day for five days induces a significant decrease in the activity of 3-HAO in both the 
absence and presence of Fe2+ ( p < 0.001). 
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Figure 8.6. Effect of AC on 3-HAO enzyme activity in rat liver homogenate in vitro. 
Each bar represents the mean ± SD (n = 5). *** (p < 0.001) in comparison to control; ** 
(p < 0.01) in comparison to 0 µM AC; * (p < 0.05) in comparison to 0 µM AC (ANOVA 
and Student–Newman–Keuls Multiple Range Test). 
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Figure 8.7. Effect of AC on 3-HAO enzyme activity in rat liver homogenate in vivo. 
Each bar represents the mean ± SD (n = 5). *** (p < 0.001) in comparison to controls (0 
and 100 µM Fe2+) # (p < 0.001) in comparison to 0 µM Fe2+ (control and AC treated rats) 
(ANOVA and Student–Newman–Keuls Multiple Range Test). 
 
8.4.4.  Discussion 
3-HAO is a non-haeme ferrous extradiol dioxygenase enzyme (Schwarcz et al., 1984). 
Key enzymes in the pathways of aromatic compounds are the metal-dependent ring 
cleavage dioxygenases, which act on the corresponding catechol-type derivatives, 
cleaving them at the intradiol position (ortho cleavage) or the extradiol position (meta 
cleavage) (Harayama et al., 1992). While intradiol dioxygenases typically depend on 
Fe3+, most extradiol dioxygenases depend on Fe2+ (Andújar et al., 2000). In section 
1.2.4.2.3.3., the role of Fe2+ in the transfer of electrons in the reaction which 3-HAO 
catalyses, was explained. In fact, the active site of 3-HAO is only complete if it contains 
a Fe2+ ion (Zhang et al., 2005). Thus, it is expected that the presence of Fe2+ would 
enhance the activity of 3-HAO (figures 8.6. and 8.7.). 
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In Chapter 7, it was discovered that AC has the ability to bind Fe2+; AC could be binding 
free Fe2+ ions, such that there are fewer of these ions available for interaction with the 
active site of 3-HAO. In vitro, this occurs in a concentration-dependent manner because a 
higher concentration of AC contains a greater number of AC molecules which can thus 
bind more Fe2+ ions, in comparison to lower concentrations of AC. As was the case for 
TDO, and IDO, in vivo AC inhibited 3-HAO activity in the absence and presence of 
exogenously added coenzyme or cofactor, implying that AC is binding endogenous and 
not only exogenous Fe2+. 
Similar to the inhibition of kynurenine-3-hydroxylase, inhibition of 3-HAO comes with 
great risk, as it too challenges the balance between neuroprotection and 
neurodegeneration. In the KP (figure 1.10), QA is the precursor of nicotinic acid which is 
used in the production of nicotinamide and ultimately NAD. As described in section 
1.3.6., this molecule has a role to play in reversing ATP depletion in mitochondrial 
dysfunction. Thus, it can be concluded that inhibition of 3-HAO may adversely affect the 
ability of the CNS to replenish NAD in a cellular environment which may already be 
metabolically compromised, through mitochondrial dysfunction, one of the major 
mechanisms of neurodegeneration (section 1.2.2.3.). Thus it may be necessary to use 
agents such as AC which inhibit the production of QA together with bioenergetic 
supplementation to curtail or prevent this effect. This needs to be investigated further.  
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CHAPTER 9 
THE BIOSYNTHESIS AND METABOLISM OF 
SEROTONIN 
 
9.1.  INTRODUCTION 
The effect of viral infections on brain neurotransmitters is important since these are 
regarded as potential aetiological factors for the development of chronic degenerative 
diseases. Furthermore, certain clinical symptoms of encephalitis may reflect dysfunctions 
in monoamine metabolism induced by the infection (Lycke and Roos, 1972). Anatomical 
studies suggest that HSV-1 has a particular affinity not only for neurons located in or 
associated with limbic structures such as the hippocampus, as previously described 
(section 1.1.4.3.), but also for neurons in or near several brain regions known to contain 
monoaminergic cell bodies, for example, the substantia nigra pars compacta (DA cell-
containing area), the dorsal raphe nucleus (5-HT cell-containing area) and the locus 
coeruleus (Norepinephrine-containing area) (Neeley et al., 1985). Experimentally 
induced HSE in mice was observed to cause marked increases in brain concentrations of 
5-HIAA, in comparison to uninfected mice. Work by Lycke and Roos, (1972) showed no 
evidence that impaired elimination of this metabolite from brain to blood could account 
for the phenomenon. Neither did the observed increase depend on a reduced capacity of 
nerve cell granules to take up 5-HT. However, after administration of substances 
inhibitory or stimulative to the synthesis of 5-HT, the HSV infection initiated increased 
neuronal activity characterised by a greater synthesis, release and ultimately turnover of 
5-HT.  
 
Interest in correlations between monoamines and depression was stimulated by the 
finding that first-generation antidepressant drugs enhance the availability of 5-HT and 
norephinephrine (NE) at central receptors (Kopin, 1981). Tricyclic antidepressants 
achieve this via reuptake inhibition (van Praag, 1982b) and inhibition of TDO in the liver 
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which, via increased TRP concentration in blood and then brain, increase central 5-HT 
synthesis (Badawy and Evans, 1981); and MAO inhibitors act via inhibition of 5-HT 
degradation. This observation led to the idea that antidepressants enhance serotonergic 
and noradrenergic activity and this effect is in part responsible for their therapeutic 
activity (van Praag, 1982b). 
 
Postmortem brain studies of AD patients have reported loss of serotonergic neurons 
(Mann and Yates, 1983; Yamamoto and Hirano, 1985) and nerve terminals (Bowen et al., 
1983; Palmer et al., 1987) as well as reduced levels of 5-HT, its major metabolite           
5-HIAA, and serotonergic receptor density (Adolfsson et al., 1979; Cross et al., 1984). 
An intact hippocampal function necessitates both the cholinergic and the serotonergic 
systems (Vizi and Kiss, 1998; Gulyas et al., 1999), as well as interaction between these 
two systems. Kornum and coworkers (2006) have recently discovered: (1) that an 
increase in acetylcholine tonus induces neuronal activation in the hippocampus, and (2) 
that 5-HT depletion results in a decrease of this acetylcholine-induced neuronal activation 
(Kornum et al., 2006). Thus, the observations in the postmortem brain studies of AD 
patients may manifest as reduced neuronal activity in the hippocampus, possibly 
contributing to the depression of LTP and thus the impairment of learning and memory. 
 
5-HT has thus emerged as a dynamic, important brain neurotransmitter in normal brain 
function. In view of the role of alterations in normal 5-HT synthesis, utilisation and 
metabolism in HSE, depression and AD, illustrated above, the effect of AC on these 
aspects of the monoamine was investigated, to assess whether this agent could favourably 
challenge or oppose these consequences of the disorders. 
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9.2. THE EFFECT OF AC ON 5-HT AND RELATED          
NEUROTRANSMITTERS LEVELS IN RAT 
FOREBRAIN HOMOGENATE IN VIVO 
 
9.2.1.  Introduction 
An inverse relationship exists between liver TDO activity and brain 5-HT levels (Daya et 
al., 1989). Thus, the inhibition of liver TDO by AC may lead to a rise in brain 5-HT and 
its major metabolite, 5-HIAA. NE accelerates the synthesis of [14C] 5-HT from [14C] TRP 
by cultured rat pineals (Shein and Wurtman, 1971). Since the enzymes which catalyse   
5-HT biosynthesis in brain and pineal appear to be similar, this raises the possibility that 
noradrenergic neurons in brain which make functional synaptic contact with serotonergic 
neurons might stimulate 5-HT synthesis in these neurons (Shein and Wurtman, 1971). In 
turn, 5-HT is known to play a role in NE release in the brain (Xi-Ming Li et al., 2002). 
The precursors of 5-HT and NE are TRP and tyrosine respectively. Both these molecules 
are large neutral amino acids and may thus compete with one another for transport into 
the brain, by the neutral amino acid transporter. The increase in peripheral TRP through 
the inhibition of liver TDO by AC may thus reduce the uptake of peripheral tyrosine into 
the brain, possibly increasing 5-HT, but decreasing NE.  
 
In general, there appears to be a distinct interdependency between the two 
monoaminergic systems, therefore, the effect of AC on 5-HT, 5-HIAA and NE levels in 
rat brain was determined. In the forebrain of saline-treated wild-type mice, the two most 
abundant monoamines are 5-HT and NE and of the two indoleamine metabolites,            
5-HIAA is the most abundant, while 5-hydroxytryptophol represents only about 5% of 
total metabolite contents (Reader et al., 2000), thus this region of the rat brain was chosen 
for assessment of these monoamines and metabolites. 
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9.2.2.  Materials and Methods 
9.2.2.1. Animals 
Adult male Wistar rats were purchased from the NHLS (Johannesburg, South Africa) and 
cared for as described in section 2.2.2.1. 
 
9.2.2.2. Chemicals and Reagents 
AC sodium (Zovirax®, powder for injection) was obtained from Glaxo Wellcome, 
Midrand, South Africa. Heptane sulphonic acid (HSA), EDTA, triethylamine (TEA), 
phosphoric acid (PA), perchloric acid (HCLO4), 5-HT, NE and 5-HIAA were purchased 
from Sigma Chemical Co., St. Louis, MO, U.S.A. HPLC grade acetonitrile (ACN) was 
purchased from Saarchem, Johannesburg, South Africa. 
 
9.2.2.3. Drug Treatment 
This was performed as described in section 8.2.2.4.1. 
 
9.2.2.4. Brain Removal 
On the morning of the sixth day, the rats were killed by cervical dislocation. The brain 
was removed as described in section 2.2.2.7. A portion of the forebrain was dissected, 
frozen in liquid nitrogen and stored at -70 ˚C. 
 
9.2.2.5. Preparation of the Tissue 
The forebrains were thawed on ice, weighed out and individually homogenised (1 mg/10 
µl) in ice-cold HCLO4 (0.1 M) containing 0.01 % EDTA, by sonication at 50 Hertz for 30 
seconds using an ultrasonic cell disruptor. The homogenate was kept on ice for 20 
minutes before being centrifuged at 10 000 x g for 10 minutes. The supernatant (10 µl) 
obtained was injected directly into a High Performance Liquid Chromotography-
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Electrochemical Detector (HPLC-ECD) system for analysis (Muralikrishnan and 
Mohanakumar, 1998). 
 
9.2.2.6. Instrumentation 
Samples were analysed on an isocratic HPLC system coupled to an electrochemical 
detector. The chromatographic system consisted of a Waters Millipore Model 510 pump, 
Waters electrochemical detector and a Rikadenki chart recorder. The chart speed was set 
at 15 cm/hr. Samples were introduced into the system using a Rheodyne 772Si fixed loop 
injector, fitted with a 20 µl loop. 
 
9.2.2.7. Chromatographic Conditions 
Separation was achieved using a C18 (Waters Spherisorb, 5 µm, 250 x 4.6 mm n-
octadecylsilane column). The mobile phase composition was 8.65 mM HSA, 0.27 mM 
EDTA, 13 % ACN, 0.4-0.45 % TEA and 0.22% PA (v/v) and was degassed using a 
0.45µm membrane filter prior to use. It was recycled but changed every 3 days. The flow 
rate was set at 0.7ml/min and the electrochemical detection was performed at + 0.74 V. 
The results were expressed as pmoles/mg tissue. 
 
9.2.2.8. Statistical Analysis 
This was performed as described in section 4.2.2.9. 
 
 9.2.3. Results 
Table 9.1. illustrates that the forebrains of rats treated with AC show a significant 
increase in the levels of 5-HT (p < 0.001) and 5-HIAA (p < 0.001) and a decrease in 5-
HT turnover (p < 0.05) in the forebrain in comparison to controls. However, no 
significant changes are observed in the NE levels after treatment. 
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Table 9.1. Effect of AC on rat forebrain NE, 5-HT and 5-HIAA levels 
 
Treatment 
Group 
NE 
(pmoles/mg 
tissue) 
5-HT 
(pmoles/mg 
tissue) 
5-HIAA 
(pmoles/mg 
tissue) 
5-HT turnover 
(5-HIAA: 5-HT) 
Control 1.93 ± 0.44 2.00 ± 0.43 2.70 ± 0.31 1.37 ± 0.25 
AC 2.01 ± 0.40 ns 3.76 ± 0.20 *** 3.91 ± 0.38 *** 1.11 ± 0.11 * 
 
Each value represents the mean ± SD (n = 4). *** (p < 0.001), * (p < 0.05) and ns (p > 
0.05) in comparison to controls (ANOVA and Student–Newman–Keuls Multiple Range 
Test). 
  
9.2.4.  Discussion 
It has been shown that the inhibition of liver TDO has the potential to increase brain      
5-HT levels (Hardeland and Rensing, 1968; Daya et al., 1989). The results of this chapter 
show that AC increases the 5-HT level which implies that it may be effective in HSE, 
depression and AD where reduced 5-HT levels have been reported or suspected. In the 
previous chapter, AC has been shown to inhibit liver TDO, therefore this is likely to be 
the mechanism of action in this regard. 5-HT synthesis may also possibly be enhanced by 
NE (Shein and Wurtman, 1971), however, since AC had no effect on NE levels, the 
inhibition of TDO and thus increased brain TRP levels is confirmed as the only and most 
likely mechanism of increased brain 5-HT levels by AC. 
 
By enhancing NE release 5-HT would be shifting vesicular NE to synaptic NE, thus the 
increase in 5-HT has no influence in NE levels in this experiment which is non-
discriminatory in terms of vesicular and synaptic pools of neurotransmitters.  
 
The proposed competition for transport into the brain between TRP and tyrosine did not 
decrease NE levels as expected. It appears that this hypothesis does not hold true because, 
unlike the direct relationship between TRP and 5-HT, levels of tyrosine in the brain do 
not directly correlate with levels of the neurotransmitter DA, from which NE is produced 
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(Groff and Gropper, 1999). The effect of increased dietary sources of tyrosine on levels 
of tyrosine in the brain appears to vary with region of the brain, and the effect of 
increased levels in the brain on neural activity is influenced by the firing rate of the 
neuron (McTavish et al., 1999: Groff and Gropper, 1999). For example, when the firing 
rate is markedly increased as in Parkinson's disease or DA-depleting lesions, tyrosine can 
increase levels of DA (Groff and Gropper, 1999). 
 
Most 5-HT is oxidised to 5-HIAA by the enzymes MAO and aldehyde dehydrogenase 
(Wurtman et al., 1968). Thus, the rise in forebrain 5-HIAA levels after AC treatment may 
be a result of increased forebrain 5-HT levels being available as substrate for MAO. 
However, despite this, 5-HT turnover was reduced, which implies that AC may have the 
potential to slow the metabolism of 5-HT, thus maintaining the increased levels for 
longer. This would once again be useful in AD, depression and in particular, HSE, where 
5-HT turnover is increased. 
 
The elevation of 5-HT in diencephalic/telencephalic areas of serotonergic presynaptic 
terminal innervation and at the soma in the raphe (Fuller, 1994) decreases both cell firing 
and release of 5-HT by activating the somatodendritic 5-HT1A and terminal 5-HT1B/1D 
autoreceptors respectively (Blier and de Montigny, 1994). This consequently dampens 
the increase in synaptic 5-HT. However, after chronic (14 days) administration of an 
agent which enhances 5-HT levels in these brain regions, for example, a selective 5-HT 
reuptake inhibitor, these receptors and the 5-HT transporter itself become desensitised 
allowing a larger increase in synaptic 5-HT, particularly in terminal areas (Bel and 
Artigas, 1993; Blier and de Montigny, 1994). The combined action of AC through the 
inhibition of TDO and a decreased rate of metabolism of 5-HT may produce 5-HT levels 
greater than either effect alone, which may lead to a faster downregulation of                  
5-HT1A/1D/1B receptors (and therefore a faster return to normal firing and release), as well 
as maintaining synaptic 5-HT at a higher level prior to autoreceptor downregulation. A 
rapid attainment of high synaptic 5-HT may enhance the onset of postsynaptic changes in 
emotive processing and hasten the therapeutic onset (Bel and Artigas, 1993; Blier and de 
Montigny, 1994). This hypothesis is supported by clinical data which shows a faster 
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onset of antidepressant action with combinations of a reuptake inhibitor and the 5-HT 
precursor, tryptophan (Walinder et al., 1976; Thomson et al., 1982). To assess the extent 
to which this hypothesis may be applicable to AC, its effect on 5-HT metabolism will be 
investigated in section 9.3. 
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9.3.         THE EFFECT OF AC ON INDOLE METABOLSM IN 
RAT PINEAL GLANDS  
 
9.3.1.      Introduction 
The 5-HT concentration is very high in the pineal gland and levels exceed any other 
organ in the body (Reiter, 1981; Reiter, 1989; Reiter, 1991a;). The pineal concentration 
of this indoleamine may be decreased due to three main pathways: (1) oxidative 
deamination by monoamine oxidase (MAO), (2) N-acetylation and (3) release to the 
extracellular spaces (Reiter, 1989; Reiter, 1981; Cardinali, 1981). The fate of 5-HT in the 
first two pathways is outlined in figure 1.13. Availability of 5-HT for these pathways 
depends on the granular 5-HT in equilibrium with “free” 5-HT (Cardinali, 1981). It is in 
the latter state in which 5-HT is metabolised. For these reasons, the pineal gland was the 
brain organ/region of choice to assess 5-HT metabolism.  
 
After years of disregard, the pineal gland has finally taken its place in mainstream 
biology and medicine. It is an organ of particular fascination in that it serves as an 
interface between the environment and the body. Its primary functions co-ordinate the 
effects of light/dark cycles on physiology, via the secretion of one of the 5-HT 
metabolites, the neurohormone, melatonin (Arendt, 1988). Melatonin (aMT) synthesis in 
the mammalian pineal gland is regulated by endogenous oscillators and photoreceptors in 
the retina of the eye, which is functionally and anatomically connected to the pineal gland 
by a neural network (Hagan and Oakley, 1995). Neural pathways from the 
suprachiasmatic nucleus, where glutamate is the neurotransmitter, relay episodic 
sympathetic nerve impulses via the superior cervical ganglion, terminating at the 
postganglionic sympathetic fibres within the pineal gland (Petterborg et al, 1991). NE is 
released from the nerve terminals. This leads to a stimulation of postsynaptic ß-
adrenergic receptors of the pinealocytes which activates the second messenger, adenylate 
cyclase via a stimulatory guanine nucleotide-binding regulatory protein, Gs (Reiter, 
1991b). Adenylate cyclase catalyses the conversion of ATP to cAMP (Strada et al., 
1972). The increase in intracellular levels of cAMP (up to 60-fold in the rat pineal) 
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results in elevated N-acetyl transferase (NAT) activity. Through the cAMP dependent 
protein kinase, cAMP increases the transcription of mRNA (Reiter, 1991b), and thus 
translation to increase NAT synthesis. This enzyme then converts 5-HT to N-
acetylserotonin (NAS) which is converted to aMT. Light has an inhibitory effect on the 
sympathetic nerves to the pineal gland (Klein, 1973), thus more aMT is synthesised 
nocturnally. 
 
Collectively, data indicate a role for melatonin in the antioxidant defence system of 
organisms. Most importantly, there is evidence which suggests that these actions of aMT 
are not merely pharmacological, but physiologically relevant too (Reiter, 1997). For 
example, aMT is protective against free radical damage, even at physiological 
concentrations (Reiter, 1997).  
  
Thus, the aim of this experiment is to investigate whether AC could manipulate 5-HT 
pineal indole metabolism to increase 5-HT and/or aMT. The value of the former was 
emphasised in section 9.2.4., whilst that of the latter has been highlighted above. These 
actions would confer on AC a novel role in neuroprotection with respect to learning and 
memory impairing disorders, HSE, AD and depression. 
 
To carry out this investigation, organ culture, a valuable and sensitive technique was 
used. It enables the researcher to manipulate experimental conditions in such a way as to 
avoid complications of in vivo interactions. The pineal gland is ideal for organ culture 
due to its small size, and its ability to remain viable for as long as six days under 
optimum conditions. It is capable of using exogenous radioactive (14C) 5-HT to produce 
the various indoles (Daya et al., 1989), therefore the direct effect of AC on 5-HT 
metabolism could easily be established. 
 
Bidimensional Thin Layer Chromatography (TLC) was used to separate the pineal indole 
metabolites. This method provides a remarkably simple and inexpensive means for 
separating and identifying components of small samples of complex, inorganic, organic 
and biochemical substances. Furthermore, it permits reasonably accurate quantitative 
The Biosynthesis and Metabolism of Serotonin_________________________________ 
 193 
determination of the components of such mixtures (Skoog and West, 1980). In TLC, 
separation is achieved on a planar surface, rather than with a column, which offers the 
unique advantage of two-dimensional operation. In this manner, samples which could be 
only partially separated with either solvent alone may be completely separated by the 
combination of solvents. Thus the selective properties of two different solvents can be 
utilised in developing a single chromatogram (Ewing, 1960). 
 
9.3.2.  Materials and Methods 
9.3.2.1. Animals 
Adult male Wistar rats were purchased from the NHLS (Johannesburg, South Africa) and 
cared for as described in section 2.2.2.1. 
 
9.3.2.2. Chemicals and Reagents 
AC sodium (Zovirax®, powder for injection) was obtained from Glaxo Wellcome, 
Midrand, South Africa. 14C labelled 5-HT was obtained from Amersham International, 
England. The culture medium, Minimun Essential Medium (MEM), was purchased from 
Highveld Biological (PTY) LTD, Lyndhurst, South Africa and fortified with the 
antibiotics, amphoteracin B, streptomycin and benzyl penicillin (Hoechst, South Africa). 
The aluminium TLC plates coated with silica gel 60, Type F254 (0.25 mm), were 
purchased from Merck, Darmstadt, Germany. Beckman Ready-Sol multipurpose liquid 
scintillation fluid was purchased from Beckman RIIC Ltd, Scotland. The indole 
standards, 5-HT, NAS, aMT, 5-hydroxytryptophol (5-HTOH), 5-methoxytryptophol     
(5-MTOH), 5-methoxytryptomaine (5-MT), 5-HIAA and 5-methoxyindoleacetic acid   
(5-MIAA) were purchased from Sigma Chemicals Co, St Louis, USA. Ascorbic acid, 
ethanol, chloroform and glacial acetic acid were purchased from Saarchem, Krugersdorp, 
South Africa.  
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9.3.2.3.        Drug Treatment 
This was performed as described in section 8.2.2.4.1. 
 
9.3.2.4. Pineal Gland Removal 
On the morning of the sixth day, the rats were killed by cervical dislocation. The brain 
was exposed in the manner described in section 2.2.2.1, and the pineal organ was 
carefully removed. The stalk and any tissue adhering to the gland were also removed. 
 
9.3.2.5. Organ Culture of the Pineal Glands 
The pineal glands were placed individually into sterile borosilicate (75 x 10 mm) Kimble 
tubes containing 52 µl of MEM culture medium, supplemented with penicillin            
(100 U/ml), streptomycin (100 µg/ml) and amphotericin B (2.5 µg/ml). (14C) 5-HT (8 µl) 
with a specific activity 55 mCi/mmoles was added. The tubes were then saturated with 
carbogen (95 % Oxygen/5 % Carbon dioxide) and sealed. The tubes were incubated at  
37 ˚C in the dark for 24 hours in a Forma Scientific model 3028 incubator. At the end of 
the 24-hour incubation period the reaction was terminated by the removal of the pineal 
glands from the culture medium. 
 
9.3.2.6. Separation of Indoles by Thin Layer Chromatography 
A modification of the technique employed by Klein and Notides (1969) was used to 
separate the radiolabelled indoles. The TLC plates were activated by placing them in an 
oven at 100 ˚C for 10 minutes. 10 µl of the culture medium was spotted on a 10 x 10 cm 
thin layer chromatographic (TLC) plate. The spot was dried using a gentle stream of 
nitrogen. The indole standard solution was prepared using 1 mg of each of the pineal 
metabolites: 5-MT, aMT, 5-HT, NAS, 5-MIAA, 5-HIAA, 5-MTOH and 5-HTOH. The 
pineal indoles were dissolved in 2.5 ml absolute ethanol. The solution was then vortexed 
after the addition of 2.5ml 1% ascorbic acid (an antioxidant) in 0.1 M HCl. The standard 
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solution (10 µl) was spotted onto the culture medium and also dried using a gentle stream 
of nitrogen. 
 
The spotted plates were placed in a TLC tank containing chloroform: methanol: glacial 
acetic acid in a ratio of 93:7:1 and developed twice in this direction. The total front 
movement allowed during each development was 9cm and after each development the 
plates were dried under a gentle stream of nitrogen. After this, the plates were allowed to 
develop once in ethyl acetate at right angles to the first direction of development. The 
plates were once again dried under a gentle stream of nitrogen and the spots were 
observed and marked under UV light. The addition of 1 part glacial acetic acid results in 
the complete separation of 5-MIAA from 5-HIAA. Solvent B separates 5-HTOH from 
NAS and improves separation of aMT from 5-MIAA and 5-MTOH. The small amount of 
acid which remains on the gel from the first solvent development enhances the effective 
separation by solvent B. 5-HT and 5-MT remain at the origin (Klein and Notides, 1969). 
 
The spots were excised and individually placed in plastic scintillation vials. Absolute 
ethanol (1 ml) was added to each vial, together with 3 ml Beckman Ready-Sol 
scintillation fluid and then vortexed for 30 s. The radioactivity of each metabolite was 
then measured in a Beckman LS 2800 scintillation counter. The results were obtained as 
counts per minute (CPM) and corrected for the counting efficiency of the scintillation 
counter to disintegrations per minute (DPM). The results were expressed as DPM/10µl/ 
pineal. 
 
9.3.2.7. Statistical Analysis 
This was performed as described in section 4.2.2.9. 
 
9.3.3.  Results 
A typical bi-dimensional thin layer chromatogram of the pineal indole metabolites 
obtained in this experiment is shown in Fig. 9.1. An acceptable extent of separation is 
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observed. As discussed in section 9.2.2.6., 5-HT and 5-MT do not migrate from the 
origin; therefore the results expressed for the origin are those of 5-MT and 5-HT.  
 
 
 
Figure 9.1. Typical bi-dimensional thin layer chromatogram illustrating the location of 
the pineal indole metabolites.  
 
Figure 9.2. shows that there is a significant decrease in the DPM/10µl/pineal for the 
combination of 5-HT and 5-MT (p < 0.001) and for 5-HIAA (p < 0.01) of the AC 
treatment group in comparison to the control group, whilst a moderate increase in the 
DPM/10µl/ pineal is observed for 5-HTOH, NAS and aMT (all p < 0.05). The effect of 
AC on 5-MIAA and 5-MTOH is insignificant. 
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Figure 9.2. Effect of AC on indole metabolism in the rat pineal gland in vivo. Each bar 
represents the mean ± SD; n = 4. *** (p < 0.001), ** (p < 0.01), * (p < 0.05) and ns (p > 
0.05) in comparison to controls (ANOVA and Student–Newman–Keuls Multiple Range 
Test). 
 
9.3.4.  Discussion 
The results show that under normal circumstances (control conditions), 5-HT in the 
pineal gland is either taken up by the sympathetic nerve terminals and subjected to MAO 
degradation (Olivieri et al., 1990) to form 5-HIAA and 5-HTOH or it is taken up by the 
pinealocytes for conversion to NAS and then aMT. The decrease in 5-HT + 5-MT after 
AC treatment is thus related to increased uptake and utilisation of 5-HT at one or both of 
these two sites. It is not likely due to a decrease in 5-MT, as this would generate a 
concomitant increase in 5-HT, because less of it is converted to 5-MT. It therefore 
appears that AC has a stimulatory rather than the expected inhibitory effect on 5-HT 
metabolism. Since there is a significant increase in both metabolites of 5-HT formed in 
the pinealocytes, namely,NAS and aMT, the increased uptake and utilisation of 5-HT 
after AC treatment most likely occurs there and not at the sympathetic nerve terminals.. 
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The effect of AC on 5-HTOH and 5-HIAA is possibly through one of two mechanisms. 
AC may have the ability to inhibit the activity of aldehyde dehydrogenase or to enhance 
the activity of alcohol dehydrogenase. The effects of either of these postulated 
mechanisms would be an increase in 5-HTOH and a decrease in 5-HIAA, which may 
occur under some metabolic conditions, when the redox potential of the brain has shifted 
to a more reducing state than normal (Bender, 1983). AC may contribute to such 
conditions since many of the previous chapters have alluded to an antioxidant property of 
this agent. The shunt in this pathway of 5-HT metabolism may also account for the 
reduced turnover of forebrain 5-HT to 5-HIAA (section 9.2.) observed after AC 
treatment. More of the 5-HT acted upon by the MAO enzyme under control conditions 
was converted to 5-HTOH rather than 5-HIAA after treatment. 
 
From section 9.3.1., it is evident that when provided with the same concentration of 
radioactive 5-HT, NAT activity and therefore the production of NAS in the pineal gland  
may be enhanced by i) increased levels of NE, ii) a ß-adrenoreceptor agonist, iii) 
increased levels of ATP, iv) increased activity of adenylate cyclase or v) increased levels 
of cAMP. Section 9.2. demonstrated that AC has no effect on rat forebrain NE levels, 
thus it is unlikely that AC enhances NAT activity in the pineal through increasing levels 
of this catecholamine.  
 
The activation of adenylate cyclase in the pineal gland occurs via a stimulatory guanine 
nucleotide-binding regulatory protein, (Gs), (Reiter, 1991b). This activation, through the 
action of a hormone (in this case the catecholamine, NE) and a GTP coincides with a 
release of GDP bound to the Gs. This indicates that a GTPase reaction, which hydrolyses 
GTP to GDP at the regulatory site, Gs generates an inactive adenylate cyclase possessing 
tightly bound GDP, and that the hormone increases adenylate cyclase activity by 
inducing a repetitive introduction of the activator GTP to replace the hydrolysed 
nucleotide, GDP (Reiter, 1991b). Thus elevated GTPase activity in the presence of 
hormone results from the enhanced displacement of GDP by the substrate GTP (Cassel 
and Selinger, 1978). Triphosphorylated AC, as a GTP analogue may thus be substrate and 
AC treatment over 5 days may provide a constant supply of the analogue and therefore 
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contribute to increased NAT activity and consequently increased NAS. However, as 
described in section 1.3.7.1.3.3., host cell TK is approximately 1 millionfold less capable 
of converting AC to its monophosphate derivative than virus-encoded TK, which would 
slow the formation of the triphosphorylated AC and perhaps explain the modest increase 
(p < 0.05) in NAS. An increase in aMT follows an increase in NAS as there is more of 
the latter available for conversion to the neurohormone by the enzyme HIOMT.  
 
As described in section 1.2.4.2.4., reduced levels of aMT are secreted from the pineal 
gland of patients with AD and depression. Whether or not the increase in aMT induced 
by AC is sufficient to regain the normal physiological concentrations of aMT is 
debatable. Furthermore, although aMT is protective against free radical damage, at 
physiological concentrations (Reiter, 1997), such low concentrations may not be 
successful at alleviating or eliminating oxidative stress caused by neurotoxins implicated 
in HSE, depression and AD, such as QA. 
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CHAPTER 10 
SUMMARY OF RESULTS, GENERAL CONCLUSIONS AND 
RECOMMENDATIONS FOR FUTURE STUDIES 
 
Irrespective of socio-economic class, most spheres of our lives depend on our ability to 
store and recall information. The neuropathology of CNS disorders in which learning and 
/ or memory is impaired is often associated with an immune response to one or more 
stressors. In HSE, this is the HSV-1 virus, whereas in AD, it may be the AP and NFT, 
whilst in major depression, it is a psychological stressor. During the immune response, 
microglia are activated, producing and releasing many neurotoxic products including QA, 
which have the ability to cause neurodegeneration. Although QA may not be the sole 
cause of neurodegeneration, it is likely to have some role to play, particularly if 
neurotoxic concentrations in the hippocampus are achieved. Numerous studies point to a 
neuroprotective potential for guanine, guanosine and their derivatives and analogues. AC, 
a guanosine analogue, is of particular relevance in this regard because it is the current 
drug of choice in the treatment of one of these debilitating diseases, namely, HSE. 
 
This research project has aptly demonstrated that the antiherpetic guanosine analogue 
drug, AC, has the ability to improve QA-induced spatial memory deficits in a rat model. 
Furthermore, it has proved successful in elucidating some of the mechanisms, both direct 
and indirect, by which this effect is elicited. 
 
The extent to which i.p. post-treatment of AC improves spatial memory deficits induced 
by intrahippocampal injections of QA was investigated in Chapter 2 using the Morris 
water maze task. The results of the behavioural study show that AC significantly 
improves QA-induced spatial memory deficits by virtue of the shorter latencies to escape 
to the platform of QA-infused rats which received i.p. post-treatment in comparison to 
those which did not.  It was speculated that this effect is related to the ability of AC to 
protect against QA-induced hippocampal neurodegeneration which prevents the retrieval 
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of the spatial information stored in potentiated synapses through LTP and 
autosassociation at the NMDA receptors. 
 
It is well established that QA induces neurodegeneration via the two cell death processes, 
namely, necrosis and apoptosis. The aim of Chapter 3 was therefore to assess the effect of 
intrahippocampal QA alone and in combination with i.p. post-treatment of AC on 
hippocampal neuromorphology and cytoarchitecture. The Nissl stained cells in the CA1 
and CA3 regions show visible destruction of the structural features of these regions in 
rats which received intrahippocampal QA. The nature of the damage fits the profile and 
characteristics of the various stages of necrotic cell death. The majority of the 
hippocampal neuronal cells in QA-infused rats, post-treated with AC, appear to maintain 
structural integrity, thus the QA-induced necrotic death is alleviated. It was suggested 
that AC exhibits this action via interference with the three mechanisms of 
neurodegeneration, namely, excitotoxicity, oxidative stress and mitochondrial 
dysfunction which QA is known to induce. Further studies are warranted to determine the 
effect of QA alone and in combination with AC on apoptotic cell death. Moreover, 
NMDA receptor binding and cell viability studies in which a reduction in the number of 
NMDA receptors correlates to a reduction in the number of viable neurons, could be 
performed. This would provide supporting, statistically significant evidence of an 
increased loss of neurons after intrahippocampal QA alone and an amelioration of this 
effect after i.p. post-treatment with AC. 
 
Excitotoxicity is a mechanism of neuronal cell death mediated by overstimulation of 
ionotropic glutamate receptor sub-types, such as NMDA and AMPA. In addition to 
eliciting a direct excitotoxic effect through NMDA overactivation, it has more recently 
been shown that in vivo, QA has the ability to inhibit vesicular and astrocytic glutamate 
uptake and to enhance synaptosomal glutamate release. In this manner, QA indirectly 
enhances excitotoxicity through the elevation of glutamate levels in the synaptic cleft. 
Therefore, with the knowledge that QA has the ability to enhance synaptosomal 
glutamate release, and that this is reversed by guanosine (Tavares et al., 2005), the effect 
of AC (a guanosine analogue) on QA alone and in combination with AC on synaptosomal 
Summary of Results, Conclusions and Recommendations for Future Studies_________ 
 202 
glutamate release was investigated in Chapter 4. The experimental results show that 
although QA enhances synaptosomal glutamate release, AC is not able to alter this. 
Interestingly, one of the effects of excitotoxicity is mitochondrial dysfunction. It was 
postulated that QA therefore causes mitochondrial dysfunction which results in energy 
failure. This in turn disrupts ionic gradients and the regulation of glutamate uptake is lost, 
leading to increased excitatory amino acid levels. The finding that AC has no effect on 
the QA-induced increase in glutamate release could possibly indicate that AC is not able 
to salvage mitochondrial respiratory function after a QA-induced excitotoxic insult. The 
effect of AC on mitochondrial function needs to be investigated further. 
 
A previous study demonstrated that activation of presynaptic NMDA autoreceptors may 
provide a positive rather than the usual negative feedback on presynaptic glutamate 
release in synaptosomal preparations (Breukel et al., 1998). This stimulating activity of 
QA at these specific receptors is thought to be another mechanism by which this 
neurotoxin elicits an increase in glutamate release. Despite AC belonging to the class of 
guanosine analogues, which are known to have antagonistic activity at the NMDA 
receptors (Tavares et al., 2005), it failed to reduce QA-induced glutamate release. It was 
suggested that this discrepancy occurred because Tavares and coworkers (2005) 
administered guanosine i.p. prior to the infusion of QA and thus, guanosine was already 
present to prevent the binding of QA. In this study, however, QA was infused 24 hours 
before initiation of the AC treatment and may have had more time to bind to presynaptic 
NMDA autoreceptors to elicit the response (glutamate release) before sufficient AC is 
present to inhibit the QA effect. To confirm this hypothesis, this experiment needs to be 
repeated with a change in the treatment regime, in which pre-treatment rather than post-
treatment of AC is administered. Even if the results of such a study do show that pre-
treatment of AC reduces glutamate release, it would not mean that pre-treatment is 
necessarily superior to post-treatment, since the former would likely prevent LTP from 
occurring at the postsynaptic NMDA receptor and therefore aggravate rather than 
improve spatial memory deficits.  
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Further studies also need to be conducted to determine the effect of AC on QA-induced 
inhibition of vesicular and astrocytic glutamate uptake. Since it is the increase in 
intracellular calcium levels which initiates the various cell responses to NMDA 
overstimulation, it may also prove useful to investigate the effect of AC on intracellular 
calcium levels and the binding of calcium ions. 
 
Oxidative stress is a state within cells where the generation of free radicals exceeds the 
capacity of the endogenous antioxidant defence system. Chapter 5 explores one such free 
radical, namely O2·- and one such endogenous antioxidant molecule, namely GSH. QA 
has the ability to induce oxidative stress primarily via the Ca2+-dependent events during 
excitotoxicity but may also act independently of NMDA stimulation.  
 
It was demonstrated that QA does not induce O2·- generation in rat brain homogenate in 
vitro which indicates that QA has no direct effect on the electron transport chain activity 
of the mitochondria from which most O2·- originates. This suggests that the ability of QA 
to cause mitochondrial dysfunction reported by Bordelon and coworkers (1997) is 
mediated by NMDA receptor overactivation (excitotoxicity). QA was added to 
homogenised tissue, in which the integrity of the cells is destroyed and thus unable to 
evoke a response to the NMDA overstimulation. Even though QA does not enhance the 
formation of O2·-, it is important to note that at the higher end of the concentration range, 
AC is able to reduce the amount of O2·- present under those conditions. The presence of 
this O2-· is not influenced by the NMDA stimulation associated with QA, which implies 
that the reduction in O2-· brought about by AC must be through its ability to scavenge this 
free radical, rather than prevention of its formation. The mechanism by which AC 
scavenges O2-· was proposed in section 5.2.4. 
 
QA injected intrahippocampally (in vivo) is able to induce a significant increase in O2·-. 
The ability of QA to cause mitochondrial dysfunction, via its perpetuating excitotoxic 
mechanism (chapter 4) may account for the QA effect on O2·-, although this needs to be 
investigated further. The dampening of the QA-induced increase in O2·- by AC is most 
likely primarily or even solely related to its capacity to scavenge this free radical, which 
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was described in the previous experiment. This is argued in the light of the doubt cast on 
AC being able to restore mitochondrial function or to act as an anti-excitotoxin when 
administered as post-treatment.  
 
GSH levels are diminished in the rat hippocampus after an intrahippocampal injection of 
QA. After the dismutation of O2·- to H2O2, it is reduced to H2O by GPx with GSH as a 
reducing agent. Therefore the effect of QA on GSH levels suggests that an inverse 
relationship exists between O2·- levels and GSH levels. GSH is known to have its own 
free radical scavenging properties. Therefore it may also become depleted through 
reaction with the various other free radicals produced during a QA-induced excitotoxic 
insult. AC treatment blunts the QA effect on GSH levels likely through its ability to 
scavenge O2·-. It may also be able to scavenge various other free radicals, such as HO· and 
thus reduce GSH depletion; this needs to be explored. Further investigations into the 
effect of AC, in the absence and presence of intrahippocampal QA on the activity of the 
antioxidant enzymes SOD, GPx and GR are also warranted. 
 
The mechanisms of neurodegeneration, particularly oxidative stress ultimately cause 
oxidative damage to lipid, protein and nucleic acid biomolecules of the cells, which 
directly or indirectly leads to neurodegeneration. Chapter 6 illustrates that QA 
significantly induces LP in rat brain homogenates in vitro and that AC suppresses this 
effect. It is thought that in vitro, QA enhances the HO·-producing Fenton reaction by 
forming a complex with Fe2+ which is more easily oxidisable than free Fe2+ is. The ability 
of AC to inhibit the Fenton reaction directly was assessed by conducting Fe2+-induced 
LP. AC once again has an inhibitory effect and therefore the ability of AC to reduce QA-
induced LP was speculated to be through binding of Fe2+ and / or Fe3+. AC also reduces 
QA-induced LP in vivo, which may occur in the presence of the free radicals generated 
from the QA-Fe complex or via NMDA-dependent excitotoxicity. The efficacy of AC in 
the in vivo experiment is thus possibly related to its ability to scavenge free radicals or to 
bind ferrous and / or ferric ions. AC has been shown to bind O2·- in Chapter 5. It was also 
argued that the in vivo results exhibited an inverse relationship to the degree of integrity 
of the cell membranes of the cell bodies of the hippocampal neurons in the histological 
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analyses (Chapter 3), which implied that the integrity of neural membranes in general is 
highly dependent on the degree of LP. To establish the nature of protection AC offers to 
biomolecules in its entirety, further studies should be conduced to determine its effects on 
the oxidation of proteins and nucleic acids. 
 
In view of the possibility that AC alleviates Fe2+-induced and QA enhanced Fe2+-induced 
LP through the chelation of ferrous and/or ferric iron, the purpose of Chapter 7 was to 
conduct iron chelation studies. The UV/VIS data demonstrates that AC interacts with 
both Fe2+ and Fe3+ and that the interaction with the latter is stronger. A mechanism of 
AC-metal complex formation was proposed. The AdCSVs from an electrochemical 
analysis confirm that AC interacts with Fe2+ and Fe3+ and that the latter interaction is 
stronger, forming a more stable complex. The results also indicated that QA, like AC 
interacts with Fe2+ to form comparatively weak, unstable complexes. The electrochemical 
analysis further characterised the redox potentials of the complexes in comparison to the 
free ferrous or ferric ions. It was concluded that the AC-Fe3+ and the QA-Fe2+ complexes 
are more difficult to reduce, but easier to oxidise than the respective free metal ion, whilst 
the opposite is observed for the AC-Fe2+ complex. These results thus provided an 
explanation for the inhibition of redox cycling of iron by AC complexation to ferrous and 
ferric ions and the enhancement of the oxidation of ferrous iron by QA complexation to 
Fe2+. In the last part of the chapter, the ferrozine assay was used to determine which 
ligand, QA or AC, has greater Fe2+ chelating activity. The results of the assay 
demonstrate that overall AC has a greater chelating activity, indicating that it is more 
likely to bind Fe2+ in the presence of both ligands and therefore provides an adequate 
explanation for the inhibition of QA-induced LP by AC (Chapter 6).  
 
The KP, in which the neurotoxin QA is produced endogenously, contains neuroactive 
intermediates derived from L-KYN, the primary degradation product of TRP. However, 
the KP does not only occur in the CNS, but in the periphery as well and the dynamics of 
the KP are such that there is interplay between KP metabolism in the periphery and the 
brain. The aim of Chapter 8 was to assess the effect of AC on the biosynthesis of QA by 
measurement of the activity of the enzymes which catalyse the first and last steps in the 
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conversion of tryptophan to QA, namely, TDO, IDO and 3-HAO. Since it is the blood-
borne L-KYN which drives the cerebral KP, TDO and IDO, which catalyse the 
conversion of TRP to L-KYN, were measured peripherally in the liver and small intestine 
respectively. Although cerebral QA can only be formed by 3-HAO from 3-HA in the 
brain, liver 3-HAO activity was used as a model of brain 3-HAO activity since the 
enzyme is present in greater abundance in the liver which simplifies the method of 
quantification required. There was merit in doing this because the there appears to be 
general accordance between 3-HAO in the brain and from peripheral sources.  
 
AC inhibits apoenzyme and total enzyme activity of TDO in vitro at 100 µM, but not at 
10 µM. The treatment of the animals with AC (5 mg/kg) decreases the apo-, holo- and 
total enzyme activity of TDO. It was proposed that AC most likely interferes with the 
conjugation of haeme to the apoenzyme by competitive inhibition, which explained the 
results of the in vitro studies. This argument was extended to the in vivo results where 
there is inhibition of endogenous and exogenous haeme and therefore blunting of the 
activity of both forms of the enzyme by AC. The competition between AC and haeme for 
binding to the apoenzyme needs to be explored further. Since stressors activate the HPA 
axis, causing the release of glucocorticoids which induce TDO, it may be interesting to 
assess the effect of AC on this phenomenon. This is particularly relevant because 
glucocorticoids regulate the LHPA axis by interacting with glucocorticoid receptors in 
the brain, including in the hippocampus.  
 
The cofactors, O2·- and Fe2+ are required for the activity of IDO and 3-HAO respectively, 
thus the activity of both enzymes is enhanced in the presence of the respective cofactors,  
in vitro and in vivo. AC inhibited the activity of both enzymes in the presence of the 
cofactors in vitro and in the absence and presence of the cofactors in vivo. The results 
were expected due to the O2·- scavenging and Fe2+ binding properties of AC demonstrated 
in previous chapters of this thesis. In a similar pattern to that of TDO inhibition, it was 
speculated that in vivo, AC exhibited these properties obliterating exogenous and 
endogenous cofactor. To confirm the findings of the studies in Chapter 8, the effect of 
AC directly on QA levels in the different regions of the brain need to be investigated.  
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The liver cytosolic enzyme, TDO is the major determinant of the levels of peripheral 
circulating TRP, therefore, the untoward effect of enhanced activity of TDO is not only 
an increase in blood-borne L-KYN for the biosynthesis of the neurotoxin QA, but it also 
reduces the availability of TRP for uptake into the brain, where it is utilised for the 
synthesis of the neurotransmitter serotonin. 5-HT has thus emerged as a dynamic, 
important brain neurotransmitter in normal brain function and the consequences of its 
abnormal synthesis, utilisation and metabolism are dire. Therefore, Chapter 9 
investigated the effect of AC on these aspects of the monoamine.  
 
AC (5mg/kg for 5 days) increases the 5-HT forebrain levels, but has no effect on the NE 
level which may have a role to play in stimulating 5-HT synthesis from TRP. It was 
therefore concluded that the inhibition of TDO and thus increased brain TRP levels is 
confirmed as the only and most likely mechanism of increased brain 5-HT levels by AC. 
AC also induces a rise in the forebrain 5-HIAA level which was attributed to the fact that 
there is increased forebrain 5-HT levels available as substrate for MAO and aldehyde 
dehydrogenase which oxidise 5-HT to 5-HIAA. However, despite this, 5-HT turnover 
was reduced, which implies that AC may have the potential to slow the metabolism of   
5-HT, thus maintaining the increased levels for longer. Increased 5-HT levels are known 
to have a role to play in aggression, therefore it would be interesting to assess whether 
AC could aggravate aggressive behaviour, using a rat model of aggression.  
 
The results of the pineal organ culture showed that AC treatment decreases the pineal 
level of 5-HT + 5-MT. It was hypothesised that this effect is related to an increased 
uptake and utilisation of 5-HT by the pinealocytes to form NAS and subsequently, aMT, 
which are both increased after AC treatment. It therefore appears that AC has a 
stimulatory rather than the expected inhibitory effect on 5-HT metabolism. Further 
investigation is required using a liquid-phase extraction method rather than TLC as a 
method of separation, to allow for total separation of the two indoleamines, 5-HT and 5-
MT, which could then be quantified individually. This would provide more conclusive 
results on the effect of AC on 5-HT uptake and utilisation by the pineal gland. An 
increase in the pineal level of 5-HTOH and a decrease in 5-HIAA is observed and is 
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thought to occur via one of two mechanisms; AC may have the ability to inhibit the 
activity of aldehyde dehydrogenase or to enhance the activity of alcohol dehydrogenase. 
Therefore, the direct effect of AC on the activity of these two enzymes needs to be 
investigated It was also concluded that the shunt in the serotonin metabolism pathway, 
such an effect on aldehyde dehydrogenase or alcohol dehydrogenase would cause, may 
also account for the reduced turnover of forebrain 5-HT to 5-HIAA.  
 
It was speculated that AC, in its triphosphorylated form may provide a constant supply of 
substrate for GTPase, thereby enhancing adenylate cyclase activity, which in turn 
increases cAMP levels, enhancing NAT activity and therefore increasing the NAS level. 
This postulate may be explored further by assessing the effect of AC on adenylate cyclase 
activity, cAMP levels and NAT activity in the pineal gland. The increase in NAS was 
however modest, possibly due to the reduced capability of AC to be phosphorylated in 
non-virulent cells. An increase in aMT follows an increase in NAS as there is more of the 
latter available for conversion to the neurohormone by the enzyme HIOMT. The effect of 
AC on NAS and aMT levels should be investigated in models of experimental HSE to 
determine whether this increase is more pronounced in the presence of virulent cells. An 
effect of AC on endogenous aMT levels formed from endogenous 5-HT is also 
warranted. 
 
This thesis points towards a possible neuroprotective role for AC and other guanosine 
derivatives and analogues in known memory impairing neurodegenerative disorders, such 
as AD or potential neurodegenerative disorders, such as HSE and depression.  
Excitotoxicity, oxidative stress, LP, accumulation of iron, the enhanced biosynthesis of 
QA and reduced biosynthesis of 5HT and aMT are reported to be commonly encountered 
in AD, HSE and depression. Therefore, these triggers and/or markers of 
neurodegeneration form the central themes around which this thesis is assembled. Each 
has ability to either directly or indirectly shift the neurodegenerative-neuroprotective 
balance towards neurodegeneration and the question which threaded these themes 
together was; to what extent, if any, could AC counter the one-sided effect and swing it 
towards neuroprotection?  
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It has emerged that AC has the potential to convincingly reduce oxidative stress, LP, iron 
levels and the biosynthesis of QA and to enhance the production of 5HT. Therefore, AC 
has direct neuroprotective effects and may be effective in AD, depression and HSE. The 
inhibition of TDO by AC indicates that the drug may prove very useful in negating the 
induction of this enzyme by glucocorticoids, released in response to activation of the 
LHPA axis by stressors in AD, depression and HSE, or by possible corticosteroid anti-
inflammatory therapy used in HSE. Thus the increased biosynthesis of QA and decreased 
5-HT, which may occur due to the action of glucocorticoids, is reduced. Through the 
amelioration of GSH levels, the binding of free iron and reducing the activity of IDO, AC 
may reduce proliferation of HSV-type 1 independent of its antiviral action, and in this 
manner accomplish an indirect neuroprotective effect in which reduced CNS viral load 
implies a reduced immune response and therefore reduced release of neurotoxic 
substances. These actions endow on AC additional mechanisms of action, other than its 
antiviral action which may contribute to its effectiveness in the treatment of HSE. 
 
The inhibition of 3-HAO comes with great risk, as it challenges the balance between 
neuroprotection and neurodegeneration. QA is the precursor of nicotinic acid which is 
used in the production of nicotinamide and ultimately NAD, which has a role to play in 
reversing ATP depletion in mitochondrial dysfunction. Thus, it can be concluded that 
inhibition of 3-HAO may adversely affect the ability of the CNS to replenish NAD in a 
cellular environment which may already be metabolically compromised, through 
mitochondrial dysfunction. Thus it may be necessary to take agents such as AC which 
inhibit the production of QA together with bioenergetic supplementation to curtail or 
prevent this effect. This needs to be investigated further. 
 
The effect of AC on reducing excitotoxicity and enhancing aMT was arguable and 
therefore inconclusive. It has emerged that the iron binding potential of AC may be a 
double-edged sword. Further investigations are warranted to assess the extent to which 
such iron deprivation may interfere with physiologically required levels of iron. This may 
contribute to “sickness behaviour” and anaemia particularly in patients already 
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predisposed to or exhibiting such signs and symptoms. If these speculations are 
confirmed, AC may not be the safest effective drug in such patients. 
 
The next step forward may well be to continue preliminary animal studies, with the same 
or similar research objectives set out in this research project together with the 
recommended studies using more specific models of experimental HSE, AD and 
depression. Furthermore, it may also be worth comparing the effects of AC and other 
guanosine analogues and derivatives, so that structure-activity relationships with respect 
to neuroprotective properties can be generated. For example, it would be interesting to 
compare the neuroprotective effects of AC and guanine to determine the role that the 
acyclic chain plays in imparting these properties to AC. 
 
Pharmaceutical companies invest millions every year bringing novel drug molecules to 
phase I clinical trials for neurodegenerative disorders, whilst before them may lie a 
plethora of effective, registered drugs like the prototype, AC. After success in further 
preliminary animal studies, the advancement of such drugs directly to phase II or III 
clinical trials may be advocated since after years of use, the pharmacokinetic and safety 
profiles of these are already well established. This may assist in making the search for 
treatment of these debilitating disorders far more cost-effective.  
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APPENDIX II 
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APPENDIX III 
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APPENDIX IV 
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